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ABSTRACT OF THE DISSERTATION
RBPjκ-Independent, NICD-Dependent Signals in Rbpj-/- Hair Follicle Keratinocytes
Cause a Milder Phenotype in RBPjcKO Animals
by
Mustafa Turkoz
Doctor of Philosophy in Biology and Biomedical Sciences
Developmental, Regenerative and Stem Cell Biology
Washington University in St. Louis, 2014
Prof. Raphael Kopan, Chairperson

Notch is a membrane-bound transcription factor that mediates signals between adjacent
cells. It is the central member of a highly conserved pathway that is important for proliferation,
cell fate decisions, and apoptosis not only during development, but also in adulthood acting
either in stem cell maintenance or differentiation. In the skin, Notch is essential for epidermal
differentiation, maintenance of hair follicle morphology and terminal differentiation of the inner
and outer root sheath cells. Ligand-dependent activation, γ -secretase-dependent cleavage, and
RBPjκ-mediated downstream transcriptional activities of Notch receptors constitute the
“canonical” Notch signaling pathway. This implies that loss of γ -secretase (no Notch
Intracellular Domain (NICD) release), Notch receptors (no NICD), or RBPjκ (no activation of
downstream targets) should generate similar phenotypes based on the canonical model.
Unexpectedly, keratinocyte-specific deletion of Rbpj gene (RBPjcKO) produced a significantly
milder phenotype than the keratinocyte-specific deletion of both Notch1 and Notch2 genes
(N1N2dcKO) or Presenilin1 and Presenilin2 genes (PSdcKO). Based on these observations, we
xiv	
  

sought to determine the underlying mechanisms and investigated the potential role of noncanonical Notch signaling in generating these phenotypic differences.
First, we characterized N1N2dcKO, PSdcKO, and RBPjcKO embryonic skin. We found
that all these mutants are similar at birth with no significant differences in the gross morphology
of their epidermis and hair follicles as well as mRNA and protein expression patterns.
Secondly, we genetically dissected the Notch signaling pathway to define the elements
ameliorating the phenotype. We showed that even a limiting amount of cleaved Notch1ICD is
sufficient for the milder phenotype observed in RBPjcKO animals.
Lastly, we showed that the loss of Notch signaling in the hair follicles drives the severe
phenotypes in PSdcKO and N1N2dcKO animals. Although the levels of epidermal TSLP
expression are similar in all Notch mutants, RBPjcKO hair follicles are less distorted and
produce less TSLP leading to lower serum TSLP levels. The reduced TSLP in serum results in
less aggressive B cell expansion allowing RBPjcKO animals to live significantly longer than
N1N2dcKO and PSdcKO animals. In conclusion, γ -secretase cleaved Notch1ICD likely
stimulate RBPjκ-independent signals in the Rbpj-/- hair follicle keratinocytes causing a milder
phenotype in RBPjcKO animals. Future experiments will interrogate whether RBPjκindependent NICD activity directly generates a different transcriptional response or affects other
signaling pathways.
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CHAPTER I

INTRODUCTION

Author Contribution
The author wrote the text and prepared the figures in this chapter.
1

Multicellular organisms start their life as a single cell that is capable of giving rise to
every cell type in the entire organism. During the transition from single cell to multicellular
organism, cells proliferate, interact with their environment and each other, migrate, specialize,
and even die in a precise manner to form organs. All of these cellular events require tightly
regulated communication between cells. These highly complicated interactions and
communications are mediated by signaling pathways. Notch, first described in 1914 by John S.
Dexter, is the receptor for one of the major pathways. The Notch signaling pathway is essential
for many processes during development of metazoans. This dissertation mainly focuses on a
novel role for Notch signaling during mouse hair follicle development.
Notch Signaling
The Notch signaling pathway, conserved from metazoans to mammals, has been shown
to be important for many different cellular functions including proliferation, cell fate decisions
and apoptosis, not only during development, but also during adult stage for stem cell
maintenance and differentiation (Artavanis-Tsakonas et al., 1995; Gridley, 1997; Weinmaster,
1997; Greenwald, 1998; Artavanis-Tsakonas et al., 1999; Miele and Osbourne, 1999; Radtke and
Raj, 2003; Dang, 2012). At present, two receptors (Glp-1 and Lin-12) in C.elegans; one receptor
(Notch) in Drosophila melanogaster, and four receptors (Notch 1-4) in mammals have been
identified for this signaling pathway (Favier, 2000; Katoh 2007). Notch receptors are classified
as type I transmembrane proteins (~300 kDa) that contain a large extracellular domain (ECD),
one transmembrane domain (TMD), and intracellular domain (ICD) (Figure 1-1; Kopan and
Ilagan, 2009). Receptor activation is mediated by the DSL (Delta and Serrate in Drosophila,
Lag2 in C.elegans) family of ligands that are expressed on the surface of neighboring cells
(Figure 1-1 & Figure 1-2). Mammals have 5 DSL ligands: Delta-like 1,3, and 4, and Jagged 1
2

and 2 (Figure 1-1).
Ligand binding triggers a conformational change in the Notch receptors exposing the
negative regulatory region in the Lin12-Notch Repeats (LNR) and heterodimerization domain of
the receptor (Figure 1-1). This allows the enzymatic cleavage by ADAM/TACE (a disintegrin
and metalloprotease/TNF-α converting enzyme) family proteins at the S2-cleavage site within
the heterodimerization domain (Figure 1-1 & Figure 1-2). S2 cleavage generates the substrate for
γ-secretase (multi-subunit protease complex consisting of PSEN1, PSEN2, nicastrin, APH-1, and
PEN-2; Kaether et al., 2006), which further cleaves Notch at the S3 and S4 sites within the
transmembrane domain of the receptor (Figure 1-1 & Figure 1-2). S3-cleavage is a critical step in
the activation of the pathway, since it liberates the Notch intracellular domain (NICD) (Schroeter
et al., 1998). NICD then translocates to the nucleus, where it interacts its DNA-binding partner,
CSL (CBF1/RBPjκ in mammals, Suppressor of Hairless in Drosophila melanogaster, Lag1 in
C.elegans) (Lecourtois et al., 1997). CSL normally functions as a repressor via interacting with
and/or recruiting SKIP, SMRT, CoR, and HDAC proteins to form a transcriptional repressor
complex (Kao et al., 1998; Zhou et al., 2000; Zhou and Hayward, 2001). NICD binding
transforms CSL into a transcription activator by dissociating repressor complex and recruiting
the coactivators such as Lag-3/mastermind, p300/CBP, and PCAF/GCN5 (Schuldt and Brand,
1999; Petcherski and Kimble, 2000; Oswald et al., 2001; Kurooka and Honjo, 2000; Wallberg et
al., 2002) to initiate target gene transcription of basic helix-loop-helix (bHLH) transcription
factors such as Hairy Enhancer of Split (HES) and HES-related proteins (Jennings et al., 1994;
Jarriault et al., 1995; Nellesen et al., 1999; Bessho et al., 2001; Iso et al., 2003; Fischer et al.,
2004). This linear pathway is called the canonical Notch signaling pathway (Figure 1-2).
To keep the terminology simple, I will use mammalian homolog names of Notch
3

signaling components (i.e. Delta 1,3,4 and Jagged 1,2; Notch 1-4, and RBPjκ) for the rest of
this dissertation.
Non-canonical Notch Pathway
Although canonical Notch signaling is well established and essential for many processes,
several studies have suggested a possibility of non-canonical Notch signaling (Shawber et al.,
1996; Wang et al., 1997; Giniger, 1998; Zecchini et al. 1999; Dumont et al., 2000; Ramain et al.,
2001; Berechid et al., 2002; Crowner et al., 2003; Brennan and Gardner, 2002; Demehri et al.,
2008; Le Gall et al., 2008; Sanders et al., 2009; Acosta et al., 2011; Kwon et al., 2011;). The
simplest description of canonical Notch signaling entails DSL ligand-dependent activation of the
Notch receptors, cleavage by γ-secretase and transcription mediated by RBPjκ. Those pathways
not conforming into the prototypical linear pathway scheme would be considered as noncanonical Notch signaling, which can be divided into four major different sub-categories:
a) Delta/Jagged-independent activation of Notch receptor
In this category of the non-canonical pathway, activation of Notch receptor is mediated
by other ligands (Table 1-1 = D’Souza et al., 2008) such as F3/Contactin1 (Hu et al., 2003), NB3 (Cui et al., 2004) or Delta/Notch-like EGF-related receptor (DNER) (Mukherjee et al., 2005),
but not by canonical DSL family ligands. However, in this type of non-canonical signaling, the
cleavage is still controlled by γ-secretase. After liberation of NICD from the cell membrane,
NICD translocates to the nucleus and upregulates gene expression in an RBPjκ-dependent or
independent (Hu et al., 2003) manner (Table 1-1).
b) Ligand Back Signaling
Notch ligands, Delta and Jagged, also undergo proteolytic cleavages mediated by
ADAM/TACE (Qi et al., 1999) and γ-secretase (Ikeuchi & Sisodia, 2003; LaVoie & Selkoe,
4

2003; Bland et al., 2003; Six et al., 2003; Zolkiewska, 2008) upon receptor-ligand engagement.
The cleavages of Delta/Jagged are thought to result in the production of a Ligand Intracellular
Domain (LICD) that can translocate into the nucleus to mediate signal transduction in ligandpresenting cells (Ikeuchi & Sisodia, 2003; LaVoie & Selkoe, 2003; Duryagina et al., 2013; Bland
et al., 2003; Six et al., 2003; Kolev et al., 2005).
c) Cleavage-independent receptor-dependent non-canonical Notch Signaling
In this model of non-canonical signaling, the activation of Notch receptors does not
involve ligands and/or γ-secretase. A membrane-bound, uncleaved form of the receptor at the
cell membrane/endosomal compartment mediates a non-canonical function of the receptor.
Corbin’s group proposed a role for non-canonical Notch in muscle precursor fate determination
(Rusconi and Corbin, 1998; Rusconi and Corbin, 1999); however the molecular nature of this
function is still unknown. Martinez Arias’ group and Srivastava’s group suggested interaction
between Notch and Wnt pathways (Brennan et al. 1999) involving a negative regulation of
Armadillo/β-catenin. They claim that Axin and Apc involve in the trafficking of Notch receptor
and compromising Notch trafficking elevates the activity of activated form of Armadillo
(Hayward et al., 2005; Sanders et al., 2009; Muñoz-Descalzo et al., 2011; Kwon et al., 2011). In
addition, Martinez Arias’ group also claimed another function of uncleaved-Notch inducing
downregulation of JNK activity (Zecchini et al. 1999)
d) NICD-dependent, RBPjκ-independent non-canonical Notch Signaling
In this type of non-canonical signaling, DSL ligand activation and γ-secretase dependent
cleavage are required but interaction with DNA binding partner, RBPjκ, is not necessary to
accomplish the function of the NICD. Many different labs have showed evidence for this
pathway. Although some those studies did not provide a specific mechanism (Shawber et al.,
5

1996; Nofziger et al., 1999; Mizutani et al., 2007), others suggest involvement of Deltex
(Ordentlich et al., 1998; Ramain et al., 2001; Yamamoto et al., 2001; Endo et al., 2002; Endo et
al., 2003; Hu et al., 2003; Hori et al., 2004), Ras (Hodkinson et al., 2007), β-catenin (Acosta et
al., 2011) or Rho/ROCK pathways (Yugawa et al. 2013).
Skin Development in mammals
Skin is the largest organ of the body in mammals covering the entire surface and
functioning as a sensory organ and a protective barrier not only blocking harmful insults and
dangerous threats from outside but also preventing water loss from inside out.
The major components of mammalian skin are the epidermis (four layers of epithelium),
the epidermal appendages (e.g. hair follicles, sebaceous glands, sweat glands, mammary glands),
and the dermis (Figure 1-3A). During early embryogenesis, surface ectoderm gives rise to the
epidermis and epidermal appendages, whereas dermis is derived from mesoderm.
Epidermal Development in mammals
Mouse epidermal development begins around embryonic development day E8.5 - E9
from a single layer of ectodermal cells called surface ectoderm (Figure 1-3B). Surface
ectodermal cells, expressing markers keratin 8 (K8) and K18, start to express K6 and K17 to give
rise to periderm, an outer layer of epithelial cells (Figure 1-3B). Periderm is a transitory
embryonic tissue that sheds off when epidermal differentiation is completed (McGowan and
Coulombe, 1998; Sanes et al., 1986; M’Boneko and Merker, 1988). At the same time (E8.5-E9),
some of the K8 and K18 positive ectodermal cells initiate the epidermal cell fate program by
turning on the expression of K5 and K14 genes (Fuchs, 2007; Koster and Roop, 2007; Nagarajan
et al., 2008). By E13, the progenitors, K5 and K14 positive epidermal basal cells cover the entire
embryo in a single layer and are ready to initiate the epidermal differentiation program (Figure 16

3B). Subsequently, at around E13.5 some of the basal keratinocytes lose their contact with the
basement membrane and migrate towards the outer layer where they begin to express the spinous
cell markers, K1 and K10 (Fuchs and Green, 1980; Byrne et al., 1994) (Figure 1-3B). Around
E16.5, spinous cells continue to further differentiate and express loricrin, filaggrin, and
transglutaminase, which are the markers for granulocytes (Figure 1-3B; Rothnagel et al., 1987).
These specific markers are involved in the maturation of cornified layer, which serves as the
protective barrier for the organism (Segre, 2006). By E18.5, epidermal differentiation is
completed and all four layers of epidermis (basal layer, spinous layer, granular layer, and stratum
corneum) are formed with a precise balance between proliferation and differentiation (Figure 13B; Blanpain and Fuchs, 2009).
Function of Notch Signaling during Epidermal Development
Activation of Notch receptors has been shown to be critical for cell cycle exit and
keratinocyte differentiation (Lowell et al., 2000; Nickoloff et al., 2002; Rangarajan et al., 2001;
Blanpain et al., 2006; Moriyama et al., 2008). Notch1 and Notch3 receptors are detectable in the
basal layer at E13.5 and in suprabasal layers after E14.5, whereas expression of Notch2 receptor
can be detected after E14.5 only in suprabasal layers (Figure 1-3D; Romano et al., 2012). Also,
Jagged1 expression is restricted to the suprabasal layer; in contrast Jagged2 is detected in the
basal cells (Powell et al., 1998)
During the early stage of epidermal differentiation, activated Notch1 inhibits growth in
basal cells by activating p21WAF1/Cip1 expression in an RBPjκ-dependent manner (Rangarajan et
al., 2001). Notch1 activation in basal cells results in the downregulation of integrin α3/β1 and
α6/β4 expression and loss of contact with the basement membrane, whereas Notch activation in
spinous cells causes increased expression of early differentiation markers such as involucrin, K1
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and K10 and suppression of late markers, loricrin and filaggrin (Rangarajan et al., 2001;
Blanpain et al., 2006). The Notch-mediated induction of differentiation mechanisms in basal
cells are controversial in terms of RBPjκ-dependence. Rangarajan et al. (2001) have proposed
that activation of Notch1 or Notch2 can induce involucrin and K1 through an RBPjκindependent mechanism, however Blanpain et al. (2006) have demonstrated that these inductions
are RBPjκ and Hes1-dependent.
Hair Follicle Development in mammals
Hairs are one of the distinguishing characteristics of mammals. They function as a
protective barrier from harmful external insults, conserve the body temperature from extreme
temperature changes, serve as a sensory organ and provide a camouflaging coat. Mammalian hair
follicles are formed during embryonic development and undergo cycles of growth (anagen),
regression (catagen), and rest (telogen) throughout the lifespan of the animal. In this dissertation,
I will focus more on the hair follicle morphogenesis since the phenotypes we are investigating
manifest before the second hair cycle starts. Mouse hair follicles develop in three major waves
during embryonic development:
•

Guard Hair - Primary Hair Follicles: are formed starting from E13.5. (1-5% of hair coat)

•

Awl Hair - Secondary Hair Follicles: are formed starting from E16-17 (~25%)

•

Zig-Zag Hair - Third Wave: produces the tertiary placodes around E18.5 (~70%)
Morphogenesis of mouse hair follicles depends on reciprocal interactions between

epithelial and mesenchymal cells (Sengel and Mauger, 1976; Hardy, 1992). Although earlier
studies on skin development claimed that an unknown signal from the dermis is necessary to
initiate hair follicle induction (Dhouailly, 1973; Hardy 1992), the signals first identified to be
required for mouse hair follicle induction were Wnt signals (Wnt2, 7b, 10a, and 10b) emanating
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from epidermal keratinocytes around E12.5-E13.5 (Noramly et al., 1999; Millar, 2002; SchmidtUllrich and Paus, 2005; Fuchs, 2007; Fu et al., 2013). These and additional Wnt ligands (Wnt3,
4, and 6) collectively activate Wnt/β-catenin signaling initially in the upper dermis (DasGupta et
al., 1999; Fu et al., 2013), then within the future hair placode epithelium (Fuchs, 2007; Fu et al.,
2013), and lastly in the dermal fibroblasts (Yang et al., 2012). Deletion of β-catenin in the basal
(K5+/K14+) keratinocytes inhibits hair placode formation (Huelsken et al., 2001). The main
function of the Wnts in the ectoderm is to inhibit Fibroblast Growth Factor (FGF) activity,
thereby allowing increased levels of Bone Morphogenetic Protein (BMP) to induce the epidermal
cell fate program (Stern, 2005; Fuchs, 2007).
Epithelial cells that receive Wnt signals turn on the expression of Ectodysplasin-A (EDA)
and its receptor, EDAR (Durmowicz et al., 2002; Laurikkala et al., 2002). The combination of
Wnt/β-catenin and EDA/EDAR activation in epithelial cells regulates expression of FGF20,
which leads to reorganization of the underlying mesenchyme (Huh et al., 2013). All of these
events trigger an epithelial thickening by downregulating E-cadherin expression (Jamora et al.,
2003), condensation of dermal fibroblasts and induction of the hair follicle placode formation
around E13.5 (Figure 1-3C; Hardy, 1992). The EDA/EDAR signaling pathway has been shown
to be critical for primary hair placode induction and regulating hair follicle density (Mou et al.,
2006; Pummila et al., 2007). It controls these processes in three major steps: (1) stabilization of
β-catenin, thus controlling the expression pattern of Wnt/β-catenin pathway (Mou et al., 2006),
(2) activation of NF-κB pathway at day E14.5 (Schmidt-Ullrich et al., 2006) and (3) activation of
Sonic Hedgehog (Shh) through EDAR-associated death domain (EDARADD) and NF-κB
(Tucker et al., 2000; Laurikkala et al., 2002; Pummila et al., 2007; Cui et al., 2011). Shh from
epithelial cells activates Noggin expression in the dermal fibroblasts condensing beneath the
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placode where Noggin carries out two important functions: (1) suppressing BMP signals in the
epithelial cells (Mou et al., 2006; Pummila et al., 2007), and (2) activating Lef1 gene expression
within placodes in combination with Wnt/β-catenin signaling (Botchkarev et al., 1999;
Botchkarev et al., 2002; Jamora et al., 2003; Liu et al., 2004). Noggin and Lef1 have been shown
to be critical for secondary hair follicle formation, since Noggin-/- or Lef1-/- animals can initiate
primary hair follicles, but secondary hair follicle induction is completely blocked (van Genderen
et al., 1994; Botchkarev et al., 2002).
After placode formation, epithelial cells start to invaginate towards the mesenchyme to
form hair germ at around E15.5 (Figure 1-3C; Hardy, 1992). Shh and NF-κB signals are essential
for epithelial proliferation and invagination, however they are not crucial for earlier induction
events (Dahmane et al., 1997; St-Jacques et al., 1998; Xie et al., 1998; Grachtchouk et al., 2000;
Mill et al., 2003; Huntzicker et al., 2006). Shh-/- skin can form the hair placodes similar to wt
skin; however due to the disrupted epithelial-mesenchymal crosstalk, hair placodes have
impaired proliferation and invagination (Mill et al., 2003). In summary, Wnt/β-catenin, FGF,
Shh, TGF-β/BMP and Eda/Edar/NF-κB signaling pathways together regulate early steps of hair
morphogenesis and are essential for proper induction of hair follicles during embryonic
development (St-Jacques et al., 1998; Botchkarev et al. 1999; Headon and Overbeek; 1999;
Huelsken et al., 2001; Zhang et al., 2009; Woo et al., 2012;).
The reciprocal exchange of additional signals leads to hair placode growth downwards to
form the hair germ around E15.5, the hair peg around E17.5 and the hair bulb around E18.5 for
the primary hair follicles (Figure 1-3C; Hardy, 1992). The highly proliferative leading edge
composed of the growing epithelial cells is called the matrix. These epithelial cells migrate
downwards, surround the mesenchymal cells (dermal papilla) and form the hair bulb (Figure 110

3C; Sengel and Mauger, 1976; Hardy, 1992). The dermal papilla functions as an inductive center
for follicular growth and differentiation, not only during morphogenesis, but also for hair cycles
during the adult stage (Hardy, 1992). Epithelial cells constantly interact with the dermal papilla
and eventually give rise to seven terminally differentiated cell types. The outermost layer of cells
constitutes the outer root sheath (ORS), which is continuous with the epidermis (Figure 1-3G).
The next three layers of cells (Henle’s Layer, Huxley’s layer, and IRS cuticle) collectively form
the inner root sheath (IRS) (Figure1-3G). The innermost three layers of cells (cuticle, cortex and
medulla) make up the hair shaft. (Figure 1-3G)
Hair follicle stem cells reside in the bulge (Figure 1-3C), an adjacent compartment of the
hair follicles, contribute to reconstruction of the hair follicles during the anagen phase of the
adult hair cycles (Cotsarelis et al., 1990)
Notch Function during Hair Follicle Development
During embryonic development, Notch1 mRNA (Kopan and Weintraub, 1993; Powell et
al., 1998) and protein (Figure 1-3D) expression can be observed as early as at E13.5 in the single
layer of epidermis, thereupon in the epidermal cells within the hair placode (E13.5-E14.5), and
inner cells of the epidermal invaginations (E15.5-E16.5). However, mesenchymal cells do not
express Notch1 (Powell et al., 1998) and Notch2 is not expressed in embryonic hair follicle cells
(Favier et al., 2000). Delta1 protein expression is restricted to the mesenchymal cells within the
bulb of dermal papilla (Powell et al., 1998). Jagged1 and Jagged2 mRNA expression overlaps
with Notch1 transcripts in the embryonic hair follicle (Powell et al., 1998).
In neonatal hair follicles, Notch1 mRNA is found throughout the hair matrix cells and
Notch2 mRNA in IRS cells, whereas Notch3 protein is detected in precursor cells, differentiating
cortex, and cuticle cells (Figure 1-3F, G; Pan et al., 2004; Kopan and Weintraub, 1993; Powell et
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al., 1998). Delta1 expression disappears from the dermal papilla in adult hair follicles (Estrach et
al., 2008). Jagged1 and Notch1expression are co-localized in the upper follicle bulb, whereas
Jagged2 is detected in the inner bulb cells (Figure 1-3F,G; Powell et al., 1998) The Jagged1Notch1 expression pattern is consistent with their role in regulating the differentiation of bulb
matrix cells into hair shaft cortical and cuticle cells (Figure 1-3F,G; Powell et al. 1998)
Loss-of-function and gain-of-function studies suggest that Notch signaling is not essential
for hair follicle induction, invagination, nor the formation of hair peg and hair bulb (Lin et al.,
2000; Yamamoto et al., 2003; Pan et al., 2004; Uyttendaele et al., 2004; Blanpain et al., 2006;
Estrach et al., 2006; Moriyama et al., 2006; Ambler and Watt, 2007; Lee et al., 2007; Estrach et
al., 2008; Demehri et al., 2009). Interestingly, Notch pathway conditional-knock-out (cKO)
animals are similar compared to the wild-type (WT) animals in their number and distribution of
hair follicles (Blanpain et al., 2006; Demehri et al., 2009; Estrach et al., 2006; Lee et al., 2007;
Pan et al., 2004; Yamamoto et al., 2003; Estrach et al., 2008; Vauclair et al., 2005). Moreover,
the loss-of-Notch pathway components does not interfere with the expression patterns of
signaling pathways (e.g. Wnt/β-catenin, FGF, Shh, TGF-β/BMP and EDA/EDAR/NF-κB) that
participate in early placode formation and/or embryonic hair follicle development (Vauclair et
al., 2005).
Even though Notch signaling is not required for embryonic development of hair follicles
(i.e. initial induction, specification and differentiation), it does have a function in maintenance of
follicular morphology (Pan et al., 2004) and hair follicle terminal differentiation (Blanpain et al.,
2006). A complete loss-of-Notch signaling in hair follicle keratinocytes causes failure of IRS
cellular identity as well as aberrant activation of the epidermal differentiation program in ORS
cells, ultimately leading to the conversion of hair follicles into epidermal cysts (Pan et al., 2004).
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Besides these functions in the mature hair follicles, Notch controls the expression of
Wnt5a through canonical signaling in dermal papilla cells (Hu et al., 2010). Wnt5a from dermal
papilla cells acts on hair keratinocytes and turns on FoxN1 (Hu et al., 2010), a key hair follicle
differentiation gene (Mecklenburg et al., 2001).
Consequences of loss-of-Notch Signaling in the epidermal keratinocytes
To investigate the role of Notch signaling during mouse epidermal and hair follicle
morphogenesis, we have utilized Msx2-Cre transgene-mediated deletion of Notch signaling
components in skin keratinocytes (Pan et al., 2004; Lee et al., 2007; Demehri et al., 2008). Msx2
minimal promoter-controlled expression of Cre starts around E9.5 (Sun et al., 2000) within a
cluster of cells in the primitive ectoderm, generating a chimeric pattern of deletion in the dorsal
and ventral midline (Figure 1-4A; Demehri et al., 2008; Demehri et al., 2012).
Previous studies showed that keratinocyte-specific deletion of total Notch signaling
causes differentiation defects in the epidermis (Figure 1-4B&C; Rangarajan et al., 2001; Pan et
al., 2004; Blanpain et al., 2006; Demehri et al., 2008) and impaired hair follicle morphology
manifested by loss of IRS cellular identity and activation of epidermal differentiation program in
ORS cells (Pan et al., 2004; Demehri et al., 2008). These skin perturbations collectively induced
the expression of thymic stromal lymphopoietin (TSLP) in suprabasal keratinocytes (Figure 14D; Demehri et al. 2008) and in defective ORS cells within the epidermal cysts (Figure 1-4E;
Demehri et al., 2008). TSLP is a cytokine that has critical roles in immune cells during T-cell
development and maturation (Omori et al., 2007; Rochman et al., 2008), B-cell development and
differentiation (Scheeren et al., 2010), and activation of antigen presenting cells (Ziegler et al.,
2013). Secretion of TSLP into the systemic circulation induces proliferation of pre-B cells
originating from the fetal liver (Demehri et al., 2008). Eventually this hyperproliferation of
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immature B cells results in B-cell Lymphoproliferative Disease (BLPD) in mutant animals,
leading to their death around 30 days (Figure 1-4G&F; Demehri et al., 2008).
As canonical Notch signaling is thought to be a linear pathway, one would expect that the
loss of γ-secretase (no NICD release), Notch receptors (no NICD) or RBPjκ (no activation of
downstream targets) should generate similar phenotypes. Unexpectedly, keratinocyte-specific
deletion of Rbpj gene (RBPjcKO) produced a significantly milder phenotype than the
keratinocyte-specific deletion of both Notch1 and Notch2 genes (N1N2dcKO) or both
Presenilin1 and Presenilin2 genes (PSdcKO). Measurable differences in four phenotypes have
been observed (Demehri et al, 2008).
1. Lifespan: N1N2dcKO and PSdcKO animals die around P25-P30, while RBPjcKO
animals can live on average for 150 days. (Figure 1-4G)
2. White Blood Cell (WBC) Counts: N1N2dcKO and PSdcKO animals have 100k/ul
WBC counts, whereas RBPjcKO animals have significantly lower (~25k/ul) WBC counts
(Figure1-4G).
3. Serum TSLP Levels: Both N1N2dcKO and PSdcKO animals have very high serum
TSLP levels (>5ng/mL) on average; however, RBPjcKO animals exhibit significantly
lower (~0.65ng/mL) serum TSLP levels (Figure 1-4G).
4. Total skin morphology of RBPjcKO animals is significantly different from that of the
N1N2dcKO or PSdcKO animals (Figure 1-4G). RBPjcKO skins contain less hair follicle
cysts and immune-cell infiltration into the mutant skin is much less compared to the other
mutants.
Based on these differential phenotypes, we hypothesized that RBPjκ-independent signals
may be responsible for these differences. We investigated the possibility of non-canonical Notch
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signaling playing a role in these phenotypic differences. In Chapter II, we will characterize the
N1N2dcKO, PSdcKO, and RBPjcKO mutants and showed that at birth, they are similar and have
no significant differences in the gross morphology of their epidermis and hair follicles as well as
mRNA and protein expression pattern. In Chapter III, we will dissect the Notch signaling
pathway to find the necessary elements for the RBPjκ-independent phenotype and showed that γsecretase generated Notch1ICD molecule is necessary and sufficient to trigger a milder
phenotype in RBPjcKO animals. In Chapter IV, we will provide evidence that levels of
epidermal TSLP expression are similar in all Notch mutants. RBPjcKO hair follicles are less
distorted and hence produce less TSLP. This, in turn, leads to less serum TSLP levels in
RBPjcKO animals. A milder BLPD allows them to live significantly longer than N1N2dcKO and
PSdcKO animals. In conclusion, NICD molecules likely stimulate RBPjκ-independent signals in
the Rbpj-/- hair follicles thereby causing a milder distortion hair follicle phenotype in RBPjcKO
animals.

15

REFERENCES:
Acosta H, Lopez SL, Revinski DR, Carrasco AE. (2011) Notch destabilises maternal β-catenin
and restricts dorsal-anterior development in Xenopus. Development, 138 (12) , pp. 25672579.
Ambler CA, Watt FM. (2007) Expression of Notch pathway genes in mammalian epidermis
and modulation by beta-catenin. Dev Dyn, 236(6):1595-601.
Artavanis-Tsakonas S, Matsuno K, Fortini ME. (1995) Notch signaling. Science; 268(5208)
pp.225-32. Review.
Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999) Notch signaling: cell fate control and signal
integration in development. Science 284(5415), pp. 770-6. Review.
Barrick D, Kopan R. (2006) The Notch transcription activation complex makes its move. Cell
124(5):883-5.
Berechid BE, Kitzmann M, Foltz DR, Roach AH, Seiffert D, Thompson LA, Olson RE,
Bernstein A, Donoviel DB, Nye JS. (2002) Identification and characterization of presenilinindependent Notch signaling J. Biol. Chem., 277, pp. 8154–8165
Bessho Y, Miyoshi G, Sakata R, Kageyama R. (2001) Hes7: a bHLH-type repressor gene
regulated by Notch and expressed in the presomitic mesoderm. Genes Cells, 6 , pp. 175–185
Bland CE, Kimberly P, and Rand MD. (2003) Notch-induced proteolysis and nuclear
localization of the Delta ligand, J. Biol. Chem. 278, pp. 13607–13610.
Blanpain C, Lowry WE, Pasolli HA, Fuchs E. (2006) Canonical notch signaling functions as a
commitment switch in the epidermal lineage. Genes Dev 20: 3022–3035.
Blanpain C, Fuchs E. (2009) Epidermal homeostasis: a balancing act of stem cells in the skin.
Nat Rev Mol Cell Biol. 10(3):207-17. Review.
16

Brennan K, Baylies M, Arias AM (1999) Repression by Notch is required before Wingless
signalling during muscle progenitor cell development in Drosophila. Curr Biol, 9 (13), pp.
707-10.
Brennan K. and Gardner P. (2002) Notching up another pathway. BioEssays, 24, pp. 405–410
Botchkarev VA, Botchkareva NV, Roth W, Nakamura M, Chen LH, Herzog W, Lindner G,
McMahon JA, Peters C, Lauster R, McMahon AP, Paus R. (1999) Noggin is a mesenchymally
derived stimulator of hair-follicle induction. Nat Cell Biol, 1(3):158-64.
Botchkarev VA, Botchkareva NV, Sharov AA, Funa K, Huber O, Gilchrest BA. (2002)
Modulation of BMP Signaling by Noggin is Required for Induction of the Secondary
(Nontylotrich) Hair Follicles. J. Invest. Dermatol 118:3–10.
Byrne C, Tainsky M, Fuchs E. (1994) Programming gene expression in developing epidermis.
Development.120(9):2369-83.
Cotsarelis G, Sun TT, Lavker RM. Label-Retaining Cells Reside in the Bulge Area of
Pilosebaceous Unit: Implications for Follicular Stem Cells, Hair Cycle, and Skin
Carcinogenesis. Cell, 61 (1990), pp. 1329–1337
Crowner D, Le Gall M, Gates MA, Giniger E. (2003) Notch steers Drosophila ISNb motor
axons by regulating the Abl signaling pathway. Curr. Biol., 13, pp. 967–972
Cui XY, Hu QD, Tekaya M, Shimoda Y, Ang BT, Nie DY et al. (2004) NB-3/Notch1 pathway
via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol
Chem 279: 25858–25865.
Cui C-Y, Kunisada M, Childress V, Michel M, Schlessinger D. (2011) Shh is required for
Tabby hair follicle development. Cell Cycle 10: 3379–3386.

17

Dahmane N, Lee J, Robins P, Heller P, Altaba AR. (1997) Activation of the transcription
factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature, 389, 876–
881.
Dang TP. Notch, apoptosis and cancer. Adv Exp Med Biol. 2012;727:199-209.
DasGupta R, Fuchs E. (1999) Multiple roles for activated LEF/TCF transcription complexes
during hair follicle development and differentiation. Development, 126, 4557–4568.
Demehri S, Liu Z, Lee J, Lin MH, Crosby SD, Roberts CJ, Grigsby PW, Miner JH, Farr AG,
Kopan R. (2008) Notch-deficient skin induces a lethal systemic B-lymphoproliferative
disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol. May 27;6(5):e123.
Demehri S, Kopan R. (2009) Notch signaling in bulge stem cells is not required for selection
of hair follicle fate. Development, 136(6):891-6.
Demehri S, Turkoz A, Manivasagam S, Yockey LJ, Turkoz M, Kopan R. (2012) Elevated
epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the
skin. Cancer Cell, 22(4):494-505.
Dhouailly D. (1973) Dermo-epidermal interactions between birds and mammals:
differentiation of cutaneous appendages. J Embryol Exp Morphol 30:587–603
Dhouailly D. (1977) Dermo-epidermal interactions during morphogenesis of cutaneous
appendages in amniotes. In Front. Matrix Biol. (Ed. L. Robert), Creteil. 4: 86-121.
D'Souza B., Miyamoto A., Weinmaster G. (2008) The many facets of Notch ligands. Oncogene
27, 5148-5167.
Dumont E, Fuchs KP, Bommer G, Christoph B, Kremmer E, Kempkes B. (2000) Neoplastic
transformation by Notch is independent of transcriptional activation by RBP-J signalling.
Oncogene. ;19:556–561.
18

Durmowicz MC, Cui CY, Schlessinger D. (2002) The EDA gene is a target of, but does not
regulate Wnt signaling. Gene, 285, 203–211.
Duryagina R, Thieme S, Anastassiadis K, Werner C, Schneider S, Wobus M, Brenner S,
Bornhäuser M. (2013) Overexpression of Jagged-1 and its intracellular domain in human
mesenchymal stromal cells differentially affect the interaction with hematopoietic stem and
progenitor cells. Stem Cells Dev, 22(20):2736-50.
Endo Y, Osumi N, Wakamatsu Y. (2002) Bimodal functions of Notch-mediated signaling are
involved in neural crest formation during avian ectoderm development. Development,
129(4):863-73
Endo Y, Osumi N, Wakamatsu Y. (2003) Deltex/Dtx mediates NOTCH signaling in
regulation of Bmp4 expression in cranial neural crest formation during avian development.
Dev Growth Differ. 45(3):241-8.
Estrach S, Ambler CA, Lo Celso C, Hozumi K, Watt FM. (2006) Jagged 1 is a beta-catenin
target gene required for ectopic hair follicle formation in adult epidermis. Development,
133(22):4427-38.
Estrach S, Cordes R, Hozumi K, Gossler A, Watt FM. (2008) Role of the Notch ligand Delta1
in embryonic and adult mouse epidermis. J Invest Dermatol,128(4):825-32.
Favier B, Fliniaux I, Thélu J, Viallet JP, Demarchez M, Jahoda CA, Dhouailly D. (2000)
Localisation of members of the notch system and the differentiation of vibrissa hair
follicles: receptors, ligands, and fringe modulators. Dev Dyn. 218(3):426-37.
Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. (2004) The Notch target genes
Hey1 and Hey2 are required for embryonic vascular development. Genes Dev., 18(8):901–
911.
19

Fu J, Hsu W. (2013) Epidermal Wnt controls hair follicle induction by orchestrating
dynamic signaling crosstalk between the epidermis and dermis. J Invest Dermatol.
Apr;133(4):890-8.
Fuchs E and Green H. (1980) Changes in keratin gene expression during terminal
differentiation of the keratinocyte. Cell 19(4):1033-42.
Fuchs E, Raghavan S. (2002) Getting under the skin of epidermal morphogenesis. Nat Rev
Genet.3(3):199-209. Review.
Fuchs E. (2007) Scratching the surface of skin development. Nature 22;445(7130) pp.834-42.
Review.
Giniger E. (1998) A role for Abl in Notch signaling. Neuron, 20, pp. 667–681
Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC, Dlugosz AA. (2000) Basal cell
carcinomas in mice overexpressing Gli2 in skin. Nat. Genet. 2000, 24, 216–217.
Greenwald I. (1998) LIN-12/Notch signaling: lessons from worms and flies. Genes Dev.
15;12(12):1751-62.
Gridley T. (1997) Notch signaling in vertebrate development and disease. Mol Cell Neurosci.
9(2):103-8. Review.
Hardy MH. (1992) The secret life of the hair follicle. Trends Genet.;8(2):55-61. Review
Hayward P., Brennan K., Sanders P., Balayo T., DasGupta R., Perrimon N., Martinez Arias A.
(2005) Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and
regulating its transcriptional activity. Development 132, 1819-1830.
Headon DJ, Overbeek PA.(1999) Involvement of a novel Tnf receptor homologue in hair
follicle induction. Nat Genet., 22(4):370-4.

20

Hodkinson PS, Elliott PA, Lad Y, McHugh BJ, MacKinnon AC, Haslett C, Sethi T. (2007)
Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem,
282(39):28991-9001.
Hori K, Fostier M, Ito M, Fuwa TJ, Go MJ, Okano H, Baron M, Matsuno K. (2004) Drosophila
deltex mediates suppressor of Hairless-independent and late-endosomal activation of Notch
signaling. Development 131, 5527-5537.
Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, Takeda Y, Chia W, Sankar N, Ng YK,
Ling EA, Maciag T, Small D, Trifonova R, Kopan R, Okano H,Nakafuku M, Chiba S, Hirai H,
Aster JC, Schachner M, Pallen CJ, Watanabe K, Xiao ZC. (2003) F3/contactin acts as a
functional ligand for Notch during oligodendrocyte maturation. Cell, 115(2):163-75.
Hu B, Lefort K, Qiu W, Nguyen BC, Rajaram RD, Castillo E, He F, Chen Y, Angel P, Brisken
C, Dotto GP. (2010) Control of hair follicle cell fate by underlying mesenchyme through a
CSL-Wnt5a-FoxN1 regulatory axis. Genes Dev. 24(14):1519-32.
Huelsken J, Vogel R, Erdmann B et al. (2001) beta-Catenin controls hair follicle
morphogenesis and stem cell differentiation in the skin. Cell 105:533–545
Huh SH, Narhi K, Lindfors PH, Haara O, Yang L, Ornitz DM, Mikkola ML. (2013) Fgf20
governs formation of primary and secondary dermal condensations in developing hair
follicles. Genes Dev., 27, 450–458.
Huntzicker EG, Estay IS, Zhen H, Lokteva LA, Jackson PK, Oro AE. (2006) Dual degradation
signals control Gli protein stability and tumor formation. Genes Dev., 20, 276–281.
Ikeuchi T and Sisodia SS. (2003) The notch ligands, delta1 and jagged2, are substrates for
presenilin-dependent “gamma-secretase” cleavage. J. Biol. Chem., 278, pp. 7751–7754 Iso T,

21

Kedes L, Hamamori Y. (2003) HES and HERP families: multiple effectors of the Notch
signaling pathway. J Cell Physiol. (3):237-55. Review.
Jamora C, DasGupta R, Kocieniewski P, Fuchs E. (2003) Links between signal transduction,
transcription and adhesion in epithelial bud development. Nature 422:317–322.
Jarriault, S. Brou, C. Logeat, F. Schroeter, E.H. Kopan, R. and Israel, A. (1995) Signalling
downstream of activated mammalian Notch. Nature 377, pp. 355–358.
Jennings B, Preiss A, Delidakis C, Bray S. (1994) The Notch signalling pathway is required
for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila
embryo. Development, 120, pp. 3537–3548.
Kaether C, Haass C, Steiner H. (2006) Assembly, trafficking and function of gammasecretase. Neurodegener Dis 3 (4–5): 275–83
Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM and
Kadesch T. (1998) A histone deacetylase corepressor complex regulates the Notch signal
transduction pathway. Genes Dev. 12, 2269-2277
Kolev V, Kacer D, Trifonova R, Small D, Duarte M, Soldi R, Graziani I, Sideleva O, Larman B,
Maciag T, Prudovsky I. (2005) The intracellular domain of Notch ligand Delta1 induces cell
growth arrest. FEBS Lett, 579(25):5798-5802.
Kopan R, Schroeter EH, Weintraub H, Nye JS. (1996) Signal transduction by activated
mNotch: importance of proteolytic processing and its regulation by the extracellular
domain. Proc Natl Acad Sci USA. Feb 20;93(4):1683-8.
Kopan R, Ilagan MX. (2009) The canonical Notch signaling pathway: unfolding the
activation mechanism. Cell.137(2):216-33.

22

Koster MI, Roop DR. (2007) Mechanisms regulating epithelial stratification. Annu Rev Cell
Dev Biol. 23:93-113. Review.
Kurooka H. and Honjo T. (2000) Functional interaction between the mouse notch1
intracellular region and histone acetyltransferases PCAF and GCN5. J. Biol. Chem. 275,
17211-17220
Kwon C, Cheng P, King IN, Andersen P, Shenje L, Nigam V., Srivastava D. (2011) Notch posttranslationally regulates β-catenin protein in stem and progenitor cells. Nature Cell Biology,
13 (10) , pp. 1244-1251.
Laurikkala J, Pispa J, Jung HS, Nieminen P, Mikkola M, Wang X, Saarialho-Kere U, Galceran J,
Grosschedl R, Thesleff I. (2002) Regulation of hair follicle development by the TNF signal
ectodysplasin and its receptor Edar. Development, 129, 2541–2553.
LaVoie MJ and Selkoe DJ. (2003) The Notch ligands, Jagged and Delta, are sequentially
processed by alpha-secretase and presenilin/gamma-secretase and release signaling
fragments, J. Biol. Chem. 278, pp. 34427–34437.
Lecourtois M, Schweisguth F. (1997) Role of suppressor of hairless in the delta-activated
Notch signaling pathway. Perspect Dev Neurobiol.;4(4):305-11. Review.
Le Gall M, De Mattei C, Giniger E. (2008) Molecular separation of two signaling pathways
for the receptor, Notch. Dev. Biol. 313, 556-567.
Lee J, Basak JM, Demehri S, Kopan R. (2007) Bi-compartmental communication contributes
to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal
keratinocytes. Development, 134(15):2795-806.

23

Lin MH, Leimeister C, Gessler M, Kopan R. (2000) Activation of the Notch pathway in the
hair cortex leads to aberrant differentiation of the adjacent hair-shaft layers. Development,
127(11):2421-32.
Liu X, Driskell RR, Luo M, Abbott D, Filali M, Cheng N, Sigmund CD, Engelhardt JF. (2004)
Characterization of Lef-1 promoter segments that facilitate inductive developmental
expression in skin. J Invest Dermatol. 123(2):264-74.
Lowell S, Jones P, Le Roux I, Dunne J, Watt FM. (2000) Stimulation of human epidermal
differentiation by Delta–Notch signalling at the boundaries of stem-cell clusters. Curr. Biol.
10:491–500
M'Boneko V, Merker HJ. (1988) Development and morphology of the periderm of mouse
embryos (days 9-12 of gestation). Acta Anat (Basel). 133(4):325-36.
McGowan K, Coulombe PA. (1998) The wound repair-associated keratins 6, 16, and 17.
Insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture.
Subcell Biochem.31:173-204.
Mecklenburg L, Nakamura M, Sundberg JP, Paus R. (2001) The nude mouse skin phenotype:
The role of Foxn1 in hair follicle development and cycling. Exp Mol Pathol 71: 171–178.
Miele L, Osborne B. Arbiter of differentiation and death: Notch signaling meets apoptosis.
(1999) J Cell Physiol. 181(3):393-409. Review.
Millar SE (2002) Molecular mechanisms regulating hair follicle development.J Invest
Dermatol 118:216–225

24

Mill P, Mo R, Fu H, Grachtchouk M, Kim PC, Dlugosz AA, Hui CC. (2003) Sonic hedgehogdependent activation of Gli2 is essential for embryonic hair follicle development. Genes
Dev., 17, 282–294.
Mizutani K, Yoon K, Dang L, Tokunaga A, Gaiano N. (2007) Differential Notch signalling
distinguishes neural stem cells from intermediate progenitors. Nature 449, 351-355.
Mou C, Jackson B, Schneider P, Overbeek PA, Headon DJ. (2006) Generation of the primary
hair follicle pattern. Proc. Natl. Acad. Sci. USA, 103, 9075–9080.
Moriyama M, Osawa M, Mak SS, Ohtsuka T, Yamamoto N, Han H, Delmas V, Kageyama R,
Beermann F, Larue L, Nishikawa S. (2006) Notch signaling via Hes1 transcription factor
maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol.173(3):333-9.
Moriyama M, Durham AD, Moriyama H, Hasegawa K, Nishikawa S, et al. (2008) Multiple
roles of Notch signaling in the regulation of epidermal development. Dev Cell 14: 594–604.
Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S. (2005)
Regulation of Notch signalling by non-visual beta-arrestin. Nat Cell Biol 7: 1191–1201.
Muñoz-Descalzo S, Tkocz K, Balayo T, Arias AM. (2011) Modulation of the ligandindependent traffic of Notch by Axin and Apc contributes to the activation of Armadillo in
Drosophila. Development, 138(8), pp.1501-6
Nagarajan P, Romano RA, Sinha S. (2008) Transcriptional control of the differentiation
program of interfollicular epidermal keratinocytes. Crit Rev Eukaryot Gene Exp 18(1):57-79.
Nellesen DT, Lai EC, Posakony JW. (1999) Discrete enhancer elements mediate selective
responsiveness of enhancer of split complex genes to common transcriptional activators.
Dev Biol.;213 (1):33-53
25

Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. (2002) Jagged-1
mediated activation of Notch signaling induces complete maturation of human
keratinocytes through NF-κB and PPARγ. Cell Death Differ. 9:842–855
Nofziger D, Miyamoto A, Lyons KM, Weinmaster G. (1999) Notch signaling imposes two
distinct blocks in the differentiation of C2C12 myoblasts. Development, 126(8):1689-702.
Noramly S, Freeman A, Morgan BA (1999) beta-catenin signaling can initiate feather bud
development. Development 126:3509–3521.
Omori M, Ziegler S. (2007) Induction of IL-4 expression in CD4(+) T cells by thymic
stromal lymphopoietin. J. Immunol.;178:1396-1404.
Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, Kadesch T.
(1998) Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell
Biol, 18(4):2230-9. Oswald F, Tauber B, Dobner T, Bourteele S, Kostezka U, Adler G, Liptay S
and Schmid RM. (2001) p300 acts as a transcriptional coactivator for mammalian Notch-1.
Mol. Cell. Biol. 21, 7761-7774.
Pan Y, Lin MH, Tian X, Cheng HT, Gridley T, Shen J, Kopan R. (2004) Gamma-secretase
functions through Notch signaling to maintain skin appendages but is not required for
their patterning or initial morphogenesis. Dev Cell, 7(5):731-43.
Paus R, Müller-Röver S, Van Der Veen C, Maurer M, Eichmüller S, Ling G, Hofmann U,
Foitzik K, Mecklenburg L, Handjiski B. (1999) A comprehensive guide for the recognition
and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol.
113(4):523-32.
Petcherski AG and Kimble J. (2000) Mastermind is a putative activator for Notch. Curr. Biol.
10, R471-R473.
26

Powell BC, Passmore EA, Nesci A, and Dunn SM. (1998) The Notch signalling pathway in
hair growth. Mech. Dev. 78: 189–192.
Pummila M, Fliniaux I, Jaatinen R, James MJ, Laurikkala J, Schneider P, Thesleff I, Mikkola
ML. (2007) Ectodysplasin has a dual role in ectodermal organogenesis: Inhibition of Bmp
activity and induction of Shh expression. Development, 134, 117–125.
Qi H, Rand MD, Wu X, Sestan N, Wang W, Rakic P, Xu T, Artavanis-Tsakonas S. (1999)
Processing of the Notch ligand Delta by the metalloprotease Kuzbanian. Science; 283:91-94.
Radtke F, Raj K. (2003) The role of Notch in tumorigenesis: oncogene or tumour
suppressor? Nat Rev Cancer. (10):756-67. Review.
Ramain P, Khechumian K, Seugnet L, Arbogast N, Ackermann C and Heitzler P. (2001) Novel
Notch alleles reveal a Deltex-dependent pathway repressing neural fate. Curr. Biol. 13,1729
-1738.
Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, et al. (2001) Notch signaling
is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO
J 20: 3427–3436.
Rochman Y, Leonard WJ. (2008) The role of thymic stromal lymphopoietin in CD8+ T cell
homeostasis. J. Immunol.;181:7699-7705.
Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S, Sinha S. (2012) ΔNp63
knockout mice reveal its indispensable role as a master regulator of epithelial development
and differentiation. Development. 139(4):772-82.
Rothnagel JA, Mehrel T, Idler WW, Roop DR, Steinert PM. (1987) The gene for mouse
epidermal filaggrin precursor. Its partial characterization, expression, and sequence of a
repeating filaggrin unit. Biol Chem.;262(32):15643-8.
27

Rusconi JC, Corbin V. (1998) Evidence for a novel Notch pathway required for muscle
precursor selection in Drosophila. Mechanisms of Development 79: 39–50.
Rusconi JC, Corbin V. (1999) A widespread and early requirement for a novel Notch
function during Drosophila embryogenesis. Dev Biol., 215(2) pp. 388-98.
Sanes JR, Rubenstein JL, Nicolas JF. (1986) Use of a recombinant retrovirus to study postimplantation cell lineage in mouse embryos. EMBO J. 5, 3133–3142.
Sanders PG, Muñoz-Descalzo S, Balayo T, Wirtz-Peitz F, Hayward P, Arias AM (2009) Ligand
independent traffic of Notch buffers activated Armadillo in Drosophila. PLoS Biol. Aug;
7(8)
Schmidt-Ullrich R, Paus R. (2005) Molecular principles of hair follicle induction and
morphogenesis. Bioessays 27:247–261
Schmidt-Ullrich R, Tobin DJ, Lenhard D, Schneider P, Paus R, Scheidereit C. (2006) NFkappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and
controls post-initiation hair placode down growth. Development, 133, 1045–1057
Scheeren FA, van Lent AU, Nagasawa M, et al (2010). Thymic stromal lymphopoietin induces
early human B-cell proliferation and differentiation. Eur. J. Immunol.2010;40:955-965
Schroeter EH, Kisslinger JA, Kopan R. (1998) Notch-1 signaling requires ligand-induced
proteolytic release of intracellular domain Nature, 393 pp. 382–386
Schuldt AJ and Brand AH. (1999) Mastermind acts downstream of notch to specify neuronal
cell fates in the Drosophila central nervous system. Dev. Biol. 205, 287-295
Segre JA. Epidermal barrier formation and recovery in skin disorders. (2006) J Clin Invest.
116(5):1150-8.
28

Sengel P, Mauger A. (1976) Peridermal cell patterning in the feather-forming skin of the
chick embryo. Dev Biol. 1;51(1):166-71.
Sennett R and Rendl M. (2012) Mesenchymal-epithelial interactions during hair follicle
morphogenesis and cycling. Semin Cell Dev Biol. October; 23(8): 917–927.
Shawber C, Nofziger D, Hsieh JJ, Lindsell C, Bögler O, Hayward D, Weinmaster G. (1996)
Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway.
Development, 122(12):3765-73.
Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE, Sonenshein GE & Osborne
BA. (2006) Notch1 augments NF-kappaB activity by facilitating its nuclear retention. Embo
J 25, 129-38
Six, E., Ndiaye, D., Laabi, Y., Brou, C., Gupta-Rossi, N., Israel, A. and Logeat, F. (2003) The
Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase,
Proc. Natl. Acad. Sci. USA 100, pp. 7638–7643.
Stern CD (2005) Neural induction: old problem, new findings, yet more questions.
Development 132:2007–2021
St-Jacques B, Dassule HR, Karavanova I, Botchkarev VA, Li J, Danielian PS, McMahon JA,
Lewis PM, Paus R, McMahon AP. (1998) Sonic hedgehog signaling is essential for hair
development. Curr. Biol. 8, 1058–1068.
Sun X, Lewandoski M, Meyers EN, Liu YH, Maxson RE, Martin GR. (2000) Conditional
inactivation of Fgf4 reveals complexity of signalling during limb bud development Nat.
Genet, 25, pp. 83–86

29

Tucker AS, Headon DJ, Schneider P, Ferguson BM, Overbeek P, Tschopp J, Sharpe PT. (2000)
Edar/Eda interactions interactions regulate enamel knot formation in tooth morphogenesis.
Development 127: 4691–4700.
Uyttendaele H, Panteleyev AA, de Berker D, Tobin DT, Christiano AM. (2004) Activation of
Notch1 in the hair follicle leads to cell-fate switch and Mohawk alopecia. Differentiation,
72(8):396-409.
Van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R. (1994)
Development of several organs that require inductive epithelial-mesenchymal interactions
is impaired in LEF-1-deficient mice. Genes Dev 8:2691–2703.
Vauclair S, Nicolas M, Barrandon Y, Radtke F. (2005) Notch1 is essential for postnatal hair
follicle development and homeostasis. Dev Biol, 284(1):184-93.
Wallberg, A. E., Pedersen, K., Lendahl, U. and Roeder, R. G. (2002) p300 and PCAF act
cooperatively to mediate transcriptional activation from chromatin templates by notch
intracellular domains in vitro. Mol. Cell. Biol. 22, 7812-7819.
Wang S, Younger-Shepherd S, Jan LY, Jan YN. (1997) Only a subset of the binary cell fate
decisions mediated by Numb/Notch signaling in Drosophila sensory organ lineage requires
Suppressor of Hairless. Development, 124, pp. 4435–4446
Weinmaster G. (1997) The ins and outs of notch signaling. Mol Cell Neurosci.; 9(2):91-102.
Review.
Woo WM, Zhen HH, Oro AE. (2012) Shh maintains dermal papilla identity and hair
morphogenesis via a Noggin-Shh regulatory loop. Genes Dev.; 26(11):1235-46

30

Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard
A. et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature,
391, 90–92.
Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K,
Nakamura K, Weinmaster G, Okano H, Nakafuku M. (2001) Role of Deltex-1 as a
transcriptional regulator downstream of the Notch receptor. J Biol Chem, 276(48):45031-40
Yamamoto N, Tanigaki K, Han H, Hiai H, Honjo T. (2003) Notch/RBP-J signaling regulates
epidermis/hair fate determination of hair follicular stem cells. Curr Biol. 13(4):333-8.
Yang Y, Li Y, Wang Y, Wu J, Yang G, Yang T, Gao Y, Lu Y. (2012) Versican gene:
Regulation by the beta-catenin signaling pathway plays a significant role in dermal papilla
cell aggregative growth. J. Dermatol. Sci. 68, 157–163.
Yugawa T, Nishino K, Ohno S, Nakahara T, Fujita M, Goshima N, Umezawa A, Kiyono T.
(2013) Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced
pluripotent stem cells through ROCK activation. Mol Cell Biol. 33(22):4434-47.
Zhang Y, Tomann P, Andl T, Gallant NM, Huelsken J, Jerchow B, Birchmeier W, Paus R,
Piccolo S, Mikkola ML, Morrisey EE, Overbeek PA, Scheidereit C, Millar SE, Schmidt-Ullrich
R. (2009) Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin
signaling pathways in hair follicle induction. Dev Cell. 17(1):49-61.
Zecchini V, Brennan K, Martinez-Arias A. (1999) An activity of Notch regulates JNK
signalling and affects dorsal closure in Drosophila. Curr. Biol., 9, pp. 460–469
Ziegler SF, Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H. (2013) The biology of thymic
stromal lymphopoietin (TSLP). Adv Pharmacol.66:129-55.
31

Zhou S, Fujimuro M, Hsieh JJ, Chen L, Miyamoto A, Weinmaster G and Hayward SD. (2000)
SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To
facilitate NotchIC function. Mol. Cell. Biol. 20, 2400-2410
Zhou S and Hayward SD. (2001) Nuclear localization of CBF1 is regulated by interactions
with the SMRT corepressor complex. Mol. Cell. Biol. 21, 6222-6232
Zolkiewska A. (2008) ADAM proteases: Ligand processing and modulation of the Notch
pathway. Cell Mol. Life Sci., 65 (13) pp. 2056–2068

32

Figure 1-1
Mammalian DSL Ligands

Intracellular

Extracellular
7

Mammalian Notch Receptors

1

Dll3
Extracellular
8

1

1

11 12

Intracellular

29

Dll4

Notch4

8

1

1

11 12

34

Dll1

Notch3

16

1

1

11 12

36

Jagged2

Notch2

16

1

1

11 12

36

Jagged1

Notch1
S2
S4 S3

Signal Peptide

Nuclear Localization Signal

Delta Serrate LAG2 Domain

Cysteine-rich Domain

EGF-like Repeats

Heterodimerization Domain

RAM Domain

Transactivation Domain

EGF-like Repeats

PDZ Domain

Lin12-Notch Repeat

Transmembrane Domain

ANK Domain

PEST Domain

Figure 1-1. Structure of mammalian Notch receptors and ligands (Kopan & Ilagan, 2009).
Both Notch receptors and DSL ligands are expressed on the cell surface. They contain EGF-like
repeats in the extracellular domain (ECD). In addition, receptors have Lin12-Notch repeats
(LNR) and heterodimerization domain (HD) in the ECD. S2-cleavage is mediated by ADAMTACE family proteins, whereas S3 (and S4) cleavage(s) are mediated by γ-secretase complex.
The intracellular domain (ICD) of the receptor consists of RBPjκ associated module (RAM),
nuclear localization signals (NLS), ankyrin/cdc10 (ANK) repeats, transactivation domain (TAD),
and Pro-Glu-Ser-Thr rich (PEST) domain. Note that Notch3 & Notch4 receptors do not carry
TAD and Notch4 only has one NLS.
All ligands have a DSL domain in the ECD, whereas only Jagged1 and Jagged2 contain cysteinerich domains proximal to the transmembrane domain. Jagged1, Dll1, and Dll4 ligands carry a
PDZ* domain in the ICD of the ligands.

PDZ*: post synaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1),
and zonula occludens-1 protein (zo-1)
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Figure 1-2. Overview of Canonical Notch Signaling Pathway.
Activation of Notch receptors triggered upon interaction with Notch ligands (Delta/Serrate
family proteins) from the cell surface of the adjacent cells. Following ligand binding, receptors
undergo conformational change which allows ADAM/TACE family proteins to access the S2
cleavage site within the HD. S2-cleavage generates the substrate for γ-secretase complex, which
further cleaves the remaining receptor fragment at the S3 and S4 sites. This final cleavage
liberates the NICD and allows translocation to the nucleus. In the nucleus, NICD finds its DNA
binding partner, RBPjκ, which normally functions as a repressor. NICD-RBPjκ interaction
displaces co-repressors and recruits coactivators leading to canonical target gene expression.
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Figure 1-3. Expression pattern of Notch proteins during development of mammalian
epidermis and hair follicles.
(A) Overview of mammalian skin and its appendages (adapted from Fuchs and Raghavan, 2002).
(B) Schematic view of mouse embryonic epidermal development stages. (C) Schematic view of
mouse primary hair follicle morphogenesis (modified from Paus et al., 1999). (D) Expression
pattern of Notch1 (N1), Notch2 (N2), and Notch3 (N3) receptors in mouse epidermis at E13.5
(Courtesy of Dr. Zhenyi Liu from Kopan Lab). (E) Expression pattern of N1, N2, and N3
receptors in mouse epidermis at E15.5 (modified from Romano et al., 2012) (F) Expression
pattern of Notch receptors and their ligands (Jagged1 (J1) and Jagged2 (J2)) during mouse hair
follicle development. Co-expressions are designated with shaded areas (adapted from Watt,
Estrach, & Ambler, 2008). (G) Expression patterns of Notch pathway members and some its
targets during hair follicle growth in mouse (adapted from Aubin-Houzelstein, 2012). HS: hair
shaft; IRS: inner root sheath; Me: medulla; Co: cortex; Ct: cuticle: Hu: Huxley layer; He: Henle
layer; ORS: outer root sheath.
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Figure 1-4. Consequences of loss-of-Notch signaling in skin keratinocytes.
(A) Activity and expression pattern of Msx2-Cre. Left: X-gal staining of an E15.5

Msx2-Cre

+/tg; Rosa26R embryo (adapted from Demehri et al. 2008). Right: live immunofluorescent
imaging of newborn Msx2-Cre +/tg; RosaEYFP pup. (B) H&E staining for newborn WT and
PSdcKO skin samples. Due to the differentiation defects mutant skin has hyperproliferative
epidermis. (C) Immunofluorescent staining for epidermal differentiation markers (K14, K1,
Loricrin, Filaggrin) and integrins (β1 and β4) of WT and Notch1-/- epidermis (21 days post OHT
treatment). Notch1-/- epidermis exhibits aberrant differentiation markers and integrin expression.
Bar: 8 µm. (adapted from Rangarajan et al. 2001) (D) Suprabasal cells (adapted from Demehri et
al., 2008) and (E) defective ORS cells that are converted into epidermal cysts (adapted Demehri
et al., 2008) are positive for TSLP protein in the Notch signaling deficient epidermis and hair
follicle, respectively. (F) Diagram depicting the consequences of events that are happening upon
loss-of-total Notch signaling in the skin keratinocytes: (i) differentiation defects and impaired
lipid biosynthesis. (ii) the integrity of the skin is abolished and lead to barrier defects (iii)
Suprabasal cells and epidermal cells within the hair follicle cysts start to express TSLP which
induces proliferation in fetal-liver originating pre-B cells. (iv) Expansion of immature B-cells
leads to BLPD disease, which results in the death of animals by P30 (adapted from Demehri et
al, 2008). (G) RBPjcKO animals are significantly different than other total-loss-of-Notch
signaling mutants (N1N2dcKO & PSdcKO). These differences manifest in four different
measures: (i) Lifespan (ii) WBC counts (iii) Serum TSLP levels and (iv) skin morphology.
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Table 1-1

Table 1-1. Overview of non-canonical Notch ligands and their effects on Notch Signaling
(adapted from D’Souza et al. 2008)
Non-canonical ligands are structurally diverse and do not possess DSL domain
(Delta/Serrate/LAG-2). Some of them include integral- and GPI-linked membrane proteins as
well as secreted proteins.

EGF-like (6 cys), 6-cysteine epidermal growth factor-like repeats; cys, cysteine; EMI, emilinlike domain; Ig-CAM, immunoglobulin-containing cell adhesion molecule domain; FNIII,
fibronectin type III domain; GPI, glycosylphosphatidylinositol; Q, glutamine-rich region; FReD,
fibrinogen-related domain; DOS, Delta and OSM-11-like proteins; IGFBP, insulin-like growth
factor-binding protein-like domain; VWF-C, von Willebrand factor type C-like domain; TSP-1,
thrombospondin type 1-like domain; CTCK, C-terminal cysteine knot domain; MBD, matrix
binding domain; RGD, integrin-binding motif; NT, N-terminal domain; CSD, cold shock
domain, N1, Notch1; N2, Notch2; N3, Notch3; N4, Notch4.
*Only full-length constructs were tested for binding
**Agonist of Jagged1 signaling
***Antagonist of Jagged1 signaling
**** Agonist of Dll4 (Delta-like 4) signaling
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CHAPTER II

The phenotypes in the embryo and newborn animals
are due to the canonical Notch signaling
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SUMMARY
Notch signaling plays a crucial role during epidermal differentiation and hair follicle
maintenance. Demehri et al. (2008) showed that keratinocyte-specific deletion of the Rbpj
(RBPjcKO) gene produced a significantly milder phenotype than keratinocyte-specific deletion
of both Notch1 and Notch2 (N1N2dcKO) or both Preselin1 and Preselin2 (PSdcKO) genes,
suggesting an RBPjκ-independent function of Notch signaling in the skin. To test the possibility
whether RBPjκ-independent Notch function contributes to the differences between RBPjcKO
and PSdcKO animals, I performed transcriptome (E18.5) and proteome (P0) analysis of the
epidermis. Surprisingly, the analyses revealed no difference between Rbpj-/- and PS-/- epidermis.
In addition, microarray analysis for newborn total skin samples from RBPjcKO and PSdcKO
animals produced an indistinguishable signature at birth. Taken together, these results showed
that the phenotypes in the embryo and newborn animals are due to the canonical Notch signaling
suggesting that potential RBPjκ-independent Notch function occurs after birth.
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INTRODUCTION
Epidermal development starts around E8.5 - E9 from a single layer of ectodermal cells in
the mouse embryo. By E13, K5+ and K14+ progenitors cover the entire embryo and initiate the
epidermal differentiation program. Notch signaling is essential for cell cycle exit and
keratinocyte differentiation (Lowell et al., 2000; Rangarajan et al., 2001; Nickoloff et al., 2002;
Blanpain et al., 2006; Moriyama et al., 2008). During the early stage of epidermal differentiation,
activated Notch1 in basal cells inhibits growth by activating p21WAF1/Cip1 expression and
downregulation of integrin α3/β1 and α6/β4 expression (Rangarajan et al., 2001). In spinous
cells, Notch activation cause upregulation of early differentiation markers such as involucrin, K1
and K10 and suppression of late markers, loricrin and filaggrin (Rangarajan et al., 2001;
Nickoloff et al., 2002; Blanpain et al., 2006).
Interestingly, Notch signaling is not essential for hair follicle induction, invagination and
formation of hair peg and hair bulb. Keratinocyte-specific Notch pathway conditional-knock-out
(cKO) animals do not display differences in the number or distribution of hair follicles compared
to wild-type (WT) animals (Lin et al., 2000; Yamamoto et al., 2003; Pan et al., 2004;
Uyttendaele et al., 2004; Vauclair et al., 2005; Blanpain et al., 2006; Estrach et al., 2006;
Moriyama et al., 2006; Ambler and Watt, 2007; Lee et al., 2007; Estrach et al., 2008; Demehri et
al., 2009). Furthermore, the loss-of-Notch pathway components does not interfere with the
expression patterns of other signaling pathways (e.g. Wnt/β-catenin, FGF, Shh, TGF-β/BMP and
Eda/Edar/NF-κB) that participate in early placode formation and/or embryonic hair follicle
development (Vauclair et al., 2005). Although embryonic hair follicles can form without Notch
signaling, Notch signaling functions in the maintenance of follicular morphology (Pan et al.,
2004) and in hair follicle terminal differentiation (Blanpain et al., 2006). Complete loss-of-Notch
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signaling induces conversion of hair follicles into epidermal cysts, due to the loss of cellular
identity in IRS cells, and the activation of aberrant epidermal differentiation program in ORS
cells (Pan et al., 2004).
The role of Notch signaling during skin development was analyzed using Msx2-Cre to
create mosaic loss-of-function alleles with precise temporal and spatial resolution (Pan et al.,
2004; Demehri et al., 2008). We have previously shown that Msx2-Cre-mediated skin
keratinocyte-specific deletion of Notch1 and Notch2 genes (or Presenilin1 and Presenilin2
genes) leads to a significantly more severe phenotype compared to that of an Rbpj gene deletion
(Demehri et. al., 2008). N1N2dcKO and PSdcKO animals exhibit higher serum TSLP levels (> 5
ng/mL) compared to RBPjcKO animals (Demehri et. al., 2008) translating into a higher white
blood cell (WBC) counts. Their life expectancies are also dramatically different. N1N2dcKO and
PSdcKO animals die around 30 days, but RBPjcKO animals live as long as 300 days (Figure 14G; Demehri et. al., 2008).
RBPjκ, the DNA-binding partner of all NICDs, mediates the transcriptional effects of
Notch signaling. DSL ligand-dependent activation, γ-secretase cleavage, and RBPjκ-mediated
transcriptional activity of Notch receptors define the “canonical” Notch signaling pathway
(Hsieh et al., 1995; Furukawa et al., 1995; Jarriault et al., 1995). Therefore, deletion of Rbpj gene
should result in a complete loss of canonical Notch signaling as in N1N2dcKO and PSdcKO
animals. However, the milder skin phenotype of RBPjcKO animals suggests that there might be
a function for RBPjκ-independent Notch signaling. Before investigating the RBPjκ-independent
Notch function in skin keratinocytes, I tested the possibility that the milder RBPjcKO phenotype
is not due to trivial explanations such as incomplete deletion of the Rbpj gene, incomplete
elimination of the protein, or longer half-life of the RBPjκ protein, which leads to an “epigenetic
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memory” causing a milder phenotype in RBPjcKO animals.
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RESULTS AND DISCUSSION
RBPjκ protein is eliminated in Rbpj-/- keratinocytes.
To confirm that RBPjκ protein was depleted from skin keratinocytes, Demehri et al.
(2008) performed RBPjκ immunohistochemistry on RBPjcKO skin at P0 and showed that RBPjκ
protein was undetectable in epidermal keratinocytes (Figure 2-1A; Demehri et al., 2008). I
confirmed these results in P9 animals (Figure 2-1A). Because these experiments relied on an
antibody (T6709) specific for the C-terminus of the RBPjκ protein, we could not rule out the
possibility that functional truncated proteins were generated from deleted Rbpjfloxed (Rbpjdel)
allele. Unfortunately, this is the only available antibody known to detect mouse RBPjκ protein
for immunohistochemistry. To examine if functional truncated protein(s) are made from the
Rbpjdel allele, I performed the following experiments.
Rbpjdel gene is functionally null.
Rbpjfloxed allele was constructed by inserting the floxed sites flanking exons 6 and 7
(Figure 2-1B; Han et al., 2002; Tanigaki et al. 2002) such that the regions encoding the DNAbinding and NICD-interacting domains of RBPjκ protein can be excised upon recombination.
Thus, any potential RBPjκdel protein should not have any DNA binding and transcription
activation ability. However, it has never been tested whether the Rbpjdel gene is transcribed or
whether a potential mutant protein still has some residual activity. To test whether Rbpjdel gene is
transcribed upon recombination, total mRNA from Msx2-Cre +/tg; Rbpjfloxed/+ and wild-type (wt)
epidermis were collected. I performed reverse transcription reaction to generate cDNA.
Following cDNA production, I ran polymerase chain reactions (PCR) to assess whether Rbpjdel
cDNA is expressed. I was able to detect Rbpj cDNA lacking exons 6 and 7 (Figure 2-1C)
establishing transcription of Rbpjdel mRNA in skin keratinocytes. Sequencing the Rbpjdel cDNA
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confirmed that, in the absence of exons 6 and 7, exon 5 in Rbpjdel mRNA was directly spliced to
exon 8 and transcribed through to exon 11, which was the last exon in the Rbpjwt mRNA (Figure
2-1C). This resulted in a frameshift and a premature stop codon at beginning of exon8, leading to
a truncated protein if no read-through occurs (Figure 2-1C).
I tested for potential residual activities in the putative products of Rbpjdel transcripts by
generating three expression vectors that mimic the expression of wild-type and mutant versions
of Rbpj mRNA (Figure 2-1D). In the first vector (RBPjwt), the mouse Rbpj203 isoform, the
predominant isoform, is expressed under CMV promoter and N-terminally tagged with 3xFLAG
(Figure 2-1D). The second vector (RBPjΔ67) is designed to express the transcript generated from
Rbpjdel alleles upon recombination. Although, there is a premature stop codon at exon8, this
vector allowed us to test whether any protein produced from endogenous Rbpjdel locus has any
transcriptional activity (Figure 2-1D), particularly if read-through occurs. The third vector
(RBPj58S) is designed to express only the truncated mutant RBPjκ protein that terminates at
exon8 (Figure 2-1D).
To determine whether the potential truncated RBPjκ proteins have any transcriptional
activity, all the experiments were done in the OT11 (RBPjκ-/-) cells (Kato et al., 1997). I coexpressed either RBPjwt, RBPjΔ67, or RBPj58S vectors with activated Notch1 receptor (Notch1∆E)
and a Notch-responsive reporter (e.g. TP-1 luciferase reporter, 4xCSL luciferase reporter or
HES-1 luciferase reporter). Co-expression of responsive RBPjwt and Notch1∆E strongly induced
activation of the TP-1 reporter by up to 100-fold; however, neither RBPjΔ67 nor RBPj58S was able
to activate the TP-1 reporter in the presence of Notch1∆E (Figure 2-1E). Similar results were
obtained with Hes1 (Figure 2-1E), 4xCSL, and Hes5 reporters (data not shown).
Based on the crystal structure, a portion of the DNA-binding domain of RBPjκ resides
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within the first five exons of the Rbpj gene. To test whether the RBPjκdel protein has any residual
DNA binding ability, I designed a vector that expresses the mutant RBPjκ58 protein fused to a
potent transactivation domain, VP16, to generate the RBPjκ58-VP16 fusion protein (Figure 2-1D).
We know when VP16 domain is fused to RBPjκwt protein (Figure 2-1D); the fusion protein,
RBPjκwt-VP16, can activate TP-1 reporter 200 folds even without the expression of Notch1∆E
(Figure 2-1F). If RBPjκ58 has DNA binding ability, then RBPj58-VP16 vector should able to
activate Notch-responsive reporters. Expression of Notch1∆E synergizes with RBPjwt-VP16 to
activate the TP-1 reporter by up to 800-fold (Figure 2-1F). However, RBPj58-VP16 vector cannot
activate TP-1 or 4xCSL reporter, alone or in the presence of Notch1∆E (Figure 2-1F).
To determine whether potential RBPjκ mutant protein can interfere with RBPjκwt or
NICDwt protein activity, I expressed RBPj58S vector with RBPjwt-VP16 vector. Co-expression of
RBPj58S vector with RBPjwt-VP16 vector did not induce any significant reduction in the activation
of TP-1 or 4xCSL reporter (Figure 2-1G). Similarly, overexpression of RBPj58S together with
Notch1ΔE and RBPjwt did not interfere with NICD activity to induce TP-1 or 4xCSL reporter
(Figure 2-1G) suggesting that truncated RBPjκdel protein cannot compete with RBPjkwt protein
neither for DNA-binding nor NICD interaction.
These results indicate that the putative RBPjκdel proteins produced from the Rbpjdel alleles
cannot activate Notch responsive reporter genes, either in the absence or presence of activated
Notch receptor. Moreover, RBPjκdel protein does not interfere with the function of RBPjκwt or
NICD. Collectively, these results indicate that Rbpjdel allele is a null allele and any potential
protein that is made from this allele is not able to activate canonical Notch targets.
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RBPjκ protein has 65-hour half-life.
Another possible explanation for the differences among the total loss of Notch signaling
mutants could be due to the “epigenetic memory” that is established through if the perdurance of
RBPjκ protein carries it through a critical developmental window. Conditional deletion of
Rbpjfloxed gene starts at E9.5 (Sun et al., 2000), 4 days before the induction of epidermal
differentiation (Figure 2-2A). During the stratification (E13.5 - E18.5), any RBPjκ protein that
has not yet been degraded could result in activation of some canonical Notch pathway target
genes. These targets can trigger an “epigenetic memory” in Rbpj-/- progenitors ultimately leading
to the milder RBPjcKO phenotype.
To test this possibility, I measured the half-life of the RBPjκ protein in mouse
keratinocytes in vitro. I cultured epidermal keratinocytes isolated from Rbpjfloxed/floxed animals.
When keratinocytes reached to 80-90% confluency, I treated them with Adeno-Cre or AdenoGFP. I started to observe loss of Rbpjwt mRNA within 12h post-infection and by 24h around 95%
of the wt mRNA was eliminated from the keratinocytes (Figure 2-2B). By 60h after Adeno-Cre
infection, 95% of the Rbpj mRNA expressed corresponded to the Rbpjdel (Figure 2-2B). I
collected cell lysates for western blot analysis at multiple timepoints following infection. I did
not observe a significant change in total RBPjκ protein amount within 24h post-infection (data
not shown). When I performed western blotting for lysates at later timepoints (40h-118h), I
found that RBPjκ protein had a very long perdurance (Figure 2-2C). The half-life of RBPjκ
protein was calculated to be around 65-hour in mouse keratinocytes (Figure 2-2D). In
conclusion, there is a possibility that some of RBPjκ protein still be present during stratification
which can cause an “epigenetic memory” in Rbpj-/- keratinocytes and this memory can alter gene
51

expression in RBPjcKO epidermis. To test this possibility, I analyzed the epidermal
transcriptomes of RBPjcKO, PSdcKO, and WT animals at E18.5, the results for which are
described in the following section.
No significant differences between Rbpj-/- and PS-/- epidermal transcriptomes at E18.5
To address whether perdurance of RBPjκ protein caused an “epigenetic memory” in
Rbpj-/- epidermal stem cells, we performed global gene expression profile analysis on total RNA
samples extracted from E18.5 RBPjcKO, PSdcKO, WTRBPj (WT littermates of RBPjcKO
animals) and WTPS (WT littermates of PSdcKO animals) epidermis. Three samples per genotype
were examined. After labeling, samples were hybridized on Illumina MouseWG-6 v2.0
Expression BeadChip arrays. Samples from mutant animals (RBPjcKO and PSdcKO) were
compared to each other and to their wild-type littermates.
I generated a heatmap and performed unsupervised hierarchical clustering to identify the
similarities and/or dissimilarities between genes and between samples (Figure 2-2E). The
dendrogram analyses revealed that samples from RBPjcKO epidermis cluster together with
PSdcKO epidermal samples indicating that they were more similar to each other compared to the
WT samples (Figure 2-2E). Then, I systematically characterized the amount of repression or
induction for each gene for every sample represented in the microarray. A total number of 183
genes were significantly differentially expressed in Rbpj-/- and PS-/- epidermis (Table 2-1, Table
2-2, Table 2-3).
To further evaluate the potential relevance of differentially expressed genes in Rbpj-/- and
PS-/- epidermis, I performed gene ontology (GO) and pathway enrichment analyses using
GOminer (Zeeberg et al. 2003), GOstat (Beissbarth and Speed, 2004), GOtoolbox (Martin et al.
2004), DAVID (Huang et al. 2009) and TOPPFUN (Chen et al., 2009) analysis tools. All of
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these analyses found no significant enrichment of GO terms relating to biological process,
cellular component, or molecular function in the gene sets, suggesting that there were no major
differences between gene expression patterns of Rbpj-/- and PS-/- epidermis.
RBPjcKO and PSdcKO epidermal proteome are similar at birth
Microarray analyses suggest that the gene expression patterns of Rbpj-/- and PS-/epidermis are very similar at E18.5. This result raised the possibility that the phenotypic
differences between RBPjcKO and PSdcKO animals could be due to differences at the protein
level (e.g., post-transcriptional or post-translational modifications). To investigate this
possibility, we have performed a proteomics analysis to identify the differentially expressed
proteins in Rbpj-/-, N1N2-/-, and PS-/- epidermis from newborn animals.
I collected epidermal samples from newborn RBPjcKO, N1N2dcKO, PSdcKO, and WT
animals. To avoid possible background effects, WT samples (WTpool) were generated by pooling
one sample each of WTRBPj, WTN1N2, and WTPS epidermis. Three replicates per genotype were
examined by mass spectrometry. Epidermis samples from RBPjcKO, N1N2dcKO and PSdcKO
animals were compared to each other and to the wild-type epidermis pool.
We generated a heatmap and performed unsupervised hierarchical clustering to identify
the similarities and/or dissimilarities between samples (Figure 2-3A). All replicates from the
same genotypes clustered together tightly confirming the precision of the experimental
procedure. Furthermore, samples from the Rbpj-/- epidermis clustered together with the PS-/epidermal samples and were separated from N1N2dcKO and WT samples in the dendrogram
analyses (Figure 2-3A) indicating that RBPjcKO epidermis was similar to PSdcKO epidermis in
terms of protein expression profile. Surprisingly, N1N2dcKO epidermis clustered closer to the
WTpool consistant with a functional role for Notch3 in the epidermal protein expression profile
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(N1N2dcKO animals still have Notch3-dependent canonical signaling).
Following dendrogram analysis, we further characterized the changes in abundance of
peptides. Due to the technical limitations, we only analyzed proteins that were detected by mass
spectrometry. A total number of 195 peptide sequences were significantly changed in abundance
when Rbpj-/- epidermis compared to N1N2-/- or PS-/- epidermis (Table 2-2). After careful
evaluation of the data, we found no significant enrichment of proteins/pathways that could be
responsible for phenotypic differences between RBPjcKO and PSdcKO (or N1N2dcKO)
animals. We also examined differences in the post-translational modifications (e.g.
phosphorylation, sumoylation, palmitoylation, and ubiquitination) on the peptides represented in
the analysis, however we could not find a significant difference.
In summary, both E18.5 epidermal transcriptome and P0 proteome analyses suggest that
Rbpj-/- epidermis is very similar to PS-/- (or N1N2-/-) epidermis at birth.
There are no significant differences between RBPjcKO and PSdcKO total skin
transcriptome in newborn pups
E18.5 epidermal transcriptome and P0 epidermal proteome analyses demonstrated that
Rbpj-/- epidermis was similar to PS-/- (or N1N2-/-) epidermis at birth. Both of these analyses
focused on the epidermis, however Notch deletion was not limited to the epidermis. Msx2-Cremediated deletion also occurred within hair follicle keratinocytes. Therefore, there is a possibility
that the differences in phenotypes between RBPjcKO and PSdcKO (or N1N2dcKO) animals
could have resulted from differences in the hair follicle keratinocytes.
To address this, we performed microarray analysis on RNA samples isolated from total
skin of RBPjcKO, PSdcKO, PSRBPjcKO and WT (WT littermates of RBPjcKO and PSdcKO
animals) animals at P0. Demehri et al. (2008) previously showed that PSRBPjcKO animals
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resembled PSdcKO animals in terms of lifespan, WBC counts, and serum TSLP levels. Four
samples per genotype were examined. Samples were hybridized on Illumina MouseRef-8 v2.0
Expression BeadChip arrays following labeling. Mutant samples (RBPjcKO, PSdcKO, and
PSRBPjcKO) were compared to each other and to their WT littermates.
To identify the similarities and/or dissimilarities between samples and between genes, we
performed unsupervised hierarchical clustering and heatmap analysis (Figure 2-3B). Samples
from WT epidermis clustered together to each other, however all other mutant samples
interspersed each other (Figure 2-3B). We further evaluated the changes in gene expression in
Rbpj-/-, PS-/-, PSR-/-, and WT total skin samples. These analyses showed that 22 genes were found
differentially expressed in Rbpj-/- skin compared with those in PS-/- and PSR-/- skin (Table 2-2).
To determine the functional similarities among these gene products, we performed GO
analysis using GOminer (Zeeberg et al. 2003), GOstat (Beissbarth and Speed, 2004), GOtoolbox
(Martin et al. 2004), and DAVID (Huang et al. 2009). We were unable to identify a significant
enrichment for the gene set indicating that RBPjcKO skin is similar to PSdcKO or PSRBPjcKO
skin.
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CONCLUSIONS
RBPjcKO animals have significantly different phenotypes compared with the
N1N2dcKO and PSdcKO animals (Demehri et al., 2008). We demonstrated that canonical Notch
signals are responsible for the Notch function during epidermal differentiation and hair follicle
maintenance in the embryo. Both E18.5 epidermal transcriptome and P0 epidermal proteome
analysis found no difference between RBPjcKO and PSdcKO epidermis. Moreover, global gene
expression profile analysis for newborn total skin samples suggested that RBPjcKO and PSdcKO
skin transcriptomes are indistinguishable at birth. All of these experiments suggested that there is
no evidence of “epigenetic memory” induced in RBPjcKO animals and canonical Notch signals
are responsible for the mutant phenotypes in the embryo.
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EXPERIMENTAL PROCEDURES
Generation of mice
I have generated the following strains of mice using Msx2-Cre transgene-mediated
deletion in skin keratinocytes (Pan et al., 2004). Animals were raised and kept in the Washington
University Division of Comparative Medicine facility under Washington University Policy on
Animal Care regulations.
Msx2-Cre +/tg; Rbpj floxed/floxed (RBPjcKO)
Msx2-Cre +/tg; Notch1 floxed/floxed; Notch2 floxed/floxed (N1N2dcKO)
Msx2-Cre +/tg; Presenilin1 floxed/floxed; Presenilin2 -/- (PSdcKO)
Msx2-Cre +/tg; Presenilin1 floxed/floxed; Presenilin2 -/-; Rbpj floxed/floxed (PSRBPjcKO)
Histology and H&E Staining
Skin samples were fixed in 4% paraformaldehyde (PFA) in PBS for overnight (o/n),
washed 3x with PBS and washed for 15 min with 30% Ethanol (EtOH) and 50% EtOH, and then
stored in 70% EtOH at 4°C. Skin samples were embedded in paraffin for sectioning at 8-12µm
thickness. A standard H&E staining protocol was used for histology assessment.
Immunohistochemistry
Expression of the RBPjκ protein was detected on 4% PFA fixed paraffin sections with αRBPjκ rat monoclonal antibody T6709 (1:500, Cosmo Bio Co., Ltd) for o/n at 4°C. After o/n
incubation with the primary antibody, several washes (3 x 5 min in 0.5% Triton X-100 in PBS)
were done before a 2h-incubation with an anti-rat HRP-coupled secondary antibody.
Horseradish-peroxidase-conjugated streptavidin and DAB substrate kit (Pierce) were used to
visualize the signal. Sections were weakly counterstained with methyl green.
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RNA isolation, cDNA preparation and quantitative RT-PCR
Skin samples were incubated in 5 mg/mL dispase for 3 hours at 4°C to separate the
epidermis from the dermis. Total RNA was isolated from the E18.5 epidermis, P0 total skin, and
keratinocytes cultured in vitro using TRIzol (Invitrogen) kit or RNeasy kit (Qiagen) according to
the manufacturer's instructions. RNase-free DNase I (Invitrogen, USA) was used to remove any
residual genomic DNA. RNA was dissolved in 30µl of RNAse-free water and stored at -80°C
after RNA quality control (gel electrophoresis) and concentration measurements. Reverse
transcription was performed with 1µg of total RNA, random primers and SuperScript III RNase
H-Reverse Transcriptase (Invitrogen) in a total volume of 20µl. Expression levels of transcripts
were examined by real-time qPCR in a 7500 Real-Time PCR System using SYBR Green dye
(Applied Biosystems), iQ SYBR Green Supermix (Bio-Rad) or TaqMan Probes. The results
were analyzed by absolute quantification with a relative standard curve or relative quantification
of expression according to the “ΔΔC methods” (Livak and Schmittgen, 2001) using
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a reference for normalization. Primers
were designed to amplify targets of 180–220 bp usually at the exon junctions to avoid
amplification from genomic DNA contamination. The specificity of the PCR reactions was
checked by recording a melting curve and by sequencing the amplicons.
Cloning of RBPjwt, RBPjΔ67 and RBPj58S cDNAs into p3xFLAG-CMV7 vector
Following total RNA isolation from Rbpj+/+ and Rbpj-/- keratinocytes, cDNAs were
prepared. The cDNA encoding the amino acid residues 1 through 465 of the mouse RBPjwt gene
was amplified by PCR using Klentaq LA DNA Polymerase (DNA Polymerase Technology,
Inc.).
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To construct RBPjwt and RBPjΔ67 cDNA, the following primers were used:
Rbpj-Fwd (5’-ATGCGAAATTATTTAAAAGAACGAGGGGAT-3’)
Rbpj-Rev (5’-TTAGGACACCACGGTTGCTGTGGACGATGT-3’)
To construct RBPj58S cDNA, the following primers were used:
Rbpj-Fwd (5’-ATGCGAAATTATTTAAAAGAACGAGGGGAT-3’)
Rbpj58-Rev (5’-ACTTTCCTAATTATAGTCAGCATTCTT-3’)
HindIII and BamHI sites were used to clone the cDNAs into the p3xFLAG-CMV7 (SigmaAldrich, St. Louis, MO) vector. DNA sequencing analysis was done to confirm the cloned
vectors.
OT11 (RBPjκ -/-) cell culture and Luciferase Assay
OT11 cells (a gift from Dr. Tasuku Honjo) were seeded at 5 x 104 cells/mL density in
0.5mL/well (24-well plate) in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine
serum, and 100 U/ml penicillin. The following day, cells at 60-70% confluency were transfected
in Opti-MEM-I medium with 300ng reporter vector, 10ng Notch1ΔE (if present), 100ng RBPjwt
(or RBPj58S, RBPjΔ67, RBPjVP16, RBPj58-VP16) and an appropriate amount of balance DNA (to
500ng total DNA/well) using Lipofectamine LTX and PLUS reagent according to the
manufacturer’s instructions. Cells were harvested 48h after transfection and washed once with
PBS. Cells were lysed in 100 µl of lysis buffer (100 mM KPO4 buffer, pH 7.8; 0.2% Triton; 1
mM dithiothreitol (DTT); protease inhibitors) at room temperature for 10 min. 5 µl of lysate was
used to determine β-galactosidase concentration (to normalize for transfection efficiency)
according to the Tropix Galacton chemiluminescent substrate instructions. 50 µl of lysate was
used to determine luciferase activity using assay buffer (30 mM Tricine, pH 7.8; 3 mM ATP; 15
mM MgSO4; 10 mM DTT; 0.2 mM CoA; 1 mM luciferin) and a Tropix TR717 luminometer.
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For each reporter, fold stimulation was expressed relative to the activity of the empty vector
control, which was normalized to a value of 1. All assays were performed in triplicate and error
bars show standard deviation. The data reported in the figures were the representative of a least
three independent experiments. Student’s t-test was used to determine the statistical significance.
Primary Keratinocyte Culture
Newborn (P0) pups were utilized to isolate keratinocytes from epidermis. Skin samples
were incubated in 5 mg/mL dispase o/n at 4°C to separate the epidermis from the dermis. The
next day, epidermis samples were collected and incubated with trypsin at 37°C for 10-15 min to
obtain a single-cell suspension. Cells were passed through a 70µm filter to eliminate large tissue
contamination. Finally, keratinocytes were transferred onto collagen-coated plates and incubated
in Keratinocyte Serum-free Medium (KSFM) for 3-5 days until they reached 80-90%
confluency.
Adeno-Cre/Adeno-GFP infection of keratinocytes in vitro
Rbpjfloxed/floxed animals were used to generate primary keratinocytes. When keratinocytes
reached to 80-90% confluency, they were treated for 48 hours with Adeno-Cre, which mediates
recombination of Rbpjfloxed gene or Adeno-GFP (control). Culture media was replaced with fresh
KSFM. Samples for western blot analysis were collected at 0h, 6h, 12h, 24h, 40h, 48h, 60h, 80h,
90h and 118h post-infection.
Western Blotting Analysis
Cells were lysed in RIPA-Doc buffer (150mM NaCl, 50 mM Tris-HCl, 1% Triton-X,
0.1% SDS, 0.25% Sodium Deoxycholate) containing protease and phosphatase inhibitors (Roche
Complete). Lysates were resolved through an 8% acrylamide gel for SDS-PAGE/Western
Blotting analysis. Quantifications were done by using ImageJ software (NIH). Primary α-RBPjκ
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antibody, T 6709, (rat, 1:500, Cosmo Bio Co., Ltd) was resuspended in 5% milk PBS-T. α-rat
secondary antibody conjugated with HRP was used at a 1/2000 dilution in 5% milk PBS-T and
incubated for 1-2 hours at room temperature. Dura substrate (Thermo Scientific) was used to
perform the enzymatic reaction before film development.
Microarray, Partek Data Analysis, Hierarchical Clustering, and GO Analysis
RNA samples were collected, handled independently and individually throughout the
experiments, without pooling of samples. 28S and 18S ribosomal RNA bands were visualized for
confirmation of the RNA integrity by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). Genome Technology Access Center (WUSTL) performed the quality control for
samples and labeling using Life Technologies Illumina-TotalPrep kits. Illumina MouseWG-6
v2.0 Expression BeadChip (45,281 probes) were used for E18.5 epidermis microarray and three
samples per genotype are examined. Illumina MouseRef-8 v2.0 Expression BeadChip Kit
(25,600 probes) were used for P0 total skin microarray and four samples per genotype are
examined.
Partek Genomic Suite 6.4 software is used to analyze the data. I have performed one-way
ANOVA across all samples and identified statistically significant genes by using mixed model
analysis of variance with a false discovery rate (Benjamini and Hochberg, 1995) or p-value of
P<0.05. Fold-change values >|±1.5| were used for further analysis. To identify functional groups
of genes, we have used unsupervised hierarchical clustering function of Partek software, which
can reveal biologically meaningful patterns within the microarray data. Hierarchical clustering
identifies the pair of genes that are most similar, connects them together, and then finds the next
most similar pair of genes. This process continues until all of the genes are joined into one large
cluster.
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Enrichment analyses for significantly differentially expressed probes were done with
GOminer (Zeeberg et al. 2003), GOstat (Beissbarth and Speed, 2004), GOtoolbox (Martin et al.
2004), and DAVID (Huang et al. 2009) gene enrichment analysis tools. The tools were used with
the default option. The input gene set was consists of 184 genes for E18.5 analysis and 22 genes
for P0 total skin analysis. Whole Mus musculus genome was used as reference background.
Significance threshold was P value < 0.05 for a minimum of two genes from the input list in the
enriched category.
Mass Spectrometry Analysis (provided by MS Core-WUSTL)
Skin samples were incubated in 5 mg/mL dispase for 3 hours at 4°C to separate the
epidermis from the dermis. Epidermal samples were immediately stored at -80°C before
submitting to the Mass Spectrometry Core (WUSTL). Details of the mass spectrometry methods
(In-Solution Protein Digestion and Peptide Preparation, High Resolution MS1 and MS2 Mass
Spectrometry, Data from in-solution digest) were adopted from Chen et al. (2012) based on the
instructions from James P. Malone - Mass Spectrometry Core, Senior Scientist.
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Figure 2-1. Rbpjdel gene is functionally null.
(A) Immunohistochemistry staining for mouse RBPjκ protein in dorsal skin from wt and
RBPjcKO mice confirming the absence of RBPjκ protein in Rbpj-/- keratinocytes at birth (left
panel; Demehri et al. 2008) and at P9 (right panel). (B) Map of the mouse Rbpj gene and its three
mRNA isoforms, LoxP sites are flanking Exon6 and Exon7. Upon recombination, Rbpjdel gene is
generated. Isoforms 201, 202, and 203 (the latter being most abundant isoform) are expressed in
skin. (C) Rbpjdel mRNA is not degraded by nonsense-mediated decay (NMD) and is therefore
expressed in the skin. Sequencing of the mutant fragment confirms that exons 6 and 7 are deleted
in Rbpjdel mRNA. Exon8 immediately follows Exon5 in Rbpjdel leading to a frameshift. A stop
codon is generated after 2 aminoacids within Exon8 due to the frameshift. (D) Diagrams of
Rbpj constructs used in the study. (E) Testing transcriptional activity of RBPjκdel proteins using
Notch-responsive (TP-1 and Hes1) luciferase reporters. OT-11 cells (RBPjκ-/-) were transfected
with TP1 or Hes1-luciferase reporters in addition to an activated form of Notch1 (Notch1ΔE),
RBPjwt, and RBPjdel (RBPj58S and RBPjΔ67) expression vectors and +/- DAPT (γ-secretase
inhibitor) as indicated in the table. (F) Testing the DNA binding ability of RBPjκdel protein by
overexpression of RBPjκ58-VP16 fusion protein +/- Notch1ΔE. (G) Testing dominant negative
activity of RBPjκdel protein by overexpressing RBPj58S together with RBPjVP16 or RBPjwt in the
presence of Notch1ΔE.

Abbreviations: wt (wild type), 58S (Exon5 spliced to Exon8 followed by a premature STOP
codon), Δ67 (deletion of Exon6 and 7), VP16 (a strong transactivation domain)
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Figure 2-2. RBPjκ protein has a 65-hour half-life in skin keratinocytes.
(A) Timeline for mouse epidermal stratification. Msx2-Cre-mediated deletion of target floxed
genes starts at E9.5 and a hypothetical time course RBPjκ protein degradation occurring before
stratification. (B) Recombination kinetics of Rbpjfloxed/floxed gene in keratinocytes. Graph
represents average percentage of Rbpjwt and Rbpjdel mRNA after infection with Adeno-Cre. (C)
Western blotting for RBPjκ protein. Protein samples were collected at the indicated time-points
from Rbpjfloxed/floxed keratinocytes that were infected with Adeno-Cre. (D) Time course of the
degradation of endogenous RBPjκ protein in Rbpjfloxed/floxed keratinocytes following Adeno-Cre
infection. (E) Heatmap and unsupervised hierarchical clustering for E18.5 epidermal microarray
results. Red color indicates upregulation whereas green color represents downregulation.
Distances within the dendrogram display the similarities/dissimilarities of samples (or genes).
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Figure 2-3
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Figure 2-3. Transcriptome and proteome analyses reveal that RBPjcKO is very similar to
PSdcKO at birth.
(A) Heatmap and unsupervised hierarchical clustering for newborn epidermal mass-spectrometry
results. Red color indicates relative increased abundance of corresponding peptide whereas green
color represents decreased abundance. Distances within the dendrogram display the
similarities/dissimilarities among samples. (B) Heatmap and unsupervised hierarchical clustering
for newborn total skin global gene expression analysis results. Upregulation of genes is
designated with red color whereas downregulation of genes are represented with green color. The
degree of similarities/dissimilarities among samples are indicated by the distances within the
dendrogram.
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Table 2-1.

Genes with altered expression in E18.5 PSdcKO epidermis, not changed in E18.5 RBPjcKO epidermis

0.8<no change<1.2

PROBE_ID
ILMN_2739740
ILMN_2771034
ILMN_2645460
ILMN_2629581
ILMN_1226017
ILMN_1232107
ILMN_2628708
ILMN_3143078
ILMN_2505845
ILMN_2594139
ILMN_2609421
ILMN_2728889
ILMN_2714278
ILMN_2589640
ILMN_2589662
ILMN_1254114
ILMN_2926480
ILMN_2509918
ILMN_1254358
ILMN_1232099
ILMN_1258768
ILMN_2737903
ILMN_2543929
ILMN_2682613
ILMN_1228980
ILMN_1219188
ILMN_1220315
ILMN_2770609

TargetID
KRT84
MFGE8
OOEP
COX6A2
2610035D17RIK
BEX2
DEPDC1B
BEX2
DIRAS2
6330403K07RIK
SCGB1C1
SDK1
WDR86
EDNRB
BMP7
ARTN
DIRAS2
TSPAN6
IGFBP5
TSPAN3
KATNAL2
FGD2
CENPW
IGFBP5
G430008M12RIK
AKR1B8
ZC4H2
LOC100047268

Gene Name
keratin 84
milk fat globule-EGF factor 8 protein
oocyte expressed protein Ortholog of Mouse Synonym Ooep
cytochrome c oxidase subunit VIa polypeptide 2
RIKEN cDNA 2610035D17 gene
brain expressed X-linked 2
DEP domain containing 1B
brain expressed X-linked 2
DIRAS family, GTP-binding RAS-like 2
RIKEN cDNA 3110023G01 gene
secretoglobin, family 1C, member 1
sidekick homolog 1, cell adhesion molecule (chicken)
WDR86 - WD repeat domain 86 Ortholog of Mouse Synonym Wdr86
endothelin receptor type B
bone morphogenetic protein 7
artemin
DIRAS family, GTP-binding RAS-like 2
tetraspanin 6
insulin-like growth factor binding protein 5
tetraspanin 3
KATNAL2 - katanin p60 subunit A-like 2 Ortholog of Mouse Synonym Katnal2
FYVE, RhoGEF and PH domain containing 2
CENPW - centromere protein W Ortholog of Mouse Synonym Cenpw
insulin-like growth factor binding protein 5
RIKEN cDNA G430008M12 gene
aldo-keto reductase family 1, member B8
zinc finger, C4H2 domain containing
similar to Immediate early response 5-like

PSdcKO vs. WT Change RBPjcKO vs. WT Change
3.34
UP
0.84
2.14
UP
1.17
2.09
UP
0.97
2.00
UP
1.05
1.94
UP
1.09
1.75
UP
0.93
1.73
UP
0.90
1.70
UP
0.92
1.69
UP
1.07
1.67
UP
1.12
1.65
UP
1.13
1.65
UP
1.16
1.64
UP
1.09
1.62
UP
1.01
1.62
UP
1.13
1.62
UP
0.95
1.61
UP
1.11
1.58
UP
1.08
1.56
UP
1.03
1.55
UP
1.07
1.54
UP
1.13
1.54
UP
1.10
1.53
UP
1.19
1.53
UP
1.07
1.53
UP
1.00
1.53
UP
0.97
1.52
UP
1.03
1.50
UP
1.13
-

PROBE_ID
ILMN_1235403
ILMN_1246816
ILMN_1239055
ILMN_2889832
ILMN_2743831
ILMN_2763498
ILMN_2416620
ILMN_2696110
ILMN_2697380
ILMN_2612238
ILMN_2950422
ILMN_1253237
ILMN_2421890
ILMN_1242413
ILMN_1212626
ILMN_3146204
ILMN_2910714
ILMN_3150233

TargetID
RDHE2
TRIM15
XDH
SERPINA3H
PEPD
PYCARD
MPP7
TPPP
NOTCH3
MFSD6
TPPP
PDCD4
ACACB
TMEM16J
EG665509
NDOR1
CRISP4
ABCA3

Gene Name
PSdcKO vs. WT Change RBPjcKO vs. WT Change
0.28
DOWN
0.84
epidermal retinal dehydrogenase 2
0.34
DOWN
1.01
tripartite motif-containing 15
0.38
DOWN
1.10
xanthine dehydrogenase
0.41
DOWN
1.15
predicted gene 6930; serine (or cysteine) peptidase inhibitor, clade A, member 3H
0.51
DOWN
0.83
peptidase D
0.55
DOWN
0.89
PYD and CARD domain containing
0.55
DOWN
0.84
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)
0.56
DOWN
1.13
tubulin polymerization promoting protein
0.57
DOWN
0.95
Notch gene homolog 3 (Drosophila)
0.57
DOWN
0.89
major facilitator superfamily domain containing 6
0.62
DOWN
0.87
tubulin polymerization promoting protein
0.62
DOWN
0.87
programmed cell death 4
0.64
DOWN
0.86
acetyl-Coenzyme A carboxylase beta
0.64
DOWN
0.96
transmembrane protein 16J
0.64
DOWN
0.91
S100 calcium binding protein A11 (calgizzarin) pseudogene
0.66
DOWN
0.92
NADPH dependent diflavin oxidoreductase 1
0.67
DOWN
1.01
cysteine-rich secretory protein 4
0.67
DOWN
0.98
ATP-binding cassette, sub-family A (ABC1), member 3

Cut off: 1.5 fold

Table 2-1. List of genes that are significantly altered in E18.5 PSdcKO epidermis but
unchanged in RBPjcKO epidermis.
Genome wide mRNA expression analysis was performed in E18.5 PSdcKO, RBPjcKO, WTPS,
and WTRBPj epidermis. We identified 183 genes that had differential expression pattern in Rbpj-/epidermis compared to PS-/- epidermis (<1.5 fold). 28 genes were upregulated in PSdcKO
epidermis but were unchanged in RBPjcKO; whereas 18 genes were downregulated in PSdcKO,
but were unchanged in RBPjcKO.
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Table 2-2.

Genes with upregulated expression in E18.5 RBPjcKO epidermis, but not changed in E18.5 PSdcKO epidermis

0.8<no change<1.2

PROBE_ID
ILMN_2767825
ILMN_1254093
ILMN_2693934
ILMN_2754926
ILMN_2586789
ILMN_2794628
ILMN_1231131
ILMN_1249285
ILMN_1231135
ILMN_2575986
ILMN_2768563
ILMN_1217938
ILMN_1223457
ILMN_1234184
ILMN_2834573
ILMN_2423843
ILMN_1250008
ILMN_1216107
ILMN_2668432
ILMN_2642565
ILMN_2451389
ILMN_2721385
ILMN_2581402
ILMN_2643291
ILMN_2603401
ILMN_1227146
ILMN_2774370
ILMN_2690596
ILMN_1228315
ILMN_1254635
ILMN_2761205
ILMN_2665131
ILMN_1213316
ILMN_2833634
ILMN_1231492
ILMN_2971577
ILMN_1242025
ILMN_2711267
ILMN_2469743
ILMN_2504606
ILMN_1244347
ILMN_2776561
ILMN_1243471
ILMN_2576431
ILMN_1221564
ILMN_1225191
ILMN_2749138
ILMN_2680628
ILMN_2555646
ILMN_1229652

TargetID
2210011C24RIK
2610206P12RIK
4833444G19RIK
4931406B18RIK
5730420E01RIK
5730577I03RIK
5830477G23RIK
6430514E02RIK
A230077I10RIK
A730085F06RIK
ABCB1A
AKAP8
BC026657
BC061039
BRWD1
CDH13
CHK
D130035M05RIK
ATP6V1B1
DEFCR6
DPYSL2
DST
E330009F12RIK
EIF4E3
EPYC
FRAS1
FRAS1
HEY1
HMGXB3
HPBRII4
HSPB8
IHPK1
ING3
IQUB
ITGA6
KATNAL1
KCNC4
KRT18
LOC100046793
LOC100047264
LOC384065
LOC545732
LOC635992
LPIN2
LTBP1
NAPRT1
PARD3B
PBLD
PRKCSH
PROSER1

PSdcKO vs. WT Change RBPjcKO vs. WT Change
1.06
1.62
UP
1.10
1.68
UP
0.89
1.91
UP
0.92
1.53
UP
1.10
1.53
UP
1.09
1.55
UP
1.10
1.63
UP
1.00
1.68
UP
1.02
1.55
UP
1.19
1.64
UP
0.96
1.63
UP
1.06
1.70
UP
1.04
1.53
UP
1.09
1.73
UP
1.04
1.50
UP
1.19
1.99
UP
1.10
1.75
UP
0.98
1.60
UP
1.13
1.60
UP
0.91
1.59
UP
0.95
1.53
UP
1.06
1.55
UP
1.05
1.91
UP
1.06
1.52
UP
1.15
1.81
UP
0.96
1.92
UP
0.95
1.84
UP
1.09
2.11
UP
0.94
1.70
UP
1.01
1.51
UP
1.17
1.94
UP
1.11
1.53
UP
0.97
1.50
UP
1.09
1.67
UP
1.16
1.56
UP
1.14
1.63
UP
0.91
1.67
UP
1.02
1.50
UP
1.17
1.58
UP
0.97
1.53
UP
1.01
1.53
UP
1.02
1.60
UP
1.13
1.57
UP
1.05
1.63
UP
1.03
1.77
UP
0.94
1.54
UP
1.17
1.52
UP
1.12
1.63
UP
1.04
1.53
UP
1.13
1.56
UP

Gene Name
RIKEN cDNA 2210011C24 gene
RIKEN cDNA 2610206P12 gene
RIKEN cDNA 4833444G19 gene
RIKEN cDNA 4931406B18 gene
RIKEN cDNA 5730420E01 gene
RIKEN cDNA 5730577I03 gene
RIKEN cDNA 5830477G23 gene
RIKEN cDNA 6430514E02 gene
RIKEN cDNA A230077I10 gene
RIKEN cDNA A730085F06 gene
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
A kinase (PRKA) anchor protein 8
KIAA1217 - KIAA1217 Ortholog of Mouse Synonym Etl4
bromodomain and WD repeat domain containing 1
cadherin 13
choline kinase
RIKEN cDNA D130035M05RIK gene
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
defensin related cryptdin 6
dihydropyrimidinase-like 2
dystonin; hypothetical protein LOC100047109
RIKEN cDNA E330009F12 gene
eukaryotic translation initiation factor 4E member 3
epiphycan
Fraser syndrome 1 homolog (human)
Fraser syndrome 1 homolog (human)
hairy/enhancer-of-split related with YRPW motif 1
HMG box domain containing 3
heat shock protein 8
inositol hexakisphosphate kinase 1
inhibitor of growth family, member 3
IQ motif and ubiquitin domain containing
integrin alpha 6
katanin p60 subunit A-like 1
potassium voltage gated channel, Shaw-related subfamily, member 4
keratin 18

similar to ubiquitin-conjugating enzyme E2 variant 2
lipin 2
latent transforming growth factor beta binding protein 1
nicotinate phosphoribosyltransferase domain containing 1
par-3 partitioning defective 3 homolog B (C. elegans)
phenazine biosynthesis-like protein domain containing
protein kinase C substrate 80K-H
proline and serine rich 1

Cut off: 1.5 fold

PROBE_ID
ILMN_3144358
ILMN_2539806
ILMN_2448404
ILMN_2438404
ILMN_2636183
ILMN_2725927
ILMN_2743650
ILMN_2433848
ILMN_1249578
ILMN_3065555
ILMN_1251084
ILMN_2776283
ILMN_2551339
ILMN_1231006
ILMN_2666347
ILMN_2704186
ILMN_2704184
ILMN_1212982
ILMN_2854036
ILMN_2896341

TargetID
RNASEN
SBK2
SCL0002975.1_346
SCL0003476.1_2802
SCUBE2
SERPINA3G
SETD5
SLCO2A1
SORL1
SPEER1-PS1
TBN-PENDING
TCEA3
TRIM35
TRP53
VEZT
WLS
WLS
ZFP318
ZFP553
ZFP709

Gene Name
ribonuclease III, nuclear
SH3-binding domain kinase family, member 2

PSdcKO vs. WT Change RBPjcKO vs. WT Change
1.14
1.58
UP
1.11
1.54
UP
0.97
1.81
UP
1.05
1.53
UP
1.16
1.53
UP
similar to signal peptide, CUB domain, EGF-like 2; signal peptide, CUB domain, EGF-like 2
1.04
1.63
UP
serine (or cysteine) peptidase inhibitor, clade A, member 3G
1.13
1.56
UP
SET domain containing 5
0.90
1.66
UP
solute carrier organic anion transporter family, member 2a1
1.07
1.68
UP
similar to sortilin-related receptor, LDLR class A repeats-containing; sortilin-related receptor
0.84
1.51
UP
predicted gene 6465; spermatogenesis associated glutamate (E)-rich protein 1
1.13
1.81
UP
0.86
2.08
UP
transcription elongation factor A (SII), 3
1.19
1.59
UP
tripartite motif containing 35
1.12
1.58
UP
transformation related protein 53
1.01
1.55
UP
vezatin, adherens junctions transmembrane protein
1.18
1.53
UP
wntless homolog (Drosophila)
1.17
1.52
UP
wntless homolog (Drosophila)
1.19
1.56
UP
zinc finger protein 318
1.19
1.51
UP
zinc finger protein 553
1.08
1.62
UP
zinc finger protein 709

Table 2-2. List of genes that are upregulated in E18.5 RBPjcKO epidermis but are
unaltered in PSdcKO epidermis.
Genome wide mRNA expression analysis was performed in E18.5 PSdcKO, RBPjcKO, WTPS,
and WTRBPj epidermis. We identified 183 genes that have differential expression pattern between
Rbpj-/- and PS-/- epidermis (<1.5 fold). 70 genes were upregulated in RBPjcKO epidermis, but
were unchanged in PSdcKO.
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Table 2-3.

Genes with downregulated expression in E18.5 RBPjcKO epidermis, but not changed in E18.5 PSdcKO epidermis

0.8<no change<1.2

PROBE_ID
ILMN_1240567
ILMN_2619836
ILMN_2730311
ILMN_2760525
ILMN_2610909
ILMN_2766213
ILMN_2658592
ILMN_2632293
ILMN_2664739
ILMN_1222734
ILMN_1218327
ILMN_2640082
ILMN_2767236
ILMN_2755241
ILMN_1225813
ILMN_2661904
ILMN_2634430
ILMN_2659237
ILMN_3145881
ILMN_1251150
ILMN_2513329
ILMN_1214659
ILMN_1255921
ILMN_2753029
ILMN_2665266
ILMN_2680808
ILMN_1226083
ILMN_1258846
ILMN_2898506
ILMN_2420817
ILMN_2493791
ILMN_2699167
ILMN_1252602
ILMN_2534848
ILMN_1252133
ILMN_2535555
ILMN_1213522
ILMN_1224653
ILMN_1246590
ILMN_2769573
ILMN_2741556
ILMN_2476070
ILMN_2643547
ILMN_2423481
ILMN_1233595
ILMN_2545718
ILMN_1224128
ILMN_2615054
ILMN_1219081
ILMN_3160581

TargetID
1700060J05RIK
2310039H08RIK
2610017I09RIK
4930432K09RIK
4930448I06RIK
4933414I15RIK
5830411N06RIK
6530401N04RIK
ADAM28
ALDH1A1
ALG8
ATP6V1G2
CD5L
CDCA1
CDK17
CHRM5
CILP
CML5
CNOT2
CYP2C29
DNAH17
EG633692
ELAC2
GCH1
H2-T10
HNRNPH2
IFLTD1
KRR1
LDOC1
LOC100044314
LOC100045971
LOC100046918
LOC100048622
LOC235966
LOC269859
LOC382683
LOC383460
LOC432730
LOC545208
LOC627424
LY6I
MBTD1
MPHOSPH10
MPPED2
MRPL15
MSH5
NFE2L2
OLFR521
OLFR700
PAWR

PSdcKO vs. WT Change RBPjcKO vs. WT Change
1.18
0.63
DOWN
0.98
0.50
DOWN
1.06
0.56
DOWN
0.92
0.54
DOWN
0.90
0.56
DOWN
1.00
0.57
DOWN
0.89
0.67
DOWN
0.92
0.68
DOWN
0.98
0.66
DOWN
0.86
0.67
DOWN
0.88
0.62
DOWN
0.88
0.67
DOWN
1.01
0.65
DOWN
0.98
0.64
DOWN
0.92
0.61
DOWN
0.93
0.68
DOWN
0.94
0.68
DOWN
1.05
0.67
DOWN
1.06
0.67
DOWN
0.85
0.57
DOWN
0.89
0.66
DOWN
0.92
0.65
DOWN
0.87
0.64
DOWN
0.86
0.45
DOWN
1.00
0.48
DOWN
0.97
0.54
DOWN
0.95
0.62
DOWN
0.88
0.66
DOWN
1.05
0.68
DOWN
1.01
0.64
DOWN
1.01
0.63
DOWN
0.84
0.67
DOWN
0.86
0.57
DOWN
0.96
0.61
DOWN
0.89
0.64
DOWN
0.92
0.66
DOWN
0.99
0.57
DOWN
1.10
0.62
DOWN
0.87
0.66
DOWN
0.92
0.58
DOWN
0.87
0.56
DOWN
0.89
0.66
DOWN
1.11
0.66
DOWN
0.96
0.67
DOWN
0.98
0.65
DOWN
1.15
0.65
DOWN
0.92
0.64
DOWN
0.96
0.56
DOWN
0.85
0.59
DOWN
0.92
0.64
DOWN

Gene Name
RIKEN cDNA 1700060J05 gene
RIKEN cDNA 2310039H08 gene
RIKEN cDNA 2610017I09 gene
RIKEN cDNA 4930432K09 gene
RIKEN cDNA 4930448I06 gene
RIKEN cDNA 4933414I15 gene
RIKEN cDNA 5830411N06 gene
RIKEN cDNA 6530401N04 gene
a disintegrin and metallopeptidase domain 28
aldehyde dehydrogenase family 1, subfamily A1
asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase)
ATPase, H+ transporting, lysosomal V1 subunit G2
CD5 antigen-like
hypothetical protein LOC100191040
Cyclin-Dependent Kinase 17
cholinergic receptor, muscarinic 5
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
camello-like 5
CCR4-NOT transcription complex, subunit 2
cytochrome P450, family 2, subfamily c, polypeptide 29
Dynein, Axonemal, Heavy Chain 17
elaC homolog 2 (E. coli)
GTP cyclohydrolase 1
histocompatibility 2, T region locus 10
heterogeneous nuclear ribonucleoprotein H2
intermediate filament tail domain containing 1; similar to RIKEN cDNA 4933403M22
KRR1, small subunit (SSU) processome component, homolog (yeast)
leucine zipper, down-regulated in cancer 1
hypothetical protein LOC100044094; similar to X-linked lymphocyte-regulated protein 3A

RIKEN cDNA 1500003O03 gene; similar to EF-hand Ca2+ binding protein p22

lymphocyte antigen 6 complex, locus I
mbt domain containing 1
M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)
Metallophosphoesterase Domain Containing 2
mitochondrial ribosomal protein L15
mutS homolog 5 (E. coli)
nuclear factor, erythroid derived 2, like 2
olfactory receptor 521
olfactory receptor 700
PRKC, apoptosis, WT1, regulator

Cut off: 1.5 fold

PROBE_ID
ILMN_2676406
ILMN_1220187
ILMN_2484358
ILMN_2742778
ILMN_2682945
ILMN_2918663
ILMN_2750669
ILMN_1227647
ILMN_2485774
ILMN_2611532
ILMN_2852380
ILMN_2611159
ILMN_2942344
ILMN_3160610
ILMN_2579611
ILMN_1234558
ILMN_2702499
ILMN_2521109
ILMN_1219688
ILMN_2516374
ILMN_2653642

TargetID
PCK2
PPP1CC
PPP1R3E
PPP2R2A
PSMD2
RMND5B
RNGTT
RSRC2
SCL0001371.1_19
SLC25A19
SRP54
STARD7
STC1
SVAL2
TMED7
TMEM33
TTC32
UBE2G2
V1RD15
YME1L1
ZC3H14

Gene Name
PSdcKO vs. WT Change RBPjcKO vs. WT Change
0.85
0.59
DOWN
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
0.93
0.63
DOWN
predicted gene 9231; similar to protein phosphatase 1, catalytic subunit, beta; protein phosphatase 1
1.07
0.59
DOWN
protein phosphatase 1, regulatory (inhibitor) subunit 3E
0.84
0.57
DOWN
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform
0.84
0.62
DOWN
predicted gene 5422; proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
0.91
0.55
DOWN
required for meiotic nuclear division 5 homolog B (S. cerevisiae)
1.04
0.67
DOWN
RNA guanylyltransferase and 5'-phosphatase
0.91
0.67
DOWN
arginine/serine-rich coiled-coil 2
0.97
0.66
DOWN
0.84
0.67
DOWN
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
0.93
0.62
DOWN
Signal Recognition Particle 54kDa
0.92
0.66
DOWN
START domain containing 7
1.03
0.60
DOWN
stanniocalcin 1
1.10
0.56
DOWN
seminal vesicle antigen-like 2
0.93
0.65
DOWN
Transmembrane Emp24 Protein Transport Domain Containing 7
0.89
0.68
DOWN
transmembrane protein 33
1.03
0.68
DOWN
tetratricopeptide repeat domain 32
0.89
0.68
DOWN
ubiquitin-conjugating enzyme E2G 2
0.90
0.62
DOWN
vomeronasal 1 receptor, D15
1.08
0.62
DOWN
YME1-like 1 (S. cerevisiae)
0.92
0.64
DOWN
zinc finger CCCH type containing 14

Table 2-3. List of genes that were downregulated in E18.5 RBPjcKO epidermis but were
unchanged in PSdcKO epidermis.
Genome wide mRNA expression analysis was performed in E18.5 PSdcKO, RBPjcKO, WTPS,
and WTRBPj epidermis. We identified 183 genes that have differential expression patterns
between Rbpj-/- and PS-/- epidermis (<1.5 fold). 71 genes were downregulated in RBPjcKO
epidermis but were not altered in PSdcKO.
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Table 2-4.

Genes with altered expression in P0 RBPjcKO skin, but not changed in P0 PSdcKO or PSR skin

Probeset ID
160692
7040091
5900605
610594
6330731
7050678
1190398
3940255
2710386
4560634
60603

SYMBOL
LOC434172
Ggt5
Zfp367
Sesn3
Abcb11
V1rd20
Ugt1a2
Sos1
Vwa1
Bmyc
Havcr2

Table 2-5.

Genes with altered expression in P0 PSdcKO or PSR skin, but not changed in P0 RBPjcKO skin

Probeset ID
4180367
5390639
4200368
6420133
1050092
4610010
2230465
6450403
2810129
540463
4260152

SYMBOL
Fbxw11
Cxcl2
Cttnbp2
Zfp426
Serpina3g
Slc5a9
Itih4
2410005O16Rik
Paxip1
Unc13c
Rorc

Gene Names
gamma-glutamyltransferase 5
zinc finger protein 367
sestrin 3
ATP-binding cassette, sub-family B (MDR/TAP), member 11
UDP glucuronosyltransferase 1 family, polypeptide A2
son of sevenless homolog 1 (Drosophila)
von Willebrand factor A domain containing 1
brain expressed myelocytomatosis oncogene
hepatitis A virus cellular receptor 2

Gene Names
F-box and WD repeat domain containing 11
chemokine (C-X-C motif) ligand 2
cortactin binding protein 2

0.8<no change<1.2

Cut off: 1.5 fold

PSdcKO vs. WT Change PSR vs. WT Change RBPjcKO vs WT Change
1.05
1.02
1.68
UP
1.06
1.00
1.58
UP
0.92
1.02
1.57
UP
0.97
0.97
1.57
UP
0.99
1.04
0.66
DOWN
1.01
1.01
0.65
DOWN
0.94
1.05
0.64
DOWN
1.00
0.93
0.64
DOWN
0.96
0.92
0.63
DOWN
1.04
0.91
0.60
DOWN
0.95
0.98
0.58
DOWN

0.8<no change<1.2

Cut off: 1.5 fold

PSdcKO vs. WT Change PSR vs. WT Change RBPjcKO vs WT Change
2.01
UP
1.78
UP
1.08
1.62
UP
1.70
UP
0.97
1.61
UP
1.57
UP
1.01
1.63
UP
1.52
UP
1.04
1.68
UP
1.49
UP
1.00
serine (or cysteine) peptidase inhibitor, clade A, member 3G
0.66
DOWN
0.69
DOWN
0.99
solute carrier family 5 (sodium/glucose cotransporter), member 9
0.71
DOWN
0.67
DOWN
1.00
inter alpha-trypsin inhibitor, heavy chain 4
0.69
DOWN
0.66
DOWN
0.92
0.58
DOWN
0.66
DOWN
0.97
PAX interacting (with transcription-activation domain) protein 1
0.66
DOWN
0.66
DOWN
0.93
unc-13 homolog C (C. elegans)
0.67
DOWN
0.58
DOWN
0.92
RAR-related orphan receptor C

Table 2-4 & 2-5. List of genes that are significantly altered in P0 PSdcKO and PSR vs.
RBPjcKO total skin.
We have performed global gene expression profile analysis for P0 PSdcKO, PSR, RBPjcKO,
WT total skin samples. 22 genes were identified to have significantly different expression
patterns in RBPjcKO total skin vs PSdcKO (or PSR) total skin (<1.5 fold). 4 genes were
upregulated in RBPjcKO skin but unchanged in PSdcKO and PSR skin whereas 7 genes were
downregulated in RBPjcKO but unchanged in PSdcKO and PSR. In addition, 6 genes had
increased expression and 5 genes had decreased expression in PSdcKO and PSR but were
unchanged in RBPjcKO.
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CHAPTER III

γ-secretase cleaved Notch1 ICD
is necessary and sufficient to drive
the milder phenotype in RBPjcKO animals

Author Contribution
The author performed all the experiments, wrote the text, and prepared the figures in this chapter.
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SUMMARY
In the epidermis, Notch signaling regulates epidermal integrity and barrier formation. In
the hair follicle, it has a crucial function for the maintenance of hair follicle morphology. Loss of
Notch signaling in embryonic skin keratinocytes causes differentiation defects in the epidermis,
loss of cellular identity in the IRS and induction of epidermal differentiation program in hair
follicle ORS cells. In response to these problems, suprabasal keratinocytes and epidermal cells
within the hair follicle cysts collectively express TSLP, which is then released into the systemic
circulation. The high level of TSLP induces expansion of immature B cells leading to BLPD and
eventually death of the animal. Interestingly, RBPjcKO animals had a different phenotype
compared to the N1N2dcKO and PSdcKO animals. We performed epistasis analysis to
determine the factors that are necessary and sufficient to cause the milder phenotype in the
RBPjcKO animals. We ruled out target derepression and Ligand Back Signaling (LBS) as the
underlying mechanisms mediating the milder RBPjcKO phenotypes. Our genetic analyses
suggest that γ-secretase-cleaved Notch1 ICD is necessary and sufficient to drive the milder
phenotype in RBPjcKO animals.
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INTRODUCTION
Notch1, Notch2 and Notch3 receptors play an important role in keratinocytes to maintain
skin homeostasis. Loss-of-Notch signaling leads to differentiation defects in the epidermis
(Lowell et al., 2000; Nickoloff et al., 2002; Rangarajan et al., 2001; Blanpain et al., 2006;
Moriyama et al., 2008), and a failure in maintaining IRS cellular identity as well as inappropriate
activation of the epidermal differentiation program in ORS cells (Pan et al., 2004, Demehri et al.
2008). Stepwise reduction of Notch dosage leads to progressive skin perturbations, ultimately
leading to the conversion of hair follicles into epidermal cysts (Pan et al., 2004; Demehri et al.,
2008). Differentiation defects in epidermal keratinocytes and activation of epidermal
differentiation program in ORS cells collectively trigger expression of TSLP (Demehri et al.
2008). TSLP is an epithelial-derived cytokine originally discovered for its ability to promote
activation of B lymphocytes (Friend et al., 1994; Levin et al., 1999), myeloid DCs (Reche et al.,
2001; Soumelis et al., 2002) and Th2 cell differentiation of naive T cells (Watanabe et al., 2004).
Secretion of TSLP into the systemic blood circulation induces expansion of pre-B cells resulting
in B-cell Lymphoproliferative Disease (BLPD) in mutant animals (Demehri et al., 2008).
Interestingly, serum TSLP levels in mutant animals inversely correlate with the dose of Notch in
the skin (Demehri et al. 2008). Moreover, the severity of the BLPD during the first few weeks of
life is directly correlated with the levels of TSLP in the sera (Demehri et al. 2008), such that
extreme BLPD causes death in PSdcKO and N1N2dcKO animals (Demehri et al. 2008). As a
result, TSLP levels in serum, WBC counts, and life expectancy of mutant animals showed a
strong inverse correlation with the dose of Notch signaling (Demehri et al., 2008) allowing us to
use these parameters to characterize the severity of the phenotype during the course of the
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disease (Figure 1-4).
We have previously shown that keratinocyte-specific deletion of the Rbpj gene
(RBPjcKO) produced a significantly milder phenotype than the keratinocyte-specific deletion of
both Notch1 and Notch2 genes (N1N2dcKO) or Presenilin1 and Presenilin2 genes (PSdcKO)
(Demehri et al., 2008). While dissecting the pathway to identify reasons for the milder
phenotype, we proposed three possible explanations: (1) derepression of target genes, (2) ligand
back signaling (LBS), and/or (3) cleavage-dependent RBPjκ-independent Notch1 ICD activity.
We provide evidence that γ-secretase cleaved Notch1 ICD is necessary and sufficient for the
milder phenotype in the absence of RBPjκ.
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RESULTS AND DISCUSSION
Target derepression is not mediating ameliorated RBPjcKO phenotype
RBPjκ can act as a repressor (Dou et al., 1994; Hsieh and Hayward, 1995). Therefore,
loss of RBPjκ protein might lead to the elimination of co-repressor complexes and derepression
of some of the targets, thereby improving the phenotype in RBPjcKO animals compared to the
N1N2dcKO or PSdcKO mutants. If target derepression is causing the milder phenotype, then
removing Rbpj in the background of Notch1 and Notch2 loss (N1N2RBPjcKO) or Preselin1 and
Presenilin2 loss (PSRBPjcKO) should resemble RBPjcKO mutant phenotype. To test the
possibility of target derepression, Demehri et al generated triple mutants of N1N2RBPjcKO and
PSRBPjcKO and showed that the N1N2RBPjcKO triple mutant animals were similar to
N1N2dcKO mutants and the PSRBPjcKO animals were similar to PSdcKO mutants (Demehri et
al., 2008). To confirm these findings, I compared the lifespans, WBC counts, serum TSLP levels,
and overall skin morphology of these different mutants (Figure 3-2). I observed similar results
suggesting that target derepression does not mediate milder RBPjcKO phenotype.
Ligand Back Signaling is not the reason behind the milder RBPjcKO phenotype
We confirmed that canonical Notch signaling is eliminated in RBPjcKO animals
(Chapter 2) and target derepression was not the reason behind the milder phenotype (Figure 3-2;
Demehri et al., 2008). Another possible explanation for the ameliorated RBPjcKO phenotype
could be Ligand Back Signaling (LBS). In the absence of RBPjκ, Notch ligands (Delta-like 1, 3,
4 and Jagged 1, 2) are still able to interact with Notch receptors. It has been previously shown
that not only Notch receptors, but also DSL ligands undergo proteolytic cleavages upon receptorligand interaction (Qi et al., 1999; Ikeuchi & Sisodia, 2003; LaVoie & Selkoe, 2003; Bland et al.,
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2003; Six et al., 2003; Zolkiewska, 2008). After cleavages of these ligands by ADAM
metalloproteases and γ-secretase, Delta Intracellular Domain (Delta ICD), and/or Jagged
Intracellular Domain (Jagged ICD) are produced and can translocate to the nucleus (Ikeuchi &
Sisodia, 2003; LaVoie & Selkoe, 2003; Bland et al., 2003; Six et al., 2003; Zolkiewska, 2008;
Duryagina et al. 2013). In the nucleus, Delta ICD can activate TGF-β/Activin signaling through
Smads (Hiratochi et al., 2007; Bordonaro et al., 2011) and/or Jagged ICD can stimulate AP1dependent gene expression (LaVoie & Selkoe, 2003).
To test whether LBS is mediating the milder phenotype in RBPjcKO animals, we decided
to use a mouse model that expresses an allele of the Notch1 receptor carrying a fully functional
extracellular domain but whose intracellular domain has been replaced with a heterologous
protein, in this case the tamoxifen-inducible form of Cre-recombinase) CreERT (Figure 3-3A).
Ligand binding can still trigger a conformational change in the Notch1-CreERT receptor
(N1CreERT), and induce proteolytic cleavages, thereby releasing the CreERT molecule instead
of Notch1ICD. The liberated CreERT molecule can translocate to the nucleus in the presence of
tamoxifen and recombine floxed reporter alleles such as Rosa26R (Soriano, 1999). This can be
visualized in the skin by X-gal assay (Figure 3-3B). Since ligand-receptor engagement is normal
in the cells with N1CreERT, the ligand-presenting cells are expected to produce Delta ICD
and/or Jagged ICD upon Notch-ligand interaction and able to activate Ligand ICD dependent
gene expression.
To ask if the underlying cause for the milder phenotype in RBPjcKO animals is explained
by LBS, we determined the impact of N1CreERT on the phenotype of mice lacking Notch1 and
Notch2 receptors in keratinocytes and compare it to the RBPjcKO animals. The overall hair
phenotypes in N1CreERTN2dcKO resembled N1N2dcKO animals, but not RBPjcKO animals
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(Figure 3-3C), supporting the idea that the milder phenotype is not due to LBS. Similarly, when
we analyzed the histological sections from N1CreERTN2dcKO and RBPjcKO animals, we
concluded that N1CreERTN2dcKO skin is significantly different than RBPjcKO skin (Figure 33D). N1CreERTN2dcKO skin had a higher number of cystic hair follicles with a greater severity
in morphology and a lower number of adipocytes compared to RBPjcKO skin. Analysis of
lifespan, WBC counts, and serum TSLP levels of N1CreERTN2dcKO animals were all similar to
the N1N2dcKO animals (Figure 3-3E).
In summary, the LBS hypothesis was tested by utilizing a Notch receptor,
Notch1CreERT (N1CreERT), that has functional Ligand-back-signaling, but lacking canonical
Notch signaling. Animals that express N1CreERT receptor in N1-/-N2-/- skin keratinocytes were
similar to N1N2dcKO animals in terms of their hair-loss phenotype, skin morphology, lifespan,
WBC counts, and serum TSLP levels indicating that the ameliorated RBPjcKO phenotype is not
due to LBS.
γ-secretase cleaved unstable Notch1 ICD is sufficient to drive the milder phenotype in
N1vgN2RBPjcKO animals
We eliminated target derepression (Chapter 3.1) and LBS (Chapter 3.2) hypotheses by
using triple mutants and N1CreERTN2dcKO animals, respectively. There is one possible
explanation left to test: RBPjκ-independent γ-secretase-cleaved Notch1 ICD is responsible for
the amelioration of the phenotype in these animals.
We know that Notch ICD is necessary for the milder phenotype (N1N2dcKO and
PSdcKO animals do not have NICD while RBPjCKO animals do). To determine whether
Notch1ICD is sufficient to drive the RBPjcKO phenotype, we utilized another mouse line,
Notch1 VG (Figure 3-4A). Notch1VG (N1vg) carries a point mutation in the Notch1 allele,
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leading to a Valine to Glycine amino acid conversion at position 1744 of the receptor (Huppert et
al., 2000) (Figure 3-4A). This allele has been characterized as a hypomorphic allele of Notch1
gene due to a shorter half-life of the Notch1ICD molecule upon proteolytic cleavage of the
receptor by γ-secretase (Huppert et al., 2000; Blat et al., 2002; Tagami et al., 2008). Due to
shorter half-life of the Notch1ICD, canonical Notch signaling in these animals is severely
reduced such that N1vg/vg animals are embryonic lethal at E10.5 (Huppert et al., 2000). We
decided to use the severely impaired N1vg allele to test whether unstable Notch1ICD is sufficient
to drive the milder RBPjcKO phenotype.
If N1vgN2RBPjcKO animals are similar to RBPjcKO animals, then we would conclude
that one allele of an unstable Notch1ICD is sufficient to ameliorate the N1N2RBPjcKO
phenotype in an RBPjκ-independent manner.
We compared overall hair phenotypes, lifespans, WBC counts, and serum TSLP levels in
N1vgN2RBPjcKO, N1N2dcKO and RBPjcKO animals. We found that N1vgN2RBPjcKO
animals resembled RBPjcKO animals, not N1N2dcKO animals (Figure 3-4C). When we
analyzed the histological sections from N1vgN2RBPjcKO, N1N2dcKO and RBPjcKO animals,
we concluded that N1vgN2RBPjcKO skin was significantly different from the N1N2dcKO skin.
N1vgN2RBPjcKO skin had less number of cystic hair follicles with a milder distorted
morphology compared to N1N2dcKO skin (Figure 3-3D). Analysis of lifespan, WBC counts,
and serum TSLP levels revealed that N1vgN2RBPjcKO animals were similar to the RBPjcKO
animals (Figure 3-3E), suggesting that even unstable Notch1ICD is sufficient to rescue the
phenotype.
In conclusion, I demonstrated that animals that express N1vg receptor in the background
of N1N2-loss in skin keratinocytes were similar to RBPjcKO in terms of their hair loss
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phenotype, skin morphology, lifespan, WBC counts, and serum TSLP levels indicating that
ameliorated RBPjcKO phenotype can be rescued by unstable Notch1 ICD molecule.
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CONCLUSIONS
While dissecting the pathway to identify reasons for the milder phenotype, we proposed
three possible explanations: (1) derepression of target genes, (2) ligand back signaling (LBS),
and/or (3) γ-secretase-cleaved RBPjκ-independent Notch1 ICD activity. We performed epistasis
analysis to determine the factors that are necessary and sufficient for the RBPjcKO phenotype.
We ruled out target derepression and LBS as the underlying mechanisms. We provide evidence
that γ-secretase cleaved Notch1 ICD is necessary and sufficient to drive the milder phenotype in
RBPjcKO animals.
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EXPERIMENTAL PROCEDURES
Generation of mice
I have generated the following strains of mice using Msx2-Cre transgene-mediated
deletion in skin keratinocytes (Pan et al., 2004). Animals were raised and kept in the Washington
University Division of Comparative Medicine Animal Facility under Washington University
Policy on Animal Care regulations.
Msx2-Cre +/tg; Rbpj floxed/floxed (RBPjcKO)
Msx2-Cre +/tg; Notch1 floxed/floxed; Notch2 floxed/floxed (N1N2dcKO)
Msx2-Cre +/tg; Notch1 floxed/floxed; Notch2 floxed/floxed; Rbpj floxed/floxed (N1N2RBPjcKO)
Msx2-Cre +/tg; Presenilin1 floxed/floxed; Presenilin2 -/- (PSdcKO)
Msx2-Cre +/tg; Presenilin1 floxed/floxed; Presenilin2 -/-; Rbpj floxed/floxed (PSRBPjcKO)
Msx2-Cre +/tg; Notch1 floxed/CreERT; Notch2 floxed/floxed (N1CreERTN2dcKO)
Msx2-Cre +/tg; Notch1 floxed/V-g; Notch2 floxed/floxed; Rbpj floxed/floxed (N1vgN2RBPjcKO)
Histology and H&E Staining
Skin samples were fixed in 4% paraformaldehyde (PFA) in PBS overnight (o/n), rinsed
3X in PBS and then washed with 30% Ethanol (EtOH) and 50% EtOH before storing them in
70% EtOH at 4°C. Skin samples were embedded in paraffin for sectioning at 8-12µm thickness.
A standard H&E staining protocol was used for histology assessment.
Lifespan
For longevity analysis, mice were monitored on a daily basis for weakness, loss of
appetite and morbidity. To provide a better nursing opportunity, unnecessary wt littermates were
removed. Mutant animals were left with their mothers during the course experiment.
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Measurement of WBC counts
Mandibular vein was used for blood sample collection. Complete blood counts including
WBCs, platelets, red blood cells, white cell differential counts, and hemoglobin measurements
were done with the Hemavet 950 analyzer (Drew Scientific).
Serum TSLP measurements
Total serum TSLP was determined using LEGEND MAX™ Mouse TSLP ELISA Kit
(Biolegend) following the manufacturer’s instructions.
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Figure 3-1. Epistasis analysis to determine the factors that are necessary and sufficient for
the milder RBPjcKO phenotype.
While dissecting the pathway to identify reasons for the milder RBPjcKO phenotype, we
proposed three possible explanations: (1) derepression of target genes, (2) ligand back signaling
(LBS), and (3) cleavage-dependent RBPjκ-independent Notch1 ICD activity. We have generated
the indicated genotypes and provided evidence that γ-secretase cleaved Notch1 ICD is necessary
and sufficient for the milder phenotype in the absence of RBPjκ.
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Figure 3-2
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Figure 3-2. Derepression is not the mechanism behind the milder RBPjcKO phenotype.
Triple mutant of Notch1, Notch2, and Rbpj (N1N2RBPjcKO) or Presenilin1, Preselin2, and Rbpj
(PSRBPjcKO) are as severe as N1N2dcKO or PSdcKO, respectively. We have compared
lifespans, WBC counts, serum TSLP levels (measured during second week of life) and overall
skin morphology of indicated Notch mutants and wt animals.
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Figure 3-3. Ligand back signaling does not mediate the milder phenotype in RBPjcKO
animals. (A) Diagram showing the structure of the Notch1CreERT (N1CreERT) receptor with
respect

to

Notch1wt.

(B)
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staining

for

4-OH

tamoxifen-injected
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Rosa26R/Rosa26R skin confirming N1CreERT receptor is functional and can be activated by
ligands. (C) Overall dorsal hair phenotype and (D) histological analysis of the P9 skin samples of
the WT, N1N2dcKO, N1CreERTN2dcKO, and RBPjcKO animals. (E) Analysis of lifespans,
WBC counts, and serum TSLP levels (measured during second week of life) of WT,
N1N2dcKO, N1CreERTN2dcKO, and RBPjcKO animals.
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Figure 3-4. Cleavage-dependent unstable version of Notch1 ICD (N1vgICD) is sufficient to
reconstitute RBPjcKO phenotype. (A) Diagram showing the structure of Notch1vg (N1vg)
receptor with respect to Notch1wt. (B) Overall dorsal hair phenotype and (C) histological analysis
of the P9 skin samples of WT, N1N2dcKO, RBPjcKO, and N1vgN2RBPjcKO animals. (E)
Analysis of lifespans, WBC counts, and serum TSLP levels (measured during second week of
life) of WT, N1N2dcKO, N1CreERTN2dcKO, and RBPjcKO animals.
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CHAPTER IV

Hair follicles with Rbpj-/- keratinocytes express less TSLP
thereby ameliorating the phenotype in RBPjcKO animals

Author Contribution
The author performed all the experiments, wrote the text, and prepared the figures in this chapter.
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SUMMARY
High serum TSLP levels during the first two weeks of life induce uncontrolled pre-B cell
proliferation, which ultimately results in premature death in N1N2dcKO and PSdcKO animals.
These results suggest that TSLP is the key factor mediating these phenotypes. Therefore, I
decided to determine the spatio-temporal expression pattern of TSLP mRNA in mutant animals.
First, I showed that epidermal TSLP expression is similar in all Notch mutants (RBPjcKO,
N1N2dcKO, and PSdcKO). Second, I established that RBPjcKO hair follicles express
significantly less TSLP mRNA starting at P6. Finally, I demonstrated that RBPjcKO animals
have a significant reduction in generation of keratinocytes cysts with the majority of Rbpj-/- hair
follicles being relatively mildly perturbed and containing significantly less TSLP (+) cells. In
summary, TSLP mRNA expression and hair follicle phenotype analysis suggest that Rbpj-/- hair
follicles are less distorted and these follicle keratinocytes produce less TSLP ultimately leading
to a milder phenotype in RBPjcKO animals.
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INTRODUCTION
Keratinocyte-specific deletion of Rbpj gene (RBPjcKO) produced a significantly milder
phenotype than the keratinocyte-specific deletion of both Notch1 and Notch2 genes
(N1N2dcKO) or both Presenilin1 and Presenilin2 genes (PSdcKO) (Demehri et al., 2008).
Genetic analyses of the Notch signaling pathway showed that even a limiting amount of γsecretase-cleaved Notch1ICD molecules are sufficient for ameliorating the phenotype in
RBPjcKO animals (Chapter 3) suggesting that Notch1ICD has other functions in the absence of
RBPjκ. However, this function is not evident in the developing embryo, based on our analysis of
embryonic skin from N1N2dcKO, PSdcKO, and RBPjcKO all share similar phenotypes at birth
(Chapter 2). We showed that there are no significant alterations in the gross morphology of their
epidermis and hair follicles between Notch pathway mutants. Our analyses examining mRNA
and protein expression profiles from these mutants suggest that canonical Notch signaling is
responsible for the phenotypes in the embryo and newborn animals (Chapter 2).
The differences between RBPjcKO animals and N1N2dcKO (or PSdcKO) animals are
manifested in four phenotypic measures: lifespans, WBC counts, serum TSLP levels, and skin
morphology (Demehri et al., 2008). Lifespan is directly correlated with the severity of the B-cell
lymphoproliferative disease (BLPD), which is determined by the increased levels of pre-B cell
expansion (Demehri et al., 2008). The pre-B cell expansion is a consequence of the high levels of
TSLP in the sera (Demehri et al., 2008) suggesting that TSLP is a central factor underlying the
phenotypic differences among all Notch signaling mutants. Therefore, I decided to examine the
spatio-temporal expression patterns of TSLP mRNA in mutant animals.
First, I established that TSLP mRNA expression is similar in the epidermis of all Notch
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mutants. Secondly, I provided evidence that expression of TSLP mRNA differs in the abnormal
hair follicles starting postnatal day 6 (P6). RBPjcKO hair follicles express significantly less
TSLP mRNA between P6 and P11 compared to N1N2dcKO or PSdcKO hair follicles. Finally, I
characterized the distribution of the abnormal hair follicles in Notch mutant skin and showed that
RBPjcKO animals have significantly less keratinocytes cysts. The majority of Rbpj-/- hair
follicles was mildly perturbed and contains significantly less TSLP (+) cells. Taken together,
TSLP mRNA expression analysis and hair follicle phenotype assessment suggest that Rbpj-/- hair
follicles are less distorted and produce less TSLP ultimately leading to a milder phenotype in
RBPjcKO animals.
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RESULTS AND DISCUSSION
Similar levels of TSLP mRNA expressed in Rbpj-/-, N1N2-/- and PS-/- epidermis
The differences in lifespans, WBC counts and serum TSLP levels suggest that TSLP is
the key factor driving these phenotypes in all Notch pathway mutants. Therefore, we
hypothesized that levels of TSLP mRNA transcription might be different in RBPjcKO mutants
compared to the other mutants. To test this hypothesis, I characterized the spatio-temporal
expression levels of TSLP mRNA in mutant epidermis.
To determine the levels of TSLP mRNA expression in Notch mutant epidermis, I
performed qRT-PCR analyses on extracted total RNA from WT, N1N2dcKO, PSdcKO, and
RBPjcKO epidermal samples at ages E18.5, P0, P6, P9 and P11. Unexpectedly, RBPjcKO
epidermis had higher levels of TSLP mRNA relative to N1N2-/- and PS-/- epidermis at E18.5
(Figure 4-2) contrary to the hypothesis that Rbpj-/- epidermis should express less TSLP mRNA.
However, the postnatal (P0, P6, P9, and P11) expression of TSLP mRNA was similar in the
epidermis of all Notch pathway mutants (Figure 4-2).
RBPjcKO hair follicles are less perturbed than those of N1N2dcKO and PSdcKO
To determine when the phenotype of hair follicle disruption is evident, I performed
histological analysis on Notch mutant skin samples starting from E18.5 to P11. This analysis
demonstrated that hair follicles started to have morphological problems at birth in all Notch
pathway mutants (Figure 4-1A). To further evaluate the differences among RBPjcKO,
N1N2dcKO and PSdcKO hair follicles, I have performed a quantitative assessment of hair
follicle morphology in mutant animals. I performed K14 (epidermal basal cell marker), AE13
(hair cortex marker), IRS3.1 (Inner root sheath cell marker) (Figure 4-1A) and H&E staining of
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Notch mutant skin samples starting from E18.5 to P13 (data not shown). Three independent
blinded observers assigned a morphology ranking score for each hair follicle/keratin cyst within
10 different areas (3mm x 0.5mm) of dorsal skin. An unbiased scoring system (ranging from 1
=> normal hair to 10 => keratin cyst; see the phenotype rankings in Figure 4-4) was used to
define the severity of the abnormality for the hair follicle morphology (adapted from Demehri et
al. 2009). Then I calculated the distribution of the phenotypic scores for each genotype. Detailed
investigation of the hair follicle phenotypes revealed that the distribution of abnormal hair
follicles in RBPjcKO skin was significantly different from that of N1N2dcKO and PSdcKO
(Figure 4-4, Demehri et al., 2009). The majority of the hair follicles in N1N2dcKO and PSdcKO
animals exhibited more of the cystic phenotype whereas the majority of the RBPjcKO hair
follicles were only moderately distorted (Figure 4-4) supporting the notion that the hair follicles
are the source of the difference.
RBPjcKO hair follicles have significantly less TSLP expression compared to N1N2dcKO
and PSdcKO hair follicles
To determine whether differential expression of TSLP correlates with the degree of hair
follicle disruption, I collected dorsal skin (includes both epidermis and hair follicles) samples
from P0, P6, P9 and P11 animals and extracted total RNA. When I compared the TSLP mRNA
levels at birth, I found that RBPjcKO total skin had similar levels of TSLP expression in
comparison to N1N2dcKO or PSdcKO skin (Figure 4-3). However, N1N2dcKO (~950 fold) and
PSdcKO (~850 fold) skin had significantly higher levels of TSLP transcripts compared to
RBPjcKO (~300 fold) skin starting at P6 (Figure 4-3). These findings suggest that the
differences between RBPjcKO and N1N2dcKO (or PSdcKO) animals originated in the mutant
hair follicles and not the epidermis. The timing of increased TSLP expression also corresponds
113

to the onset of the phenotypes at P6.
There are less TSLP (+) keratinocytes in RBPjcKO hair follicles
To evaluate whether RBPjcKO skin has fewer number of TSLP-producing cells, I
performed TSLP staining (Figure 4-1B) on dorsal skin samples from RBPjcKO, N1N2dcKO and
PSdcKO animals. The number of TSLP (+) cells in the epidermis, abnormal hair follicles, and
keratin cysts within 20 different areas (1mm x 0.5mm) of dorsal skin was determined. Analysis
of these results indicated that RBPjcKO hair follicles possessed significantly fewer TSLP (+)
cells (95 cells in RBPjcKO vs. 150-200 cells in N1N2dcKO and PSdcKO) (Figure 4-5)
suggesting that the decreased abnormality in the hair follicles correlates with a lower number of
TSLP (+) cells.
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CONCLUSIONS
TSLP is the core factor mediating the phenotypes in all Notch pathway mutants
phenotypes. Therefore, I decided to characterize the spatio-temporal expression pattern of TSLP
mRNA in mutant animals. First, I demonstrated that epidermal TSLP expression is similar in all
Notch pathway mutants. Second, I established that expression of TSLP mRNA differs in the
abnormal hair follicles starting at P6. RBPjcKO hair follicles express significantly less TSLP
mRNA between P6 and P11 compared to N1N2dcKO or PSdcKO hair follicles. Finally, I
provided evidence that RBPjcKO animals have significantly less keratinocytes cysts and that the
majority of Rbpj-/- hair follicles are mildly perturbed and contain significantly less TSLP (+)
cells. In summary, Rbpj-/- hair follicles are less distorted and produce less TSLP ultimately
leading to a milder phenotype in RBPjcKO animals.
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EXPERIMENTAL PROCEDURES
Generation of mice
I have generated following strains of mice using Msx2-Cre transgene mediated deletion
in skin keratinocytes (Pan et al., 2004). Animals were raised and kept in Washington University
Division of Comparative Medicine facility under Washington University Policy on Animal Care
regulations.
Msx2-Cre +/tg; Rbpj floxed/floxed (RBPjcKO)
Msx2-Cre +/tg; Notch1 floxed/floxed; Notch2 floxed/floxed (N1N2dcKO)
Msx2-Cre +/tg; Presenilin1 floxed/floxed; Presenilin2 -/- (PSdcKO)
RNA isolation, cDNA preparation and quantitative RT-PCR
If epidermis was used for experiments, skin samples were incubated in 5 mg/mL dispase
for 3 hours at 4°C to separate the epidermis from the dermis. Total RNA was isolated from
E18.5, P0, P6, P9, and P11 epidermis and P0, P6, P9, and P11 total skin using TRIzol
(Invitrogen) kit or RNeasy kit (Qiagen) according to the manufacturer's instructions. RNase-free
DNase I (Invitrogen, USA) was used to remove any residual genomic DNA. RNA was dissolved
in 30µl of RNAse-free water and stored in -80°C after RNA quality control (gel electrophoresis)
and concentration measurements. Reverse transcription was performed with 1µg of total RNA,
random primers and SuperScript III RNase H-Reverse Transcriptase (Invitrogen) in a total
volume of 20µl. Expression levels of transcripts were examined by real-time qPCR with a 7500
Real-Time PCR System using SYBR Green dye (Applied Biosystems), iQ SYBR Green
Supermix (Bio-Rad) or TaqMan Probes. The results were analyzed by absolute quantification
with a relative standard curve or relative quantification of expression according to the “ΔΔC
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methods” (Livak and Schmittgen, 2001) using Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as a reference for normalization. Primers were designed to amplify targets of 180–220
bp usually at the exon junctions to avoid amplification from genomic DNA contamination. The
specificity of the PCRs was checked by recording a melting curve and by sequencing the
amplicons.
To perform SYBR Green-based qRT-PCR for TSLP mRNA, the following primers were used:
TSLP-Fwd (5’-CCAGGCTACCCTGAAACTGA-3’)
TSLP-Rev (5’-TCTGGAGATTGCATGAAGGA-3’)
To perform probe (FAM-TAMRA)-based qRT-PCR for TSLP mRNA, the following primers &
probe were used:
TSLP-F1 (5’-ACTGCAACTTCACGTCAATTACG-3’)
TSLP-R1 (5’-AGTTCGAGCAAATCGAGGACT-3’)
TSLP-Probe (5’ FAM-GACCTGACTGGAGATTTGAAAGGGGCT-TAMRA 3’)
Histology and H&E Staining
Skin samples were fixed in 4% paraformaldehyde (PFA) in PBS o/n, washed 3X in PBS,
washed with 30% EtOH and 50% EtOH for 15 min, before storing them in 70% EtOH at 4°C.
Skin samples were embedded in paraffin for sectioning at 8-12µm thickness. A standard H&E
staining protocol was used for histology assessment.
Immunohistochemistry
Expression of K14 (basal cell marker), IRS 3.1 (inner root sheath cell marker), AE13
(hair cortex marker) or TSLP proteins were detected on 4% PFA-fixed paraffin sections with αK14 chicken polyclonal antibody (a gift from Julie Segre - NIH), α-IRS 3.1 rabbit polyclonal
antibody (a gift from Dr. Rebecca Porter - University of Dundee, Scotland, UK), α-AE13 mouse
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monoclonal antibody (a gift from Dr. Tung-Tien Sun - New York Univeristy), and α-TSLP goat
polyclonal antibody (R&D Systems - Cat No: BAF555) by o/n incubation at 4C. The next day,
several washes (3 x 5 min in 0.5% Triton X-100 in PBS) were done prior to a 2-hour incubation
with fluorophore-coupled secondary antibody to visualize the signal. Sections were mounted
with Vectashield for fluorescence with DAPI.
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Figure 4-1
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Figure 4-1. All Notch mutant hair follicles display morphological problems at birth.
(A) Immunofluorescent staining for hair follicle markers at P0: K14 (purple, epidermal basal
cell marker), AE13 (red, hair cortex marker), IRS3.1 (green, Inner root sheath cell marker), and
DAPI (blue). All Notch mutants start to have morphological problems at Bar: 100µm (B)
Immunofluorescent staining for K14 (red), TSLP (green) and DAPI (blue) on P9 skin samples.
TSLP is expressed in ORS cells (K14+ cells) White Bars: 100 µm. Yellow Bar: 200 µm.
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Figure 4-2

TSLP mRNA expression in epidermis at P0

TSLP mRNA expression in epidermis at E18.5
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Figure 4-2. Rbpj-/-, N1N2-/- and PS-/- epidermis expressed similar levels of TSLP mRNA.
Real-time PCR analyses of TSLP mRNA in Rbpj-/-, N1N2-/-, PS-/- and WT epidermis from E18.5,
P0, P6, P9, and P11 animals. Error bars indicate standard deviation.
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Figure 4-3

TSLP mRNA expression in total skin at P6
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Figure 4-3. RBPjcKO skin has significantly less TSLP expression compared to N1N2dcKO
or PSdcKO skin.
Real-time PCR analyses of TSLP mRNA in RBPjcKO, N1N2dcKO, PSdcKO and WT dorsal
skin from P0, P6, P9, and P11 animals. Error bars indicate standard deviation.

125

50

Figure 4-4
Distribution of Abnormal Hair Follicle Phenotypes in Notch mutants
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Figure 4-4. Distribution of abnormal hair follicle phenotypes in Notch pathway mutants.
A scoring system was used to compare the severities of the hair follicle phenotypes in a
quantitative manner. Three independent blind observers scored each hair follicle within 10
random areas (3mm x 0.5mm) of dorsal skin at P9 to determine the average distribution of scores
for each genotype. Error bars indicate standard deviation.
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Figure 4-5
Distribution of TSLP (+) cells in the epidermis & abnormal hair follicles
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Figure 4-5. Distribution of TSLP (+) cells in the epidermis and aberrant hair follicles for
Notch pathway mutants at P9.
Three independent observers counted TSLP (+) cells within the epidermis and hair follicles (avg.
10-13 hf per area) in 1mm x 0.5mm area of dorsal skin. 20 random areas were assessed to
determine the average number of TSLP (+) cells per genotype. Error bars indicate standard
deviation.

129

CHAPTER V

Conclusions
and
Future Directions

Author Contribution
The author wrote the text in this chapter.
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The main focus of this dissertation was to investigate a novel role for RBPjκ-independent Notch
signaling during mouse skin development. The possibility of this novel role came from previous
studies on different loss of Notch signaling mutants. In 2008, Demehri et al. showed that
keratinocyte-specific deletion of Rbpj (RBPjcKO) gene produced a significantly milder
phenotype than keratinocyte-specific deletion of both Notch1 and Notch2 (N1N2dcKO) or
Preselin1 and Preselin2 (PSdcKO) genes. This observation suggested an RBPjκ-independent
function of Notch signaling in the skin.
The canonical Notch signaling pathway mediates Notch function in epidermal
differentiation and hair follicle maintenance in the embryo
We tested several hypotheses in order to account for the milder phenotype in RBPjcKO animals.
I performed E18.5 epidermal transcriptome, P0 epidermal proteome and P0 total skin
transcriptome analyses that showed all of various Notch pathway mutants have an
indistinguishable transcriptional signature at birth. These results suggested that canonical Notch
signals are responsible for the Notch function during epidermal differentiation and hair follicle
maintenance during embryonic development.
γ-secretase-cleaved Notch1 ICD is necessary and sufficient to drive the milder phenotype in
RBPjcKO animals
While dissecting the Notch pathway to identify factors that may account for the milder
RBPjcKO phenotype, we assessed three possible hypotheses: (1) Derepression of target genes,
(2) Ligand back signaling (LBS), and/or (3) γ-secretase-cleaved RBPjκ-independent Notch1 ICD
activity. I generated triple mutants of N1N2RBPjcKO and PSRBPjcKO animals to test
derepression of targets and utilized N1CreERTN2dcKO animals to test the LBS model. In each
of these experiments the results clearly demonstrated that neither derepression nor LBS is the
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mechanism

behind

the

milder

RBPjcKO

phenotype.

Finally,

we

have

generated

N1vgN2RBPjcKO animals to test whether a limiting amount of Notch1ICD was sufficient to
drive the RBPjcKO phenotype. These analyses suggested that γ-secretase-cleaved Notch1ICD
was necessary and sufficient to drive the milder phenotype in N1vgN2RBPjcKO animals.
Hair follicles with Rbpj-/- keratinocytes express less TSLP ameliorating the phenotype in
RBPjcKO animals
In the first two weeks of Notch pathway mutant animals’ lives, high serum TSLP levels
induce uncontrolled pre-B cell proliferation leading to a shorter lifespan for N1N2dcKO and
PSdcKO animals suggesting that TSLP is the core factor mediating these phenotypes (Demehri
et al., 2008). Therefore, I decided to determine the spatio-temporal expression pattern of TSLP
mRNA in mutant animals. First, I demonstrated that epidermal TSLP expression is similar in all
Notch pathway mutants. Second, I showed that RBPjcKO hair follicles express significantly less
TSLP mRNA starting at P6. Finally, I provided evidence that RBPjcKO animals have
significantly less keratinocytes cysts and that the majority of hair follicles with Rbpj-/keratinocytes are mildly perturbed and contained significantly less TSLP (+) cells. In summary,
TSLP mRNA expression and hair follicle phenotype analyses suggest that hair follicles with
Rbpj-/- keratinocytes are less distorted and produce less TSLP ultimately leading to a milder
phenotype in RBPjcKO animals.
Discussion
Experiments presented in this dissertation suggest that RBPjκ-independent NICD-dependent
signals ameliorate RBPjcKO hair follicle phenotype compared to the other Notch-loss-offunction hair follicles. Less distortion in overall hair follicle morphology leads to less TSLP
production, consequently generating a milder BLPD and relatively longer lifespan for RBPjcKO
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animals. To our knowledge, this is the first study that provides evidence for a non-canonical
Notch function in the mouse hair follicles. It is still a mistery how these signals mediate a milder
hair distortion phenotype in RBPjcKO animals. Previous publications suggest potential
interactions between Notch ICD and other molecules such as Deltex (Ordentlich et al., 1998;
Ramain et al., 2001; Yamamoto et al., 2001; Endo et al., 2002; Endo et al., 2003; Hu et al., 2003;
Hori et al., 2004), Ras (Hodkinson et al., 2007), β-catenin (Acosta et al., 2011), or Rho/ROCK
(Yugawa et al. 2013). However, we still do not have evidence regarding whether any of these
molecules are playing a role during this process. We will further investigate the signaling
pathways that are upregulated/downregulated in RBPjcKO hair follicles and compare them to
N1N2dcKO or PSdcKO hair follicle transcriptome signature as suggested in Aim1 to identify
Notch interacting pathways.
We will also try to identify molecules that are directly interacting with NotchICD in the absence
of RBPjκ (Aim 2). If these molecules are potential DNA binding partners, then we will also
investigate the target genes that are responsible for the milder hair follicle phenotype (Aim3).
A note on “Epigenetic Memory” - Caveat and Solutions
Based on our transcriptome and proteome analysis at birth (Chapter 2), we claimed that there is
no “epigenetic memory” in RBPjcKO animals. This statement still holds for epidermis, however
there is still a possibility of “epigenetic memory” that is encrypted within Rbpj-/- hair follicle
progenitor cells eventually leading to the milder distortion in RBPjcKO hair follicles. Notch
signaling is necessary for maintaining IRS cellular identity in the hair follicle (Pan et al., 2004;
Blanpain et al., 2006) and activation of Notch1 receptor within mouse hair follicles can be
detected in the hair follicle corticle and cuticle precursors (Powell et al. 1998, Pan et al., 2004).
Eventhough, ORS cells do not experience Notch activation, non-cell autonomous effects induce
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an unexpected epidermal differentiation program within ORS cells in the absence of Notch
signaling. Therefore, we think loss-of-Notch signaling within the IRS and hair cortex is critical
for the phenotypic differences in the hair follicle morphology. To distinguish whether
“epigenetic memory” accounts for milder phenotype in RBPjcKO hair follicles, we will generate
a new animal that will have an inducible expression of Notch1 ICD within IRS cells in the
background of triple mutant animals, N1N2RBPjcKO or PSRBPjcKO. We will transiently
express Notch1 ICD between E18.5-P2 in which IRS cells expected to have active Notch
signaling. If Notch1 ICD + PSRBPjcKO animals resemble RBPjcKO or N1vgN2RBPjcKO
animals, then we will conclude that “epigenetic memory” is not the reason behind the phenotype.
Otherwise, “epigenetic memory” could have a role in milder RBPjcKO hair follicle phenotype.
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Future Directions
Aim 1: Determine whether TSLP expression is similar in Rbpj-/-, N1N2-/-, and PS-/- hair
follicle keratinocytes.
We want to know whether TSLP mRNA expression per cell is different in Rbpj-/- hair follicle
keratinocytes vs N1N2-/- (or PS-/-) hair follicle keratinocytes. To determine this, we will isolate
total RNA from the same grade hair follicles (rank #8-9-10) of RBPjcKO, N1N2dcKO, and
PSdcKO skin by using Laser Capture Microscopy (LCM) and perform qRT-PCR for TSLP
expression.
1. If less TSLP mRNA is produced in Rbpj-/- cells, then the question is limited to
understanding TSLP gene regulation, which we will further investigate in ORS/cyst
keratinocytes. We will perform global gene expression analysis/RNAseq to identify the
genes that are correlated with less/more TSLP expression. We will also investigate the
transcriptional regulation of TSLP gene by dissecting the core regulatory elements within
the promoter and enhancer region of the TSLP gene.
2. If the levels of TSLP mRNA are unchanged between Rbpj-/- and N1N2-/- (or PS-/-) hair
keratinocytes, then they will phenotypically resemble Rbpj-/-, N1N2-/-, and PS-/- epidermal
keratinocytes. In this case, we will investigate the reasons for the differences in
morphology between RBPjcKO and N1N2dcKO (or PSdcKO) hair follicles. The hair
follicles from RBPjcKO are less distorted compared to other Notch mutant hair follicles.
We will utilize LCM to determine which molecular pathways are altered in the RBPjcKO
hair follicles that give rise to the milder phenotype. We will compare the transcriptional
profiles of milder RBPjcKO hair follicles (rank #3-4-5-6) to the transcriptional profiles
derived from severe keratin cysts (rank #8-9-10) of RBPjcKO skin, N1N2dcKO skin, or
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PSdcKO skin. We hypothesize that the transcriptional differences are expected to be due
to the excess Notch1ICD molecules in RBPjcKO cells.
Aim 2: Determine whether γ-secretase-cleaved Notch1ICD is interacting with any other
molecule in the absence of RBPjκ.
We showed that even limiting amounts of Notch1ICD is sufficient to give rise the milder
phenotype in N1vgN2RBPjcKO animals. In the absence of RBPjκ, it is possible that Notch1ICD
may interact with other molecules/proteins that are responsible for the milder phenotype
observed in RBPjcKO animals. To identify potential Notch1ICD interacting molecules, we will
utilize a screen using double-tagged Notch1-6myc6his (N16M6H) expressing animals and
perform pull-down assays for N16M6H in the background of Rbpj-/- hair follicles. We will
identify the proteins associated with Notch1ICD using mass spectrometry analysis. These
animals were generated using a knock-in strategy and are viable as homozygous.
Aim 3: Determine transcriptional target gene expression by Notch1ICD in the absence of
its canonical DNA-binding partner, RBPjκ.
In the absence of RBPjκ, we hypothesize that Notch1ICD could interact with other transcription
factors and induce gene expression. In order to test this possibility, I will perform chromatin
immunoprecipitation (ChIP) assays with the tagged N16M6H in Rbpj-/- hair follicles and identify
DNA sequences that are bound by Notch1ICD in the absence of RBPjκ. We will also identify
potential direct transcriptional targets of Notch1ICD in Rbpj-/- hair follicles by intersecting this
candidate gene list with the genes from expression profile analysis proposed in Aim1.
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CHAPTER VI

Elevated epidermal Thymic Stromal Lymphopoietin levels
establish an anti-tumor environment in the skin

Publication & Copyright
Results and text presented in this chapter have been previously published in:
Demehri S, Turkoz A, Manivasagam A, Yockey LJ, Turkoz M, Kopan R (2012). Elevated
Epidermal Thymic Stromal Lymphopoietin Levels Establish an Anti-Tumor Environment in the
Skin. Cancer Cell. 2012 October 16; 22(4): 494–505.
Author Contribution
The author contributed only the following sections of this chapter:
• Generation of mice for Figure 6-1A.
• All the experiments in Figure 6-3, except H&E and α-RBPj antibody stainings.
• Part of the effort to perform the BM transplatation experiments in Figure 6-5 A & B,
Figure 6-6 and Figure 6-7.
Dr. Shawn Demehri carried out majority of the other experiments described in this chapter with
the assistance from other authors. Dr. Shawn Demehri and Kopan wrote the text of the published
manuscript.
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SUMMARY
Thymic Stromal Lymphopoietin (TSLP), a cytokine implicated in induction of T helper 2 (Th2) mediated allergic inflammation, has recently been shown to stimulate solid tumor growth and
metastasis. Conversely, studying mice with clonal loss of Notch signaling in their skin revealed
that high levels of TSLP released by barrier-defective epidermis caused a severe inflammation
resulting in gradual elimination of Notch-deficient epidermal clones and resistance to skin
tumorigenesis. We found CD4+ T cells to be both required and sufficient to mediate these effects
of TSLP. Importantly, TSLP overexpression in wild-type skin also caused resistance to
tumorigenesis, confirming that TSLP functions as a tumor suppressor in the skin.
Significance
We demonstrate unequivocally that TSLP triggers a dominant anti-tumor response in a Th2polarized

inflammatory

microenvironment

in

the

skin.

Importantly,

the

anti-tumor

microenvironment created by TSLP-inducers like vitamin D agonists (e.g. Calcipotriol) can
prevent and eliminate skin tumors in wild-type mice. Although our findings may reflect a skinspecific effect, it is intriguing to postulate that TSLP plays a common tumor suppressor role
during the early stages of solid tumor development. Considering the emergence of TSLP as a
potential new therapeutic target in treatment of solid cancers, this report points to an alternative
utility for TSLP as an anti-tumor immune factor that can be utilized to optimally combat and
ultimately prevent solid cancers.
Highlights
•

Notch signaling-deficient skin with severe Th2 inflammation is resistant to tumorigenesis

•

TSLP signaling is responsible for tumor resistance in Notch-signaling deficient skin

•

TSLP acts through CD4+ T cells to establish tumor resistance in Notch-deficient skin
138

•

TSLP upregulation in wild-type skin can produce in resistance to tumorigenesis
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INTRODUCTION
The mammalian skin is a model organ with established propensity for solid tumor
development. Used for decades in chemical carcinogenesis studies, it contributed to the
recognition that carcinogenesis is a step-wise process (Hanahan and Weinberg, 2000). As in
other models of cancer, skin tumors arise as a consequence of intrinsic changes in an initiated
cell that are amplified through interactions with the tumor microenvironment (Campisi, 2005;
Kessenbrock et al., 2010; Sneddon and Werb, 2007). Immune cells are one of the main
components of tumor microenvironment. Although these cells can suppress tumor growth, their
carcinogenesis-promoting role is becoming increasingly appreciated (Coussens and Werb, 2002;
Hanahan and Weinberg, 2000; Hanahan and Weinberg, 2011). Moreover, because skin is the
largest barrier organ in the body, it is under tight surveillance by the immune system, and even
subtle changes in its cellular differentiation program can alter the overall susceptibility to cancer
by eliciting a persistent inflammatory response (Quigley et al., 2009). This is partly due to a
direct epidermal contribution to the inflammation via secretion of multiple cytokines, such as
interleukin (IL) -1, IL-6 and TGF-b (Morasso and Tomic-Canic, 2005).
In the current report, the significance of inflammation in modulating tumorigenesis
emerged from studying mice in which the Notch signaling pathway is inactivated in a subset of
epidermal keratinocytes using the Msx2-Cretg/+ line. This line expresses Cre recombinase early,
transiently and only in the dorsal and ventral midline regions, generating a calico pattern of gene
deletion (Figure 6-1A). This deletion pattern has allowed us to document the cell autonomous as
well as the non-cell autonomous consequences of reducing Notch signal in the skin (Demehri et
al., 2008; Demehri et al., 2009b). Notch is a transmembrane receptor that mediates short-range
communication between adjacent cells (Kopan and Ilagan, 2009). Upon binding to the ligand
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presented by a neighboring cell, Notch undergoes proteolysis by γ-secretase enzyme to release its
intracellular domain (NICD). Subsequently, NICD translocates into the nucleus and binds to its
DNA-binding partner, RBPjκ, and regulates its downstream targets in a context-dependent
manner (Kopan and Ilagan, 2009). Notch signaling plays multiple roles in skin development
(Mascia et al., 2011), but in the context of carcinogenesis, the most relevant role is in promoting
supra-basal differentiation (Blanpain et al., 2006; Demehri et al., 2009b; Nguyen et al., 2006;
Nicolas et al., 2003b; Pan et al., 2004a; Rangarajan et al., 2001). Reduction in Notch signaling
leads to aberrant epidermal differentiation and defective barrier formation, which creates a
chronic wound-like environment prone to spontaneous skin tumors. For example, loss of Notch1
renders mice sensitive to 7,12-dimethylbenz[α]anthracene (DMBA)-induced cancer (Nicolas et
al., 2003b) through induction of a non-cell autonomous feed-forward loop between the
epidermis, dermal fibroblasts and inflammatory infiltrates (Demehri et al., 2009b). Consistent
with these findings, mice and humans lacking the components of the γ-secretase complex (Pen2,
PS1, Ncstn) have elevated rates of spontaneous tumor development (Lapins et al., 2001; Li et al.,
2007; Wang et al., 2010; Xia et al., 2001). Additionally, the γ-secretase inhibitor Semagacestat
(LY450139) led to elevated incidence of skin cancer among the participants in a phase III
clinical trial (Extance, 2010). Importantly, the latency for spontaneous tumor formation in the
epidermis is determined by the degree of disruption in its differentiation program cased by Notch
signaling loss (Demehri et al., 2009b). An epidermal-derived cytokine that rises as more of
Notch signal is lost in the skin is Thymic Stromal Lymphopoietin (TSLP), which could
contribute to the susceptibility of Notch-deficient skin to tumorigenesis (De Monte et al., 2011;
Demehri et al., 2008; Demehri et al., 2009b; Olkhanud et al., 2011; Pedroza-Gonzalez et al.,
2011).
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TSLP is an interleukin (IL)-7-like cytokine studied mainly in the context of T helper 2
(Th2)-mediated allergic inflammation in the skin and lung (Leonard, 2002; Rochman et al.,
2009; Ziegler, 2010); overexpression of TSLP is sufficient to promote the development of atopic
dermatitis and asthma, respectively (Ziegler, 2010). Importantly, transient exposure to TSLP is
sufficient to prime the skin and lung immune cells if an otherwise innocuous allergen is also
present, creating long-lasting T cells that can trigger allergic inflammation at a later time (Zhang
et al., 2009). In the gut, however, TSLP is continuously expressed and plays a physiological
function by suppressing the Th1 response thus building tolerance to the gut microbiome
(Zeuthen et al., 2008). Although TSLP is not expressed in skin under pathological conditions,
skin keratinocytes are powerful secretors of TSLP in both humans (Lee et al., 2010) and mice,
where chronic and severe barrier disruption can result in TSLP release into the serum up to 5000
folds over its baseline levels (Demehri et al., 2008; Dumortier et al., 2010; Zhang et al., 2009).
Interestingly, this drives a leukemia-like B cell lymphoproliferative disease in newborn mice
(Demehri et al., 2008) and constitutively active TSLP signaling causes acute B-lymphoblastic
leukemia in children (Cario et al., 2010; Hertzberg et al., 2010; Shochat et al., 2011). In addition,
TSLP has recently emerged as a pro-growth cytokine in breast and pancreatic cancers (De Monte
et al., 2011; Olkhanud et al., 2011; Pedroza-Gonzalez et al., 2011). These findings suggest a
therapeutic opportunity for TSLP-blocking agents, already in development for the treatment of
allergic diseases (Schmitt, 2010), as cancer immunotherapeutic agents.
Unexpectedly, mice lacking RBPjκ in their skin released high levels of TSLP, but they
did not develop spontaneous tumors and were resistant to chemical carcinogens. We
demonstrated that at high concentrations, TSLP facilitates elevated immune surveillance by the
adaptive immune system leading to rejection of the mutant cells and to tumor resistance. Global
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deletion of the TSLP receptors (IL7rα or CRLF2 (TSLPR)) led to aggressive expansion of
Notch-deleted epidermal clones and exposed the inherent predisposition of Notch signalingdeficient skin to tumor formation. Restricting TSLP reception exclusively to the CD4+ T cells
was sufficient to maintain tumor resistance and elimination of Notch-deficient cells. In addition,
elimination of only CD4+ T cells in an otherwise TSLP-responsive immune environment
abolished this anti-tumor response. Importantly, induction of epidermal TSLP expression with a
vitamin D analog, Calcipotriol (Dovonex™), endowed wild-type animals with marked resistance
to chemical skin carcinogenesis. These effects can be directly attributed to TSLP since similar
protection was seen in transgenic mice overexpressing this cytokine independent of Vitamin D
receptor activation. Taken together, these findings demonstrate the ability of TSLP to create a T
cell-based tumor-suppressing microenvironment in the skin. Considering the current view of
TSLP antagonists as potential new therapeutic agents in treatment of solid cancers, this report
highlights the potential use of TSLP or its agonists towards establishing an anti-tumor immune
response.
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RESULTS
Mice lacking all canonical Notch signaling in the epidermis are resistant to skin
carcinogenesis
Step-wise removal of Notch alleles in epidermal keratinocytes with Msx2-Cre is
associated with a corresponding decline in skin-barrier function, creation of a wound-like
environment and increased susceptibility to carcinogenesis ((Demehri et al., 2009b) and Figure
6-1A&B). Initially, susceptibility to carcinogenesis was not tested in mice with complete loss of
Notch signaling in their skin (e.g. Msx2-Cretg/+; PS1flox/flox; PS2-/- (PSDCKO; loss of γ-secretase
enzyme function)) because they die shortly after birth, not allowing enough time for skin tumor
development (Figure 6-1B). Rbpj-deficient animals (Msx2-Cretg/+; Rbpjflox/flox or RBPjCKO),
however, live for ~100 days on average, which is comparable to animals lacking all but one
Notch2 allele in their skin (Msx2-Cre

tg/+

; Notch1flox/flox; Notch2flox/+; Notch3-/- or

N1N2hN3CKO). Surprisingly, while 20% of N1N2hN3CKO mice developed spontaneous skin
tumors, none (0/40) of the RBPjCKO mice that have been examined developed spontaneous
tumors (Figure 6-1B).
To further rule out the possibility that the short life span of RBPjCKO mice masked their
cancer susceptibility, we subjected young RBPjCKO and their wild type littermates to a
multistage chemical skin carcinogenesis model (Yuspa et al., 1994). The RBPjCKO cohort was
maintained in a mixed genetic background (FVB, CD1, and C57BL/6) to facilitate tumor
development within a short treatment period. Three-week-old RBPjCKO and wild type
littermates (defined as all mice not inheriting the Cre transgene) were treated with a single
initiating dose of DMBA, followed by a twice-weekly dose of 12-O-tetradecanoylphorbol-13acetate (TPA) for 14 weeks. Surprisingly, whereas the majority of wild type littermates
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developed more than 20 papillomas/mouse, no tumors were detected in the DMBA/TPA-treated
RBPjCKO animals after 15 weeks of follow-up (n=7 in each group, p <0.0001, Figure 1C&D).
These results contrast starkly to the enhanced susceptibility to tumor formation seen in other
Notch-deficient animals (Figure 6-1B; (Demehri et al., 2009b)). The resistance of RBPjCKO
mice to skin carcinogenesis might reflect a reduced growth potential of RBPj-deficient
keratinocytes (Blanpain et al., 2006). However, even if this were the case, we would expect
initiated wild-type cells adjacent to RBPjCKO epidermis to form tumors (Demehri et al., 2009b).
Alternatively, the global resistance to tumorigenesis in RBPj-deficient skin may be due to a
switch from a tumor-promoting environment in N1CKO (Demehri et al., 2009b) to a tumorsuppressing environment in RBPjCKO skin.

Wild-type keratinocytes replace their Notch signaling-deficient neighbors over time
The calico pattern of gene deletion in Msx2-Cre-positive animals allowed us to notice a
second, potentially related phenotype in RBPjCKO mice. As these mice aged, the mutant
epidermal clones on their dorsal and ventral surfaces shrank, and Rbpj-deficient epidermal clones
eventually disappeared in the oldest individuals (Figure 6-2A and S1). Although Msx2-Cretg/+;
Notch1flox/flox; Notch2flox/flox (N1N2CKO) and PSDCKO mice die at weaning due to a lethal Blymphoproliferative disorder (Demehri et al., 2008), they can survive longer if we controlled
their B-LPD with a sublethal dose of irradiation (Figure 6-2B, (Demehri et al., 2008)). When
lethality was rescued in this manner we observed a similar regression of Notch1/2- or PS1/2deleted epidermal territories as N1N2CKO and PSDCKO animals aged. This could reflect the
passive proliferative disadvantage of Notch signaling-deficient keratinocytes or the active
process of rejection.
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H-Ras infected Notch-deficient keratinocytes are highly tumorigenic in immunecompromised mice
To ask if the resistance of RBPjCKO mice to carcinogenesis and the loss of mutant
keratinocytes are due to a low proliferative capacity of Rbpj-deficient keratinocytes, we
evaluated their tumor-forming potential in the nude mouse environment in response to the
activated H-Ras oncogene (Nicolas et al., 2003b). First, we isolated keratinocytes from newborn
Rbpjflox/flox and Rbpjflox/+ littermates. Cells were then infected with activated H-Ras-expressing
retrovirus, allowed to recover for 24 hours and then infected with Cre-expressing adenovirus. Hras-infected, Cre expressing, Rbpj-/- or Rbpj+/- cells (1.5 x 106) were injected subcutaneously into
nude mice and tumor development was monitored over time. Importantly, RBPjcKO (Rbpj-/-)
keratinocytes formed large tumors in 30 days while wild-type (Rbpj+/-) keratinocytes did not
form a significant tumor mass (Figure 6-3). Similar results were obtained using γ-secretasedeficient (PSDCKO) keratinocytes (Figure 6-3). The formation of massive tumors by Notch
signaling-deficient keratinocytes demonstrates that these cells are intrinsically competent to form
tumors in a T cell-deficient environment. Therefore, we hypothesized that the apparent resistance
of Notch signaling-deficient animals to skin tumorigenesis is most likely due to the activation of
a tumor-suppressing environment in their skin.
Notch-deficient animals develop severe allergic skin inflammation caused specifically by
epidermal TSLP overexpression
Inflammation can either promote or suppress tumorigenesis depending on its magnitude
and the immune cells involved (Coussens and Werb, 2002; Schreiber et al., 2011). As previously
shown (Demehri et al., 2009a; Dumortier et al., 2010), the severe skin-barrier defect in
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Notch/RBPj-deficient mice leads to the development of a full-blown atopic dermatitis (AD)-like
allergic inflammation. This level of skin-barrier defect and Th2 inflammation is not detected in
mice with at least one allele of Notch2 remaining (N1N2hN3CKO; Figure 6-4A, (Demehri et al.,
2009b)). In sharp contrast to the mild inflammation, dermal fibroplasia and angiogenesis, which
generated a tumor-promoting environment in N1CKO skin (Demehri et al., 2009b), RBPjCKO
skin exhibited a significant accumulation of leukocytes (CD45+ cells) beneath the Rbpj-deficient
epidermal clones (Figure 6-4A). This high level of dermal inflammation could have a
suppressing effect on tumor growth (Coussens and Werb, 2002) perhaps by inducing anti-tumor
immune responses and thus explain the loss of Notch/RBPj-deficient cells over time. Therefore,
we reasoned that reducing the inflammation could restore an environment permissive to and/or
promoting carcinogenesis. To address the role of extreme inflammation as the key factor
preventing carcinogenesis in Rbpj-deficient skin, we first examined the effect of
immunosuppressant drugs on DMBA-treated RBPjCKO mice. Treatment with the maximum
tolerable doses of Dexamethasone or Methotrexate did not significantly reduce inflammation in
RBPjCKO mice nor did it affect the rejection of mutant skin cells or allow tumor formation
(Figure 6-S2 online).
RBPjCKO keratinocytes produced significantly higher levels of TSLP than those seen in
the tumor-prone N1CKO and N1N2hN3CKO animals (Figure 6-4B). High TSLP levels are
known to drive the severe Th2 inflammation seen in RBPjCKO skin (Demehri et al., 2009a;
Dumortier et al., 2010; He et al., 2008). Therefore, we next examined the effect of loss of TSLP
signaling on inflammation by generating RBPjCKO mice that lack the IL7rα arm of the TSLP
receptor (Msx2-Cretg/+; Rbpjflox/flox; IL7rα-/- or RBPjCKO;IL7rα-/- (Demehri et al., 2009a)). IL7rα
mice were used in place of TSLPR deficient mice because the Rbpj and CRLF2 (TSLPR) genes
147

are linked on the same arm of chromosome 5, and thus we were unable to generate
RBPjCKO;TSLPR-/- animals. Deleting IL7rα in RBPjCKO or N1N2CKO (Msx2-Cretg/+;
Notch1flox/flox; Notch2flox/flox; IL7rα-/- or N1N2CKO; IL7rα-/-) mice led to a marked reduction in
skin inflammation (Figure 6-4C and Figure 6-S3 online). Flow cytometry on dermal cells
showed that CD4+ T cell population were significantly reduced (Figure 6-S7 online). To confirm
that this effect was specific to TSLP and not an indirect consequence of reduced lymphocyte
number caused by IL7rα deletion (Peschon et al., 1994), we deleted the TSLPR arm of the TSLP
receptor in PSDCKO animals (and Msx2-Cretg/+; PS1flox/flox; PS2-/-; TSLPR-/- or PSDCKO;
TSLPR-/-), which significantly prolonged their lifespan (Dumortier et al., 2010). As with
N1N2CKO;IL7rα-/- and RBPjCKO; IL7rα-/-, inflammation was greatly reduced in PSDCKO;
TSLPR-/- animals (Figure 6-S3 online). Taken together, these results demonstrate a central role
for TSLP in regulating the level of inflammation in Notch-deficient skin.
Blocking TSLP signaling in Notch-deficient animals results in the expansion of the mutant
skin and tumorigenesis
RBPjCKO; IL7rα-/- animals showed a clear reversal of the two phenotypes unique to
RBPjCKO

mice.

First,

RBPj-deficient

epidermal

clones

expanded

dramatically

in

RBPjCKO;IL7rα-/- mice and formed numerous hypertrophic cysts (Figure 6-5A). Second,
RBPjCKO;IL7rα-/- mice developed spontaneous invasive dermal and exophytic tumors over time
(Figure 6-5 and S4 online). N1N2CKO;IL7rα-/- and PSDCKO; TSLPR-/- animals also showed
expansion of their mutant skin territories (Figure 6-5A, (Dumortier et al., 2010) and the
accompanying paper by Di Piazza et al). All RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/animals eventually developed cancerous lesions that invaded through the subcutaneous muscle
layer at 10 to 15 weeks of age (Figure 6-5B and S4 online). Treating the skin of these animals
148

with a single dose of DMBA further revealed their susceptibility to tumorigenesis (Figure 6-5B).
Therefore, reducing the inflammation by eliminating TSLP reception restored a tumor-promoting
environment reminiscent of the N1CKO mice and uncovered the underlying cancer-prone
phenotype in mice lacking canonical Notch signaling in their skin.
To test whether another prominent proinflammatory cytokine shown to be overexpressed
in Notch signaling-deficient skin (Dumortier et al., 2010) contribute to skin rejection and the
tumor resistant phenotype, we blocked TNFα signaling in RBPjCKO animals. RBPjCKO
animals lacking TNFα signaling (Msx2-Cretg/+; Rbpjflox/flox; TNFRI-/-; TNFRII-/-) were
indistinguishable from their RBPjCKO littermates (Figure 6-S5 online). Therefore, we conclude
that high levels of inflammation triggered by TSLP are required to initiate the process that leads
to elimination of the Notch-, Rbpj- or Presenilin-deficient keratinocytes, which are otherwise
proliferative, and prevents tumorigenesis in this background. This supports the hypothesis that
skin tumor resistance and mutant cell rejection phenotypes are specific to TSLP-responsive
effectors.
The adaptive immune system mediates the effects of TSLP on skin rejection and tumor
resistance
In order to determine if bone marrow (BM)-derived immune cells mediated the effects of
TSLP on skin rejection and resistance to tumorigenesis, we reconstituted the immune system of
lethally irradiated RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- mice with BM from their wildtype littermates and monitored their response to DMBA treatment. Interestingly, wild-type BM
restored resistance to DMBA-induced tumors in RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/mice; concomitantly, the mice gained the ability to eliminate their mutant skin cells (Figure 6-6).
In a complementary set of experiments, we reconstituted the immune system of lethally
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irradiated RBPjCKO and PSDCKO mice with BM from their IL7rα-/- and TSLPR-/- littermates,
respectively, to determine if a pro-tumor environment would be re-established. This immune
reconstitution, however, failed to establish tolerance, and no DMBA-induced tumors formed
(Figure 6-S6 online). This could be explained by the presence of irradiation-resistant activated
and memory T cells in the mutant animals at the time of transplantation (Figure 6-S6 online).
Together, these findings demonstrate that BM-derived immune cells act downstream of TSLP,
and suggest that the effector cell type(s) formed in RBPjCKO and PSDCKO are resistant to
lethal dose of irradiation (Figure 6-S7 online).
Based on the findings above, we focused on the immune cell repertoire in RBPjCKO
(Figure 6-S8 online; (Demehri et al., 2009b)) and targeted cell types that are known to be
resistant to irradiation ((Murphy et al., 1987) and personal communications from Dr. Lisa
Coussens), are known to express TSLP receptors, and can mediate tumor resistance and skin
rejection (Vesely et al., 2011). Based on these criteria, we chose to delete CD8+ Cytotoxic T
lymphocytes (CTLs) and mast cells in RBPjCKO animals. Genetic depletion of these cells in
RBPjCKO; CD8a-/- and RBPjCKO; Kitwsh/wsh did not cause any alteration in the RBPjCKO skin
phenotypes, suggesting that neither cell type is necessary to mediates the effects of TSLP (Figure
6-S9 online). In a separate set of experiments, we used previously described depleting antibodies
(Rogers and Unanue, 1993; Shankaran et al., 2001) to deplete CD4+ T cells, CD8+ T cells,
natural killer (NK) cells, or granulocytes in RBPjCKO animals. Although we achieved the
complete depletion of these cell types, we failed to alter rejection or tumor resistance phenotypes
in RBPjCKO mice (Figure 6-S10 online). From these sets of experiments, we concluded that the
irradiation-resistant immune cell type(s) mediating the effects of TSLP were either: (a) resistant
to depletion by irradiation and antibodies, which is characteristic of activated/memory T cells
150

(Jamali et al., 1992; Murphy et al., 1987), or (b) not present among the cell types depleted with
the antibodies we used.
To distinguish these possibilities systematically, we focused on RBPjCKO; IL7rα-/- and
PSDCKO; TSLPR-/- mice, which never establish TSLP-dependent tumor resistance and thus lack
activated effector cells. Having established that Wild-type BM can reconstitute the skin rejection
and tumor resistance in RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- animals (Figure 6-6), we
examined whether the adaptive or innate immune system mediated these effects downstream of
TSLP. To accomplish this, we reconstituted the immune cells of lethally irradiated RBPjCKO;
IL7rα-/- and PSDCKO; TSLPR-/- mice with BM from Rag2-/- donors that lack adaptive immunity.
DMBA-treated RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- animals transplanted with Rag2-/BM failed to reject mutant skin, which formed hypertrophic cysts and developed tumors (Figure
6-6), in contrast to RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- reconstituted with wild-type
bone marrow that repress tumor development. This clearly demonstrates that adaptive immune
cells respond to epidermal-derived TSLP are required for the tumor resistance and mutant skin
rejection in Notch signaling-deficient animals.
CD4+ T cells are both required and sufficient to mediate the effects of TSLP on skin
rejection and tumor resistance
Among adaptive immune cell types, activated T cells are known to be resistant to
irradiation and persist after antibody depletion (Jamali et al., 1992; Murphy et al., 1987).
Considering that mice lacking CD8+ CTLs retained their tumor resistance and skin rejection
phenotypes (RBPjCKO; CD8a-/-; Figure 6-S9 online), CD4+ T cells emerged as the prime
candidate mediating the effects of TSLP in Notch signaling-deficient skin. To test this
hypothesis, 2 x 106 CD4+ or CD8+ T cells from wild-type littermates were transferred to
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sublethally irradiated RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- newborns. Adoptive transfer
of wild-type CD4+ T cells to RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- mice re-established
the tumor resistance and mutant skin rejection phenotypes in these animals, but adoptive transfer
of wild-type CD8+ CTLs did not (Figure 6-7A). This finding demonstrates that CD4+ T cells are
sufficient to receive TSLP signal and initiate the effects of TSLP in Notch signaling-deficient
skin.
To ask if CD4+ T cells were required to initiate the effects of TSLP in Notch signalingdeficient skin, lethally irradiated RBPjCKO; IL7rα-/- mice were transplanted with c-Kit+ BM
cells from their wild-type littermates and treated continually with anti-CD4, anti-CD8 or IgG
control antibodies (Figure 6-7B). Injecting the RBPjCKO; IL7rα-/- animals with depleting
antibodies weekly resulted in effective and sustained depletion of targeted cell types (Figure 67C). Importantly, only the RBPjCKO; IL7rα-/- mice that received wild-type BM progenitors plus
anti-CD4 antibody retained their mutant cells, formed hypertrophic cysts, and developed skin
tumors in response to DMBA (Figure 6-7D). Taken together, these data demonstrate that CD4+
T cells constitute the cell type receiving the TSLP signal and coordinating the immune response
necessary to reject Notch signaling-deficient skin and prevent tumorigenesis in this context.
Epidermal TSLP overexpression in wild-type skin prevents skin tumorigenesis
A critical question that emerged from our findings is whether or not the tumor suppressor
function of TSLP is specific to Notch signaling-deficient skin. To test if TSLP overexpression
can mobilize the anti-tumor immune response of an otherwise wild-type animal, we used
chemical and genetic approaches to upregulate epidermal TSLP expression in wild-type animals
and investigate their response to the multistage chemical skin carcinogenesis model. First, we
used the topical application of calcipotriol (low-calcemic Vitamin D3 analog; known also as
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MC903 or Dovonex) to induce epidermal TSLP expression in CD1 female mice (Li et al., 2006).
CD1 genetic background was chosen for these studies because the skin inflammation caused by
TSLP overexpression downstream of calcipotriol treatment did not result in a full-blown AD-like
disease (Demehri et al., 2009a). Mice were treated with a single initiating dose of DMBA
(125mg), followed by a twice-weekly dose of TPA (4mg) for 14 weeks. The test group was also
treated with topical calcipotriol (32nmol) and controls with carrier only (EtOH) five times a
week during the 14 weeks of TPA application. Strikingly, the majority of carrier-only treated
animals developed papillomas, whereas only two of the calcipotriol-treated animals transiently
developed papillomas during 15 weeks of follow-up (n = 10 for each group, p <0.0001, Figure 68A&B).
To investigate the effect of high TSLP expression on existing skin tumors, we randomly
divided the tumor-bearing CD1 animals from the carrier-only treatment group of the calcipotriol
study (Figure 6-8A&B) into two groups at the end of the 15-week TPA treatment. One of the
subgroups received calcipotriol five times weekly whereas the other received carrier only. We
monitored their tumors for an additional 7-weeks. While the carrier-treated cohort maintained
their tumor counts, the calcipotriol-treated animals lost their papillomas over time (p <0.05 at
week 6 and 7, Figure 6-8C). In addition, the tumors from the carrier-treated cohort grew bigger
over time, unlike the remaining calcipotriol-treated tumors that shrank (Figure 6-8D).
Considering that calcipotriol is a low-calcemic Vitamin D3 analog, it is possible that the
effects observed above are related to vitamin D signaling independent of its upregulation of
TSLP expression in the skin. Therefore to confirm that the anti-tumor effects observed are
mediated through TSLP, we used animals that genetically overexpress TSLP in their basal
keratinocytes. Importantly, K14-TSLPtg animals treated with DMBA-TPA also showed
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significant resistance to tumorigenesis compared to their wild-type littermates (n=22 for K14TSLPtg group and 21 for wild-type group, p <0.0001, Figure 6-8E&F). The serum TSLP
measurements confirmed the overexpression of TSLP in Calcipotriol-treated wild-type and K14TSLPtg animals (Figure 6-8G). These results clearly demonstrate that the tumor-suppressor effect
of TSLP in the skin is not specific to Notch mutants and that TSLP overexpression not only
prevents tumorigenesis, but it can also inhibit growth of existing tumors present in an otherwise
wild-type background.
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DISCUSSION
The main finding of this report is that upregulation of epidermal TSLP generates a
dominant anti-tumor T cell response in a Th2 inflammatory microenvironment (Demehri et al.,
2009a) protecting animals from spontaneous and chemically-induced skin tumors. The antitumor CD4+ T cells that receive the TSLP signal orchestrate the recognition and elimination of
proliferating pre-cancerous cells. This is in stark contrast to the pro-tumor function commonly
attributed to the Th2-polarized inflammation (Johansson et al., 2008) and to recent observations
that TSLP upregulation promotes the growth and metastasis of breast and pancreatic cancers
through a Th2 response (De Monte et al., 2011; Olkhanud et al., 2011; Pedroza-Gonzalez et al.,
2011). Importantly, we show that chemical induction of TSLP expression in wild-type animals
with DMBA-induced papillomas results in tumor regression. This latter finding suggests that
TSLP upregulation may provide therapeutic benefits in treating skin tumors and perhaps for
other solid tumors.
TSLP is a pleiotropic cytokine involved in several immune processes (Ziegler and Artis,
2010). Most notably, in the skin and the lung TSLP is expressed in response to barrier disruption
(Demehri et al., 2008), where it can skew CD4+ T cell differentiation towards Th2 subtype (AlShami et al., 2004; Tanaka et al., 2009; Ziegler and Artis, 2010) and promote Th2-mediated
allergic inflammation (Leonard, 2002). We previously identified TSLP as a sensitive readout for
the degree of disruption in epidermal differentiation and skin barrier integrity (Demehri et al.,
2008). Animals with epidermal Notch1 deletion and mild disruption in epidermal differentiation
develop a tumor-promoting environment dominated by Gr-1+ CD11b+ myeloid suppressor cells
and soluble factors including TGF-β (Demehri et al., 2009b). The contribution of TSLP to this
tumor-promoting skin environment remains to be determined. Conversely, once all canonical
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Notch-signaling is removed, these animals develop a potent tumor-suppressing environment
mediated by TSLP. While others have shown that TSLP is responsible for promoting tumor
growth and metastasis in pancreatic and breast cancer (De Monte et al., 2011; Olkhanud et al.,
2011; Pedroza-Gonzalez et al., 2011), we are the first to show an anti-cancer role for TSLP.
There are several possible explanations for these conflicting findings. First, the protective effect
of TSLP may be skin-specific. Alternatively, TSLP may have a protective effect on the early
stages of tumorigenesis but a promoting effect on later stages of tumor growth and metastasis.
However, the observation that calcipotriol treatment is capable of shrinking pre-existing tumors
suggests that this may not be the case. Finally, following the trend of our allelic series of Notchdeficient mice, TSLP levels may determine whether it promotes or inhibits tumor development
and growth, and the tipping point may vary according to the strength of the pro-tumor
environment in a specific context. Support for this concept comes for the observations that
higher TSLP levels are needed to establish a tumor-resistant phenotype in the otherwise tumorprone Notch mutant animals than the otherwise wild-type K14-TSLPtg animals. Below this
context-specific threshold level, TSLP may have a neutral or tumor-promoting effect, but above
the threshold, it acts as a potent tumor-suppressor. These concepts need to be formally tested in
future studies. Nonetheless, here we report that in both a neutral and a pro-tumor
microenvironment, TSLP concentrations capable of creating a CD4+ T cell-mediated anti-tumor
response can be reached. Once achieved, activated CD4+ T cells not only identify and prevent
growth of transformed cells but also mediate the rejection of Notch signaling-deficient cells.
In our mutant animals, large territories of mutant tissue are embedded in wild-type skin.
Therefore, the global resistance of calico RBPj-deficient skin to chemical carcinogens suggests
that the cancer-initiated wild-type keratinocytes are being suppressed alongside the initiated
156

mutant cells. Uninitiated mutant cells with three different Notch-deficient genotypes (i.e.
RBPjCKO, N1N2CKO or PSDCKO) are also rejected; but importantly, TSLP-activated CD4+ T
cells do not target the normal skin cells in the same animal. Based on these observations, we
conclude that CD4+ T cells that are trained in high local TSLP concentrations must recognize
immunogenic epitope(s) arising independent of Notch signaling in cells with abnormal
differentiation and/or proliferation profiles. This protective activity does not arise in CD4+ T
cells that lack the TSLP receptor or in animals from which CD4+ T cells are cleared before the
wild-type immune cells encounter the Notch-deficient skin. It is important to note that CD4+ T
cell activation by TSLP can occur even if all other tissues and hematopoietic lineages, including
dendritic and Langerhans cells, are rendered blind to TSLP by germline deletion of either TSLP
receptor arms (IL7rα or CRLF2/TSLPR). These data establish that TSLP-responsive CD4+ T
cells are both sufficient and required to create the tumor suppressing microenvironment, likely
by recruiting several cytotoxic immune effector cells including CTLs, NK cells and macrophages
to the skin. Considering that TSLP promotes Th2 differentiation (Al-Shami et al., 2004; Tanaka
et al., 2009; Ziegler and Artis, 2010) and Th2 cells predominate in Notch signaling-deficient
animals (Demehri et al., 2009a), we propose that the CD4+ Th2 cells are initiating the effects of
TSLP. The exact nature of the TSLP-responsive CD4+ T cells and the tumor antigens they are
reacting to remain to be indentified in future studies. Once activated, these CD4+ T cells form a
lasting pool of “memory” cells that could not be eradicated with anti-CD4 antibody or
irradiation. This observation is very exciting as it suggests that lasting anti-tumor immunity can
be achieved by targeting antigens that are specific to tumor cells. We show that this anti-tumor
immunity can be achieved even after the tumor is formed; application of a TSLP-inducer,
Calcipotriol, halted growth of fully developed skin tumors in wild-type animals. It remains to be
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determined if TSLP can also stimulate the regression of other solid tumors besides the ones
formed in the skin.
In an accompanying paper, a similar set of observations is reported. Both studies report
an anti-tumor function for TSLP in Notch-deficient skin and both demonstrate that this function
of TSLP can also be elicited in animals with intact Notch signaling. However, our colleagues
report that CD8+ CTLs together with CD4+ T cells mediate the tumor resistance phenotype. In
their study, Notch proteins are deleted globally in the skin after birth using an inducible basal
keratinocyte Cre, resulting in an intact hair follicle bulge and an immune system that matured in
the absence of TSLP or tumor antigens. This deletion paradigm precludes monitoring the
rejection of mutant skin clones. In our mice, the immune system matures in the presence of
TSLP, which begins to accumulate as soon as incomplete differentiation becomes evident (at
E16.5; (Demehri et al., 2008)), and in the presence of antigens presented by mutant cells that
may be shared by the cancer-initiated cells later on. Moreover, in our mice the hair follicle is
destroyed by P10 and bulge never forms because the outer root sheath of hair follicles adopts an
epidermal fate right after birth (Demehri et al., 2008). It is conceivable that some of the
difference between the two studies reflects methodological differences, but it is hard to explain
why CD8+ CTLs do not contribute in our system yet provide the bulk of protection in their
Notch-deficient mice. The explanation may lie in the difference between the tumor cells of
origin, the timing of the Notch signaling deletion, or reflect the involvement of multiple
cytotoxic cell types in our model. The differential role of CTLs in these two experimental
paradigms remains to be addressed in future studies. The accompanying study demonstrates that
the cystic tumors arise via a Wnt/b-catenin-dependent mechanism from bulge-derived hair
follicles whereas our tumors originate from epidermal cells that do not appear to accumulate
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nuclear b-catenin prior to tumor formation (Demehri et al., 2009b). Taken together, however, the
differences between the studies support the conclusion that TSLP can provide immunological
protection against skin cancer and support the speculation that it may do the same in other types
of solid tumors.
In summary, this study and the accompanying paper by Di Piazza et al identify a
previously unrecognized role for TSLP in inducing a robust anti-tumor response in several
experimental paradigms (Notch loss of function, Wnt gain of function (Di Piazza et al) and
DMBA-induced tumors). Moreover, these studies demonstrate that TSLP exerts its anti-tumor
effects through CD4+ T cells in a Th2-dominant inflammatory environment. Therefore, our
findings may explain why individuals who suffer from Th2-dominant allergic disorders display
reduced risk of developing certain types of cancers including non-melanoma skin cancers
(Gandini et al., 2005; Hwang et al., 2012; Prizment et al., 2007; Vajdic et al., 2009; Wang and
Diepgen, 2005). Importantly, therapeutic exploitation of this mechanism seems within reach
given the efficacy of calcipotriol, an FDA-approved drug and a potent inducer of TSLP, in
blocking DMBA-induced carcinogenesis.
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EXPERIMENTAL PROCEDURES
Mice
The following mutant animals were generated according to the methods outlined in our previous
report (Pan et al., 2004b):
Msx2-Cretg/+; Rosa-LSL-EYFP (Srinivas et al., 2001)
Msx2-Cre tg/+; Notch1flox/flox (N1CKO)
Msx2-Cretg/+; Notch1flox/flox; Notch2flox/+ (N1N2hCKO)
Msx2-Cretg/+; Notch1flox/flox; Notch2flox/+; Notch3-/- (N1N2hN3CKO)
Msx2-Cretg/+; Notch1flox/flox; Notch2flox/flox (N1N2CKO)
Msx2-Cretg/+; Notch1flox/flox; Notch2flox/flox; IL7ra-/- (N1N2CKO)
Msx2-Cretg/+; PS1flox/flox; PS2-/- (PSDCKO)
Msx2-Cretg/+; PS1flox/flox; PS2-/-; TSLPR-/- (PSDCKO;TSLPR-/-)
Msx2-Cretg/+; Rbpjflox/flox (RBPjCKO)
Msx2-Cretg/+; Rbpjflox/flox; IL7ra-/- (RBPjCKO;IL7ra-/-)
Msx2-Cretg/+; Rbpjflox/flox; CD8a-/- (RBPjCKO;CD8a-/-)
Msx2-Cretg/+; Rbpjflox/flox; Kitwsh/wsh (RBPjCKO;Kitwsh/wsh)
Msx2-Cretg/+; Rbpjflox/flox; TNFRI-/- (RBPjCKO;TNFRI-/-)
Msx2-Cretg/+; Rbpjflox/flox; TNFRI-/-; TNFRII-/- (RBPjCKO;TNFRI-/-;TNFRII-/-)
K14-TSLPtg
The pedegreed RBPjCKO cohort was maintained in mixed FVB, C57BL/6 and CD1 genetic
backgrounds, which were overall more suseptible to DMBA/TPA skin carcinogenesis. All other
animals were kept in mixed C57BL/6 and CD1 genetic backgrounds and therefore were
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relatively more resistant to chemical skin carcingens. In all cancer experiments, age-matched
littermates were compared.
All the mice were housed in Washington University animal facility in accordance with animal
care regulations. Msx2-Cretg/+; Rosa-LSL-EYFP mouse was imaged at P0 using Leica
stereoscopic fluorescence microscope with regular light (rendered magenta in Figure 6-1a) or
YFP filter. In studies related to mutant skin rejection, spontaneous/DMBA-induced
tumorigenesis and life span, mice were photographed with a digital camera weekly and
monitored for onset, number and size of tumors and any sign of failure to thrive. Moribund mice
are euthanized and skin, tumors, blood, spleen and lymph nodes were harvested.
Chemical Skin Carcinogenesis Studies
For RBPjCKO DMBA-TPA experiments, 3-week-old mutant mice and Cre-negative wild-type
littermates were treated with standard protocol for skin chemical carcinogenesis model as
previously described (Nicolas et al., 2003a). RBPjCKO mice received one dose of 25mg DMBA
(Sigma, St. Louis, MO) followed in a week by biweekly treatment with 4mg TPA (Sigma, St.
Louis, MO) for 14 weeks. In K14-TSLPtg and CD1 carcinogenesis experiments, mice were
treated with 125mg DMBA (CD1, Calcipotriol treatment) or 100mg DMBA (K14-TSLPtg). In all
the experiments, adult mice were shaved under anesthesia 2 days prior to treatment with DMBA
to ensure the hair follicles are in the second telogen.
In studies where tumorigenesis was induced with one dose of DMBA, the mutant animals
received a single dose of 125mg DMBA in 100ml of acetone during the second week of life,
after the mice were subjected to any other experimental procedures including irradiation, BMT
or adoptive T cell transfer.
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Bone marrow transplantation (BMT)
The recipient mice were lethally irradiated with 950-cGy in second week of life and transplanted
with unfractionated BM cells from their littermates, Rag2-/-;gc-/- or Rag2-/- animals as previously
described (Zhang and Ren, 1998). All transplanted animals were maintained on antibiotics
containing water to prevent infection.
Adoptive T cell transfer
For T cell isolation, splenocytes were positively selected for CD4 or CD8 surface expression
using CD4 or CD8 MicroBeads, respectively, followed by negative selection to remove any
CD11c+ dendritic cells using CD11c MicroBeads (Miltenyi Biotec Inc., Auburn, CA).
RBPjCKO;IL7rα-/- and PSDCKO;TSLPR-/- mice were irradiated with 450-cGy during the second
week of life and injected intravenously with ~2 x 106 CD4+ or CD8+ T cells isolated from the
spleen of their littermates.
BMT and Antibody Depletion
RBPjCKO;IL7rα-/- newborn mice received intraperitoneal injection of 750mg anti-CD4 (GK1.5;
Bio X Cell, West Lebanon, NH), anti-CD8 (YTS; Bio X Cell, West Lebanon, NH) or Control
IgG antibody (Sigma, St. Louis, MO) in second week of life. 48hr later, the mutant animals
received BMT using c-Kit+ bone marrow progenitors (lacking T cells) from their wild-type
littermates isolated using CD117 MicroBeads and magnetic columns according to
manufacturer’s protocol (Miltenyi Biotec Inc., Auburn, CA). Each recipient was injected
intravenously with 2x106 c-Kit+ BM cells in 100µl PBS+2%FBS. The mutant animals were then
treated topically with one dose of DMBA and continued to receive 250mg of the depleting
antibody weekly. Mice were monitored for skin rejection and tumor formation weekly and
harvested at P90.
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Histology and Immunohistochemistry
Hematoxylin and eosin (H&E), toluidine blue and immunostainings were performed on paraffinembedded 5µm skin sections. Skin samples were fixed in 4% paraformaldehyde in PBS,
dehydrated with ethanol and embedded in paraffin as previously described (Pan et al., 2004b).
For Immunohistochemistry, anti-panleukocytic marker (CD45; BD PharMingen, San Diego, CA)
and anti-RBPj antibody (clone T6709, Institute of Immunology Co., Tokyo, Japan) were used.
After treatment with biotinylated secondary antibody, HRP-conjugated streptavidin (Vectastain
ABC kit, Vector Laboratories, Burlingame, CA) and DAB substrate kit (Pierce, Rockford, IL)
were applied to visualize the signal.
Flow cytometry (FC)
Single cell suspensions from dermis or peripheral blood were prepared as described (Demehri et
al., 2009b). The following antibodies were used for FC analysis: anti-CD45 conjugated to
peridinin chlorophyll-a protein-cyanin 5.5 (PerCP-Cy5.5), anti-CD4, anti-CD8b, anti-B220, antiLy6G, anti-NK1.1, and anti-Gr-1 conjugated to phycoerythrin (PE) and anti-CD11b conjugated
to fluorescein (FITC; all from BD PharMingen); anti-CD4 conjugated to Allophycocyanin
(APC), anti-CD44 conjugated to PE and anti-CD62L conjugated to phycoerythrin-Cy7 (PE-Cy7;
from eBioscience, San Diego, CA). BD FACScan Flowcytometer (Cytek Development) was
used for FC, and FC analysis was performed using FlowJo software (Ashland, OR).
ELISA
Quantikine mouse TSLP kit (R&D Systems, Minneapolis, MN) was used to measure serum
TSLP concentrations.
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Statistical analysis
Except for Calcipotriol studies performed on wild type CD1 animals, all the animals used in this
report were kept on outbred genetic backgrounds in a pedigreed colony (i.e. all animals are
logged into a database). To minimize the confounding effects of strain or family background on
tumor outcomes, we only compared gender-matched littermates in each cancer study. Using the
power analysis described previously (Demehri et al., 2009b), we determined the number of
animals needed in each chemical skin carcinogenesis study.
As the test of significance between the study groups, we used long rank test for “Time to tumor
onset” and Student’s t-test for tumor counts, serum TSLP levels and other quantitative
measurements.
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Figure 6-1. Mice lacking Rbpj gene in portion of their epidermis are resistant to skin
tumorigenesis. (A) The calico pattern EYFP expression (green) induced by Msx2-Cre-mediated
gene deletion in Msx2-Cre, Rosa (LoxP_Stop_LoxP)-EYFP newborn. Bright light image is
shown in magenta. After birth, mutant clones become evident due to hair phenotypes. (B)
Reduction in Notch signaling dosage in the skin leads to the corresponding shortening in life
span and in spontaneous tumor latency. This trend, however, does not extend to mice lacking
RBPj (green arrow), which live ~100 days but do not develop any skin tumor (n>20 in each
group; % indicates the percentage of mice that developed skin tumors; **: p <0.01, student’s ttest; modified from (Demehri et al., 2009b)). (C,D) RBPjCKO mice are resistant to chemical
carcinogens. Treating RBPjCKO and wild-type littermates with standard DMBA-TPA protocol
from 3 to 18 weeks of age results in (C) tumor formation in majority (6/7) of wild-type mice and
(D) increase in the number of their tumors over this time. In contrast, no persistent tumor is
formed in the RBPj-deficient mice (n=7 for each group; error bars represent SEM; p <0.0001,
log-rank test). Genotypes: Msx2-Cre

tg/+

; Notch1flox/flox (N1CKO), Msx2-Cretg/+; Notch1flox/flox;

Notch2flox/+ (N1N2hCKO), Msx2-Cretg/+; Notch1flox/flox; Notch2flox/+; Notch3-/- (N1N2hN3CKO),
Msx2-Cretg/+; Notch1flox/flox; Notch2flox/flox (N1N2CKO), Msx2-Cretg/+; PS1flox/flox; PS2-/(PSDCKO), Msx2-Cretg/+; Rbpjflox/flox (RBPjCKO).
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Figure 6-2. Notch signaling-deficient epidermal clones regress with age. (A) The red dotted
line and arrowheads delineate the boundaries of the Rbpj-deficient dorsal epidermis as
determined by hair/epidermal phenotype. α-RBPj antibody staining confirms that RBP-j depleted
keratinocytes, still present in the midline, were replaced by wild-type cells in the periphery. (B)
An identical phenomenon is observed in Notch1&2 or PS1&2-deficient animals that are rescued
from their lethal blood disease (Demehri et al., 2008) by a sublethal dose of irradiation (*). Scale
bars: 1cm (mice pictures), 50µm (histology).
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Figure 6-3. H-Ras-infected RBPjKO or PSDKO keratinocytes are highly tumorigenic in
nude mice. (A) Schema showing the experimental procedure. Cells are infected with retrovirus
containing oncogenic H-Ras and then with Adeno-Cre to delete the floxed alleles. (B) 1.5x106
H-Ras-infected RBPjKO or PSDKO cells injected subcutaneously into nude mice formed large
tumors after 30 days (red circle) whereas 1.5x106 H-Ras-infected cells with one remaining allele
of RBPj or PS1 formed small nodules. Histological analysis confirmed that poorly differentiated
squamous cell carcinomas are devoid of RBPj (scale bar: 50µm).
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Figure 6-4. Elevated TSLP expression in RBPjCKO epidermis causes a severe skin
inflammation. (A) RBPjCKO animals have much higher level of skin inflammation compared
to the tumor-prone N1CKO and N1N2hN3CKO mice. (B) Reduction in Notch alleles in the skin
correlates with a corresponding increase in circulating TSLP during second week of life (error
bars represent standard deviation around the mean; *: p <0.05, student’s t-test; modified from
(Demehri et al., 2008)). (C) Loss of TSLP signaling in RBPjCKO; IL7rα-/- animals significantly
reduced CD45-positive dermal leukocytes (scale bar: 50µm).
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Figure 6-5. Loss of TSLP receptors results in mutant skin expansion and tumor formation
in Notch signaling-deficient animals. Deleting the IL7rα arm of the TSLP receptor in
RBPjCKO and N1N2CKO animals, or the TSLPR arm in PSDCKO animals, leads to (A)
expansion of mutant skin, and (B) the development of skin tumors. Treatment of RBPjCKO;
IL7rα-/- and PSDCKO; TSLPR-/- animals with one dose of 125mg DMBA during the 2nd week
of life leads to earlier onset of tumorigenesis and formation of multiple exophytic tumors. Note
that although N1N2CKO; IL7rα-/- and PSDCKO; TSLPR-/- can survive to adulthood (Dumortier
et al., 2010), they are sublethally irradiated alongside their N1N2CKO and PSDCKO littermates
to control for the irradiation effects (*:recipients of a sublethal dose of irradiation in the second
week of life; Insets in (A): invasive cancers penetrating the muscle layer; scale bars: 1cm (mice
pictures), 200µm (histology)).
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Figure 6-6. Adaptive immune cells mediate the effects of TSLP on Notch-deficient skin
rejection and tumor resistance. (A) A schematic diagram depicting the bone marrow
transplantation (BMT) procedure used to determine if bone marrow (BM)-derived cells mediate
the effects of TSLP in Notch and TSLP receptor-deficient mice. (B) BMT from wild-type donors
is sufficient to reconstitute the mutant skin rejection and tumor resistance phenotypes in host
RBPjCKO; IL7rα-/- and PSDCKO; TSLPR-/- littermates. TSLP receptor-deficient BM is used in
the control experiments. (C&D) BM from (C) Rag2-/-,gc-/- and (D) Rag2-/- donors fails to reject
mutant keratinocytes and prevent tumorigenesis in RBPjCKO;IL7rα-/- and PSDCKO;TSLPR-/animals. (E&F) DMBA treatment following BMT in the 2nd week of life confirms that
(E) RBPjCKO;IL7rα-/- and (F) PSDCKO; TSLPR-/- animals receiving TSLP-responsive BM are
resistant to tumorigenesis. In contrast, mice transplanted with TSLP-responsive, T and B celldeficient BM develop exophytic DMBA-dependent tumors. Tumors were scored at 10wks. The
success of BMT in each experiment is confirmed by endpoint genotyping of the hematopoietic
cells in the recipients (Figure 6-S11 online). Representative mice and H&E-stained skin pictures
are shown (p <0.05 compared to wild-type donor group; n>4 for each group, error bars represent
standard deviation; scale bars: 1cm (mice), 200µm (histology)).
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Figure 6-7. CD4+ T cells mediate the effects of TSLP on mutant skin rejection and tumor
resistance in Notch-deficient animals. (A) 2-week-old RBPjCKO; IL7rα-/- and PSDCKO;
TSLPR-/- pups are irradiated with 450-cGy and injected intravenously with 2x106 wild-type
CD4+, wild-type CD8+ or TSLP receptor-deficient CD4+ T cells isolated from the spleens of their
littermates. Following adoptive T cell transfer, mutant mice are treated with DMBA. Only the
mutant animals that received wild-type CD4+ T cells gain the ability to reject their mutant skin
and suppress DMBA-induced tumorigenesis (Representative P60 mice pictures are shown;
exophytic tumor count were done at P90). (B) Schematic diagram outlining the experimental
method used to test if T cells are required to mediate the effects of TSLP in Notch signalingdeficient skin. 2-week-old RBPjCKO;IL7rα-/- mice are treated with depleting antibody (750mg
anti CD4 or 750mg anti CD8α; black arrows), lethally irradiated 2 days later and transplanted
with T cell-depleted c-Kit+ BM progenitor cells from their wild-type littermates. 2 days later the
animals are treated with one dose DMBA while continuing to receive a weekly intraperitoneal
injection of the indicated depleting antibody for 10 weeks. (C) Histograms confirming that CD4+
or CD8+ T cells are completely absence from RBPjCKO; IL7rα-/- mice transplanted with c-Kit+
wild-type BM and treated with anti-CD4 or anti-CD8a antibodies, respectively. Note that PEconjugated anti-CD8b antibody is used to detect CD8+ cells, and the samples were collected one
week after the last antibody treatment. Blood and spleen CD45+ leukocytes are used to generate
the histograms. (D) Only RBPjCKO; IL7rα-/- mice transplanted with CD4+ cell depleted c-Kit+
BM cells retain their mutant keratinocytes, develop hypertrophic cysts and form skin tumors.
RBPjCKO;IL7rα-/- mice transplanted with CD8+ cell depleted c-Kit+ BM cells reject mutant
keratinocytes and do not develop any tumors in response to DMBA, as seen with transplantation
with wild-type BM (Figure 6-6). The success of adoptive T cell transfer and BMT in each
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experiment is confirmed by endpoint genotyping of the hematopoietic cells in the recipients
(Figure 6-S11 online). Mice are followed up to 90days of age for exophytic tumor count
(Representative pictures are shown; at least five mice are analyzed in each group; scale bars:
1cm).
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Figure 6-8. TSLP creates a tumor-suppressing environment in wild-type skin. (A&B)
Topical treatment of CD1 wild-type animals with calcipotriol, a known inducer of TSLP (Li et
al., 2006), resulted in an acquired resistance to chemical skin carcinogenesis compared to
littermates receiving only the carrier (EtOH). This tumor resistance is demonstrated by (A)
longer time to tumor onset (p <0.0001, log-rank test) and (B) much smaller average number of
tumors among tumor-bearing calcipotriol-treated animals (n=10 for each group; error bars
represent SEM; *: p <0.01, student’s t-test). Mice are treated with 125ug DMBA once followed
by 4ug TPA twice weekly for a total of 15 weeks treatment period. Animals in the test group
received 32nmol calcipotriol five times a week while controls received only EtOH during the 15week DMBA-TPA treatment period. (C&D) Calcipotriol-treatment halts tumor growth and
induces tumor regression in tumor-breading wild-type skin. The 8 tumor-bearing carrier-treated
mice in (A&B) were randomly divided into two groups at the end of the 15-week DMBA-TPA
treatment course. The “test” group of 4 animals was treated with 32nmol calcipotriol and the
“control” group continued to receive carrier only 5 times per week. After additional 7-week
follow-up period, the calcipotriol-treated mice (C) show significant reduction in skin tumor
numbers and (D) have smaller tumors compared to the carrier-treated mice (n=4 in each group;
tumors are highlighted with blue circles; error bars represent standard deviation; *: p <0.05,
student’s t-test; representative pictures are shown). (E&F) K14-TSLPtg animals are resistant to
chemical skin carcinogenesis. K14-TSLPtg female mice treated once with 100ug DMBA
followed by 4ug TPA twice weekly show (E) markedly longer time to tumor unset (p <0.0001,
log-rank test) and (F) significantly fewer tumors among tumor-bearing animals compared to their
wild-type female littermates (n=22 for K14-TSLPtg group and n=21 for wild-type group; error
bars represent SEM; *: p <0.01, student’s t-test). (G) TSLP levels are elevated in calcipotriol188

treated and K14-TSLPtg animals compared to their controls, reflected in the elevation of serum
TSLP levels (error bars represent standard deviation; *: p <0.0001, student’s t-test).
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CHAPTER VII

Notch2-dependent classical dendritic cells orchestrate
intestinal immunity to attaching-and-effacing bacterial
pathogens.
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ABSTRACT
Defense against attaching-and-effacing bacteria requires the sequential generation of
interleukin 23 (IL-23) and IL-22 to induce protective mucosal responses. Although CD4+ and
NKp46+ innate lymphoid cells (ILCs) are the critical source of IL-22 during infection, the
precise source of IL-23 is unclear. We used genetic techniques to deplete mice of specific subsets
of classical dendritic cells (cDCs) and analyzed immunity to the attaching-and-effacing
pathogen Citrobacter rodentium. We found that the signaling receptor Notch2 controlled the
terminal stage of cDC differentiation. Notch2-dependent intestinal CD11b+ cDCs were an
obligate source of IL-23 required for survival after infection with C. rodentium, but
CD103+ cDCs dependent on the transcription factor Batf3 were not. Our results demonstrate a
nonredundant function for CD11b+ cDCs in the response to pathogens in vivo.
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INTRODUCTION
The cytokines interleukin 23 (IL-23) and IL-22 are critical for immune responses that
maintain mucosal integrity against infections by attaching-and-effacing bacterial pathogens1, 2.
Isolated lymphoid follicles (ILFs) in the small and large intestine contain dendritic cells (DCs), B
cells and innate lymphoid cells (ILCs) that orchestrate protection against those pathogens2, 3, 4.
During such infections, ILCs produce IL-22, which promotes barrier integrity by inducing the
production of antimicrobial peptides, including RegIIIβ and RegIIIγ, by epithelial cells2, 5, 6. The
importance of IL-22 is indicated by the susceptibility of Il22−/− mice to the attaching-andeffacing bacterium Citrobacter rodentium, a model for the infection of humans with
enteropathogenic and enterohemorrhagic Escherichia coli2, 6, 7.
IL-22-producing

ILCs

are

heterogeneous

and

include

a

CD4+ subset5 and

a

CD4−NKp46+ subset8. Both subsets express the transcription factor RORγt, which is required for
their development9, 10. An important unresolved question is the identity of the cells that stimulate
ILCs to produce IL-22. ILCs do not directly detect infection by attaching-and-effacing pathogens
but instead seem to depend on IL-23 produced by other innate cells for their activation2, 8. It has
been suggested that in response to C. rodentium, either macrophages or DCs may be the main
source of IL-23 (refs.11, 12). A role for macrophages was proposed on the basis of the greater
pathogen burden of mice deficient in the chemokine receptor CX3CR1 (Cx3cr1−/− mice), as well
as the greater susceptibility of CD11c-DTR mice (which, after treatment with diphtheria toxin,
are selectively depleted of cells that express diphtheria toxin receptor (DTR) under the control of
the promoter of the gene encoding the integrin CD11c) to such infection12. Alternatively, a role
for classical DCs (cDCs) was proposed on the basis of the greater pathogen burden and lower IL23 production in mice that lack the lymphotoxin-β receptor (LTβR) in CD11c-expressing
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cells11 and by the separate observation that cDCs are the main source of IL-23 after stimulation
of Toll-like receptor 5 (ref. 13).
The opposing conclusions of those studies emphasize the difficulty in distinguishing the
roles of macrophages and cDCs in vivo, particularly for studies that rely on depletion methods
based on CD11c14. Zbtb46 has been identified as a transcription factor expressed in cDCs but not
macrophages, monocytes or plasmacytoid DCs (pDCs), and expression of DTR under the control
of the Zbtb46 promoter (Zbtb46DTR) allows selective depletion of cDCs15, 16. Other systems have
been developed that also allow selective depletion of individual cDC subsets in vivo17, 18, 19, 20.
Mice deficient in the transcription factor Batf3 lack the CD8α+ cDC subset that is identified by
its expression of CD103 in the periphery; as a result, these mice have defective CD8+ T cell
responses to several viral pathogens17, 21 and are susceptible to infection with Toxoplasma
gondii22. Similarly, mice with selective depletion of pDCs have defects in the production of type
I interferon and are susceptible to chronic infection by viruses such as lymphocytic
choriomeningitis virus19, 23. Thus, studies using systems of selective depletion have identified
nonredundant roles for CD8α+ cDCs and pDCs but not for the third major subset of DCs, the
CD11b+ cDCs.
A subset of CD11b+ cDCs in vivo expressing the adhesion molecule ESAM undergoes
depletion after conditional deletion of the gene encoding the signaling receptor Notch2 (ref. 18).
That study proposed that Notch2 signaling is selectively required for the development of splenic
CD11b+ESAM+ cDCs and intestinal CD103+CD11b+ cDCs derived from the precursor of the
cDC (pre-cDC), analogous to the unique dependence of CD8α+ cDCs on Batf3 (ref. 17).
However, CD11b+ESAM− cDCs persist in Notch2-deficient mice, which prompts the question of
how those cells are related to CD11b+ESAM+ cDCs and whether they provide compensatory
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functions. Furthermore, although that study suggested that Notch2 specifically regulates the
CD11b+ branch of cDCs, some evidence indicated a developmental defect in the CD8α+ branch
as well, although that was not further analyzed18. Unexpectedly, mice that lack
CD103+CD11b+ cDCs have only 50% less production of IL-17 by T cells stimulated ex vivo, and
responses during infection have not been examined to show a specific function for such cells in
immunological defense.
Here we demonstrate a selective function for CD11b+ cDCs in immunological defense
against pathogens. Through the use of several genetic models with selective depletion of various
subsets of cDCs in vivo, we found that Notch2-dependent intestinal CD103+CD11b+ cDCs
provided nonredundant protection against infection with attaching-and-effacing pathogens, but
macrophages or Batf3-dependent CD103+CD11b− cDCs did not. Notch2-dependent cDCs were
required for host survival mediated by the local generation of IL-23-dependent antimicrobial
responses early after infection. Developmentally, Notch2 regulated the terminal differentiation of
both the CD8α+ and CD11b+ branches of cDCs, which allowed their subsequent homeostatic
population expansion via signaling through LTβR. Our results demonstrate that intestinal
CD103+CD11b+ cDCs detect infection with attaching-and-effacing pathogens and secrete IL-23,
which is critical for IL-22 production by ILCs and the maintenance of mucosal integrity.
RESULTS
cDCs mediate defense against attaching-and-effacing pathogens
The generation of Zbtb46gfp mice, which express green fluorescent protein (GFP) driven
by theZbtb46 promoter (Zbtb46-GFP), as well as Zbtb46DTR mice, has allowed the selective
visualization and depletion of cDCs, which can help in distinguishing the requirements for cDCs
and macrophages in immune responses in vivo15, 16. We sought to determine whether expression
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of Zbtb46-GFP could be used to distinguish cDCs from macrophages in the intestinal lamina
propria and mesenteric lymph nodes (MLNs) (Figure 7-1a,b). Among MHCII+CD11c+ lamina
propria cells, CD103+CD11b− cells and CD103+CD11b+ cells were uniformly GFP+, consistent
with their identity as cDCs. Both CD103−CD11b+ cells and CD103−CD11b− cells also included a
substantial GFP+fraction (Figure 7-1a), in agreement with published studies suggesting that
cDCs may also reside in those gates16, 24, 25. In contrast, F4/80+ macrophages were present mainly
in the MHCII−CD11c+gate and did not express GFP (Figure 7-1a). In the MLNs, migratory
cDCs26, 27 were

uniformly

GFP+and

were

mainly

in

the

CD103+CD11b− and

CD103+CD11b+ gates (Figure 7-1b), consistent with the ability of cDCs, but not macrophages, to
migrate to the MLNs28. Resident cDCs were also uniformly GFP+, but were predominantly in the
CD103−CD11b− or CD103−CD11b+ gate. Thus, expression of Zbtb46 seemed to distinguish
cDCs from macrophages in the intestine independently of their expression of the integrins
CD103 (αEβ7) or CD11b (αM). Histological assessment of the small intestine of wild-type mice
reconstituted with Zbtb46gfp bone marrow (Zbtb46gfp chimeras) showed that GFP+ cDCs were
present in organized lymphoid structures, including Peyer's patches and ILFs, as well as at points
of antigen encounter in intestinal villi (Figure 7-1c). In the large intestine, GFP+ cDCs were also
present in colonic patches, ILFs and surrounding villi (Figure 7-1c).
The results reported above suggested that the administration of diphtheria toxin
to Zbtb46DTR mice should selectively eliminate cDCs but spare macrophages. Indeed, treatment
of theZbtb46DTR chimeras with diphtheria toxin resulted in a significantly lower frequency of
both CD103+CD11b− cDCs and CD103+CD11b+ cDCs in the lamina propria and the
F4/80− populations of CD103−CD11b− cDCs and CD103−CD11b+ cDCs, but did not affect
F4/80+ macrophages (Figure 7-2a,b). In addition, lymphocytes and ILCs in the lamina propria
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did not undergo depletion after treatment of Zbtb46DTR chimeras with diphtheria toxin and did
not express Zbtb46-GFP (Supplementary Figure 7-1a–c). Thus, we used this system to determine
whether

cDCs

were

required

for

protection

against C.

rodentium.

We

found

that Zbtb46DTR chimeras treated with diphtheria toxin were unable to recover after challenge
with C. rodentium and died within 8–12 d of infection (Figure 7-2c). In contrast, wild-type mice
reconstituted with wild-type bone marrow (wild-type chimeras) and Zbtb46DTR chimeras not
treated with diphtheria toxin survived beyond 15 d; they underwent some weight loss but
recovered normal weight by 30 d after infection (Figure 7-2c,d).
To confirm a specific role for cDCs and to investigate a possible role for monocytederived cells in protection from C. rodentium, we next analyzed mice deficient in the cytokine
Flt3L

(Flt3l−/−

mice)29 and

mice

deficient

in

the

chemokine

receptor

CCR2

(Ccr2−/− mice)30. Flt3l−/− mice have fewer lamina propria cDCs but maintain normal numbers of
macrophages and monocytes24, 25. Similar to diphtheria toxin–treated Zbtb46DTR chimeras,
Flt3l−/− mice succumbed to C. rodentium infection after 10–16 d (Figure 7-2e,f). In contrast,
Ccr2−/− mice have a specific defect in the recruitment of monocytes to the intestinal lamina
propria but maintain normal populations of cDCs31. Although Ccr2−/− mice underwent more
weight loss than did their wild-type (Ccr2+/+) counterparts, only 25% succumbed to infection
(Figure 7-2e,f). These results demonstrated that cDCs, rather than macrophages or monocytederived cells, were required for early innate defense against C. rodentium, but did not indicate
whether a particular cDC subset was required.
Notch2-deficient mice lack CD11b+ cDCs in vivo
Notch2 is required for the development of the CD11b+ESAM+ cDC fraction18. However,
the specific function of those cells has not been determined in vivo. To characterize how Notch2
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signaling influences cDC development, we examined the requirement for Notch2 and its
transcriptional partner RBPjκ, as well as the γ-secretase complex composed of presenilin 1
(PSEN1) and PSEN2, in the development of splenic CD8α+ or CD11b+ cDCs (Figure 7-3a).
Hematopoietic loss of either Rbpj or Notch2 mediated by Cre recombinase expressed from the
hematopoietic compartment–specific promoter Vav1 (Vav1-Cre) resulted in a lower frequency of
CD11c+MHCII+ cDCs and CD8α+ cDCs (identified by expression of the surface marker CD24)
and elimination of CD11b+ESAM+CD4+cDCs (also identifiable by expression of the signaltransduction molecule CD172a rather than CD11b; Figure 7-3a). Vav1-Cre–mediated deletion
of Psen1 and Psen2 also resulted in a similarly lower frequency of CD11c+MHCII+ cDCs and
CD8α+ cDCs and elimination of ESAM+CD4+ cDCs (Figure 7-3a). These results indicated that
deletion of RBPJ affected cDC development through loss of canonical Notch signaling rather
than through derepression of genes that are not targets of Notch. Histologically, deletion of
Notch2 eliminated the characteristic clusters of CD11b+ cDCs in the marginal zone and bridging
channels of the spleen32, which left a distribution of cDCs loosely scattered throughout the T cell
zones and red pulp (Figure 7-3b).
As loss of Notch2 also affects the development of additional hematopoietic lineages33, we
used Cre expressed from the promoter of the gene encoding CD11c (CD11c-Cre) instead of the
Vav1-Cre system to restrict the effect of Notch2 deletion to myeloid lineages for analysis of cDC
function during infection in vivo. Deletion of Notch2 by CD11c-Cre (Notch2cKO) generated
defects in cDC development identical to those that resulted from Vav1-Cre–induced deletion
of Notch2 (Figure 7-3c,d) but prevented effects on other hematopoietic lineages (Supplementary
Figure 7-2 online). Notch2cKO mice had fewer splenic cDCs than did their Notch2-sufficient
counterparts and had no ESAM+CD4+cDCs (Figure 7-3c,d). A fraction of CD24+ cDCs also
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expressed ESAM and was dependent on Notch2 signaling (Figure 7-3c,d), which suggested that
Notch2 acted in a similar way, although to a different extent, in the development of the
CD11b+ and CD8α+ subsets of cDCs. Notch2-dependent ESAM+cDCs were abundant not only in
the spleen but also in the resident cDC fraction in the MLNs (Supplementary Figure 7-2a online).
Similarly, a small fraction of resident ESAM+, Notch2-dependent cDCs was present in skindraining lymph nodes (Supplementary Figure 7-2a online). In contrast, migratory dermis-derived
cDCs in skin-draining lymph nodes and peripheral tissue–resident cDCs in the lungs and kidneys
were not affected by Notch2 deletion18 (Supplementary Figure 7-2a,b online). In the intestinal
lamina propria, deletion of Notch2 resulted in a much lower frequency of CD103+CD11b+ cDCs
(Figure 7-3e). In contrast, Batf3−/− mice selectively lacked the complementary lamina propria
CD103+CD11b−cDC

subset

(Figure

7-3e)

but

retained

normal

numbers

of

CD103+CD11b+ cDCs34. Similarly, Notch2cKO mice had considerably fewer migratory
CD103+CD11b+ cDCs in the MLNs, and Batf3−/− mice had no CD103+CD11b− cDCs (Figure 73e). The development of cryptopatches and ILFs containing CD11c+ cDCs and ILCs was
unaffected in Notch2cKO mice (Figure 7-3f and Supplementary Figure 7-2d online), consistent
with a published report showing that CD11b+ DCs are present mainly in the lamina propria and
not in ILFs35. Thus, Notch2cKO mice provided an in vivo system for the analysis of CD11b+ cDC
function in the presence of intact lymphoid structures.
Notch2 controls the terminal differentiation of cDC subsets
Although the role of Notch2 in cDC development is thought to be limited to the
CD11b+ subset of cDCs18, we observed that Notch2cKO mice also had defects in the CD8α+ cDC
subset (Figure 7-3c,d). As CD8α expression can be altered by manipulation of the Notch
pathway36, we used expression of CD24 and the DC marker DEC-205 (CD205) to identify this
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subset of cDCs (Supplementary Figure 7-3a online). To assess the transcriptional effects of
Notch2, we analyzed gene expression in both CD11b+cDCs and DEC-205+ cDCs from mice
with loxP-flanked Notch2 alleles

(Notch2f/f mice)

and

Notch2cKO mice

(Figure7.4a

and

Supplementary Figure 7-3a online). As expected, we noted substantial differences
between Notch2f/f CD11b+ cDCs and Notch2cKO CD11b+ cDCs. In particular, the expression of
known Notch targets such as Hes1 and Dtx1 was lower in Notch2cKO CD11b+ cDCs, as was the
expression of cDC-specific genes such as Lphn3, Spint1 and Dnase1l3 (Figure 7-4a). Most of the
genes regulated by Notch2 in CD11b+ cDCs were also regulated by Notch2 in DEC-205+cDCs
(Figure 7-4a). In CD11b+ cDCs, Notch2 influenced gene expression in both the ESAM+ and
ESAM− fractions (Supplementary Figure 7-3b online), which suggested that Notch2 acted early
after differentiation of the CD11b+ cDC subset from pre-cDCs, before the induction of ESAM
expression, and that its actions were not simply restricted to the development of an
ESAM+ subset. Likewise, in DEC-205+cDCs, Notch2 regulated the same set of genes in both the
ESAM+ and ESAM− fractions, which largely overlapped the genes regulated in CD11b+ cDCs
(Supplementary Figure 7-3b online).
Principal-component analysis showed that similar genes were influenced by Notch2
deficiency in CD11b+ cDCs and DEC-205+ cDCs. Principal component 1 (PC1) segregated cDCs
by lineage subset, which distinguished CD11b+ cDCs from DEC-205+ cDCs (Figure 7-4b). In
contrast, PC2 segregated both cDC lineages by the presence or absence of Notch2 signaling,
which distinguished Notch2-sufficient cDCs from Notch2-deficient cDCs of each lineage (Figure
7-4b). Next we assessed the expression of genes most heavily weighted in PC2 along the
developmental pathway from common myeloid progenitor to splenic cDC. Genes with the
highest 'loadings' in PC2, which were thus induced by Notch2, had high expression in terminally
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differentiated cDCs but low expression in DC progenitors (Figure 7-4b–d). Conversely, genes
with the most negative 'loadings' in PC2 had high expression in progenitor cells. Through the use
of reporter mice with sequence encoding GFP knocked into two such genes, Ccr2 and Cx3cr1,
we found that CD11b+ESAM+cDCs, which underwent depletion in Notch2cKO mice, were
distinguished from CD11b+ESAM−cDCs on the basis of GFP expression (Figure 7-4e, top).
Similarly, two populations were also distinguished on the basis of their expression of GFP and
CD4 (Figure 7-4e, bottom). These subsets probably reflected true differences in the maturity of
CD11b+ cDCs, as Zbtb46, which has intermediate expression in cDC progenitors and is
upregulated in mature cDCs16, had higher expression in the ESAM+ fraction of CD11b+ cDCs
than in the ESAM− fraction (Figure 7-4d,e). Accordingly, both ESAM+ cDCs and ESAM− cDCs
developed from wild-type common DC progenitors and pre-DCs in vivo (Supplementary Figure
7-4a,b online), which supported a model in which Notch2 influenced the terminal cDC
differentiation of pre-DC–derived cells.
To evaluate the stage at which Notch2 first affected cDC development, we analyzed
competitive mixed chimeras generated by reconsititution of wild-type mice with bone marrow
from wild-type donors and donors with Vav1-Cre–mediated deletion of Notch2 (Notch2vav), in
which Notch2 is deleted at an early stage of hematopoietic development (Figure 7-4f). We
observed equal competition between wild-type and Notch2vav progenitors for cells in the lineagenegative (Lin−) Sca-1+c-Kit+fraction and up to the pre-DC stage of DC development (Figure 74f and Supplementary Figure 7-5a online). However, in the mature splenic cDC compartment,
wild-type cells outcompeted Notch2vav cells (Figure 7-4f and Supplementary Figure 7-5b online),
which indicated that Notch2 first affected development after the pre-DC. We noted this effect in
both the CD11b+ and CD8α+ subset of mature cDCs and, furthermore, in both the ESAM+ and
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ESAM− fraction of each cDC subset. In summary, our analyses of gene expression and
competitive bone marrow chimeras indicated that Notch2 acted in the terminal differentiation of
CD11b+ cDCs and CD8α+ cDCs.
LTβR mediates the population expansion of Notch2-dependent cDCs
As Notch2 signaling controls the terminal differentiation of cDCs in the spleen and
intestine, its effects should be subsequent to those of Flt3L signaling, which can be observed in
the population expansion of DC progenitors in the bone marrow37. To test that hypothesis, we
compared the development of Notch2-dependent cDC subsets in wild-type and Flt3l−/− mice
(Supplementary Figure 7-6a,b). As expected, Flt3l−/− mice had a much lower abundance of all
subsets of cDCs, including CD11b+ESAM+ cDCs. However, treatment of wild-type mice with
Flt3L

resulted

in

25-fold

more

CD11b+ESAM− cDCs

but

only

2.5-fold

more

CD11b+ESAM+ cDCs (Supplementary Figure 7-6c,d online). Thus, Flt3L was necessary but not
sufficient for development of CD11b+ESAM+ cDCs, which suggested that Notch2 regulated a
step in cDC development subsequent to the actions of Flt3L.
Because the lymphotoxin LTα1β2 is required for the proliferation of splenic CD8− cDCs
located in the marginal zone and bridging channels38, we investigated whether signaling via both
Notch2 and LTβR selectively influenced the same cDC subset. We compared the development of
splenic cDC subsets in wild-type, Notch2cKO and LTβR-deficient (Ltbr−/−) mice. Ltbr−/− mice,
similar to Notch2cKO mice, had fewer CD11c+MHCII+ cDCs and CD8α+ cDCs and considerably
fewer ESAM+CD4+ cDCs (Figure 7-5a). Similarly, Nik−/− mice, which are deficient in activation
of the noncanonical pathway of the transcription factor NF-κB downstream of LTβR signaling,
and Nfkb1−/− mice, which lack the p105 subunit of NF-κB, showed selective loss of
ESAM+ cDCs but retained ESAM− cDCs (Supplementary Figure 7-7a,b online). We did not
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observe those defects in mice lacking the costimulatory receptor CD40 (Supplementary Figure 77a online), a member of the tumor-necrosis factor receptor family that can also activate NF-κB39.
As Ltbr−/− mice lack lymph nodes and Peyer's patches40, we sought to determine whether the loss
of ESAM+ cDCs in these mice was cell intrinsic by analyzing mixed chimeras generated by
reconsitution of wild-type mice with wild-type and Ltbr−/− bone marrow. We observed
substantial outcompetition of Ltbr−/− bone marrow by wild-type bone marrow in the generation
of splenic and MLN-resident CD11b+ cDCs (Figure 7-5b,c), as well as outcompetition
of Ltbr−/− CD8α+ cDCs by wild-type CD8α+ cDCs in this setting (Figure 7-5b,c). Thus,
Ltbr−/− bone marrow and Notch2cKO bone marrow had a similar competitive disadvantage relative
to that of wild-type bone marrow in the generation of both branches of cDCs.
To evaluate the epistatic relationship between Notch2 and LTβR signaling, we examined
cDC development in mixed chimeras generated by the reconsitution of wild-type mice
with Notch2cKO and Ltbr−/− bone marrow. In these mixed chimeras, CD11b+ cDCs in the spleen
and MLNs developed equally from Notch2cKO bone marrow and Ltbr−/− bone marrow (Figure 75b,c). Similarly, CD8α+ cDCs from either donor also developed equally. These results suggested
that Notch2 and LTβR acted along a similar pathway in cDC development. Furthermore, in these
mixed chimeras, Notch2cKO bone marrow did not generate any ESAM+ cDCs, whereas
Ltbr−/− bone marrow generated a small population of ESAM+ cDCs (Figure 7-5b), which
suggested that the requirement for Notch2 preceded the requirement for LTβR. In this model,
Ltbr−/− cDCs were able to activate Notch2 signaling and progress to an ESAM+ subset but were
unable to undergo homeostatic expansion, which resulted in diminished fitness relative to that of
wild-type cDCs; in contrast, Notch2cKO cDCs were unable to progress to ESAM+ cells or
undergo LTα1β2-mediated population expansion (Supplementary Figure 7-7c online). Given
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those results, we sought to determine if LTβR also had a similar role in development of Notch2dependent CD103+CD11b+ cDCs in the lamina propria. Indeed, in mixed chimeras generated by
the reconstitution of wild-type mice with wild-type and Ltbr−/− bone marrow, we noted
outcompetition of Ltbr−/− bone marrow by wild-type bone marrow in the production of
CD103+CD11b+ cDCs, unlike mice deficient in the receptor for interferon-αβ (Ifnar1−/− mice),
which did not show defects in cDC development (Figure 7-5d,e). Thus, LTβR signaling was
required for the population expansion of Notch2-dependent cDC subsets.
A nonredundant role for CD11b+ cDCs in C. rodentium infection
As Notch2cKO and Batf3−/− mice lacked CD103+CD11b+ cDCs and CD103+CD11b− cDCs,
respectively, we sought to determine whether either subset was specifically required for host
defense against an attaching-and-effacing bacterial pathogen. We compared the survival of
Notch2f/f, Batf3−/− and Notch2cKO mice after oral infection with C. rodentium. Although Notch2f/f
and Batf3−/− mice were resistant, Notch2cKO mice were highly susceptible to infection, which
caused death within 7–10 d (Figure 7-6a). Unlike Notch2f/f or Batf3−/− mice, Notch2cKO mice
underwent rapid weight loss after infection, and when killed at day 9, they had significantly
greater pathogen burden and shorter colons (Figure 7-6b–d and Supplementary Figure 7-8a,b
online). Colons of Notch2cKO mice had considerable infiltration of inflammatory cells and crypt
elongation, scattered loss of mucosal architecture, and ulceration and coagulation necrosis,
unlike those of Notch2f/f mice (Figure 7-6e,f). The development of Batf3-independent
CD8α+ cDCs during infection with intracellular pathogens such as Listeria monocytogenes has
been shown to occur as a result of compensation by the AP-1 factor Batf2 (ref. 41). However,
CD103+CD11b− cDCs

were

not

restored

in Batf3−/− mice

during

infection

with C.

rodentium (data not shown), and Batf2−/− mice survived infection without substantial weight loss
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(Figure 7-6g,h), which suggested that resistance to this attaching-and-effacing pathogen did not
require compensatory development of CD8α+ cDCs.
To determine whether CD103+CD11b+ cDCs had to migrate to draining lymph nodes to
provide protection against C. rodentium, we studied mice deficient in the transcription factor
IRF4 (Irf4−/−mice) or the chemokine receptor CCR7 (Ccr7−/− mice)

26, 42

. Irf4−/− mice have a

selective defect in the migration of CD11b+ cDCs from tissues to draining lymph nodes42. We
confirmed that migratory CD103+CD11b+ cDCs were absent from the MLNs of Irf4−/− mice,
whereas lamina propria CD103+CD11b+ cDCs were present but less abundant (Supplementary
Figure 7-8c online). Irf4−/−mice survived infection with C. rodentium until at least day 28 (Figure
7-6g,h), which excluded the possibility that early resistance required cDC migration. However,
those mice did eventually succumb to C. rodentium by day 42 after infection (Figure 7-6g,h),
perhaps because of defects in antibody responses2, 43. Next we analyzed Ccr7−/− mice, which
have a general defect in cDC migration26 but intact antibody responses. These mice were
completely resistant to infection with C. rodentium (Figure 7-6g,h), which suggested that
protection against such infection was provided by the local action of CD103+CD11b+ cDCs.
To determine whether the defects in mucosal immunity in Notch2cKO mice were specific
to infection with C. rodentium, we infected these mice with T. gondii. In contrast
to Batf3−/− mice, which are highly susceptible and uniformly succumb by 9d after infection22,
Notch2cKO mice survived infection and were indistinguishable from their wild-type counterparts
(Supplementary Figure 7-8d online). These results demonstrated that CD103+CD11b+ cDCs were
not required for resistance to T. gondii and that the function of Batf3-dependent
CD103+CD11b− cDCs seemed to be unaffected in Notch2cKO mice.
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CD11b+ cDCs are not essential for healing mucosal wounds
We sought to determine whether the enhanced susceptibility of Notch2cKO mice to C.
rodentium reflected local defects in colonic wound repair44 rather than defects in pathogenspecific immunological defense. Colonic wound repair involves local prostaglandin production
by the cyclooxygenase COX-2 (encoded by Ptgs2), which supports epithelial proliferation
required for the resolution of inflammation45. We noted that CD103+CD11b+ cDCs and
macrophages in the intestine expressed Ptgs2 (Figure 7-7a), which suggested that either cell type
might be involved in supporting wound repair. We used endoscopy-guided mucosal excision to
induce colonic injury and found that Notch2cKO mice had normal wound repair, as
did Notch2f/f and Batf3−/− mice, in contrast to Notch2f/f mice treated with the COX-2 inhibitor
NS-398 (Figure 7-7b,c). Inhibition of COX-2 after mucosal excision resulted in failed
regeneration of the β-catenin-positive epithelial layer and impaired maintenance of the
underlying α-smooth muscle actin–positive muscularis propria layer (Figure 7-7d), as reported
before44. In contrast, Notch2f/f, Notch2cKO and Batf3−/− mice had normal epithelial regeneration
and maintenance of the muscularis propria at day 6 after mucosal excision (Figure 7-7e). Thus,
cDCs were not required for the prostaglandin production involved in mucosal healing, which
suggested that the susceptibility of Notch2cKO mice to infection with C. rodentiumwas not due to
any defects in wound repair.
CD11b+ cDCs regulate IL-23-dependent mucosal immunity
To determine the basis of the susceptibility of Notch2cKO mice to infection with C.
rodentium, we analyzed differences in gene expression in colonic cells isolated
from Notch2f/f, Batf3−/− andNotch2cKO mice 9 d after infection (Figure 7-8a). Overall, for colonic
gene expression, the difference between Notch2cKO mice and Notch2f/f mice was greater than the
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difference between Batf3−/− mice and Notch2f/f mice (Figure 7-8a and Supplementary Table1
online). Ptgs2 expression was not lower in Notch2cKO mice 9 d after C. rodentium infection
(Figure 7-8a,b), consistent with the intact wound healing noted above (Figure 7-7e). However,
Notch2cKO mice had upregulation of various genes encoding inflammatory molecules, including
Il1a, Il1b, Il33 and Ccl3, and substantial downregulation of the genes Reg3b and Reg3g, which
encode antimicrobial peptides (Figure 7-8a–c). Notably, among the set of genes shown to be
induced by the stimulation of colonic cells with IL-22ex vivo, only Reg3b, Reg3g and Mup1 had
lower expression in the colons of infected Notch2cKO mice than in their Notch2f/f counterparts
(Figure 7-8c), which indicated the importance of the molecules encoded by those genes in the
defense against attaching-and-effacing pathogens2. Genes encoding the antimicrobial peptides
S100A8 and S100A9 had higher expression in Notch2cKO mice than in Notch2f/f mice (Figure 78c), consistent with a published report indicating the insufficiency of S100A8 and S100A9 in the
defense against C. rodentium2. Consistent with the findings reported above, IL-22 production
was much lower in Notch2cKO mice, but not in Batf3−/− mice, 9 d after infection with C.
rodentium (Figure 7-8d).
To eliminate the effect of inflammation on gene expression, we also assessed changes in
gene expression at day 4 after infection, a time at which no change in histology, pathogen
dissemination, colonic length or death had occurred (Figure 7-8e and Supplementary Figure 78e,f online). Again, Notch2cKO mice had lower expression of Il22 and of the IL-22-responsive
genes Reg3b and Reg3g (which, as noted above, encode antimicrobial peptides) (Figure 78e and Supplementary Table 1 online). Accordingly, ILCs isolated from Notch2cKO mice had
lower intracellular expression of IL-22 protein at day 4; however, that effect was 'rescued' by the
addition of IL-23 ex vivo (Figure 7-8f), which indicated that the lower IL-22 production was
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extrinsic of ILCs inNotch2cKO mice and instead probably resulted from a defect in the stimulation
of ILCs.
Mice deficient in the p19 subunit of IL-23 (Il23a−/− mice) are susceptible to infection
with C. rodentium1, 2, and intestinal CD103+CD11b+ cDCs have been reported to produce IL23 in vivo after stimulation of Toll-like receptor 5 (ref. 13). However, the requirement for those
cells as an obligate source of IL-23 during infection with attaching-and-effacing bacteria remains
unclear. Functional IL-23 is a heterodimeric protein composed of p19 (encoded by Il23a) and
p40 (encoded by Il12b). In the lamina propria, we found that Il23a was expressed specifically in
CD11b+CD103+cDCs in the steady state and 2 d after infection by C. rodentium, but this
transcript was undetectable in macrophages in either setting (Figure 7-8g). In addition, we found
that intracellular expression of p40 was undetectable in CD11b+ cDCs at steady state but
increased substantially after activation (Supplementary Figure 7-8g online). The inducible
expression of Il12b (encoding p40) was not dependent on the presence of CD8α+ cDCs or on the
transcription factors Batf, Batf2 or Batf3 (Supplementary Figure 7-8g,h online). Thus, expression
of IL-23 was both inducible after activation and restricted to the CD11b+ cDC subset.
To determine whether Notch2-dependent cDCs were the obligate source of IL-23 during
infection with C. rodentium, we generated mixed chimeras by reconstituting wild-type mice
with Notch2f/f bone marrow and Il23a−/− bone marrow or with Notch2cKO bone marrow and
Il23a−/− bone marrow and analyzed resistance to C. rodentium. In Notch2cKO–Il23a−/− mixed
chimeras, intestinal CD103+CD11b+ cDCs developed only from the Il23a−/− bone marrow, but all
other hematopoietic populations were unaffected in their ability to generate IL-23. The survival
of Notch2f/f–Il23a−/− chimeras after infection by C. rodentium was similar to that of chimeras
generated by transplantation of wild-type bone marrow alone; however, the survival
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of Notch2cKO–Il23a−/− chimeras was similar to that of chimeras generated with Il23a−/− bone
marrow alone, which succumbed to C. rodentium at 7–11 d after infection (Figure 7-8h). The
observation that Notch2cKO–Il23a−/− mixed chimeras were as susceptible to C. rodentium
infection as were chimeras generated with Il23a−/− bone marrow alone suggested that Notch2dependent CD11b+CD103+ cDCs were the critical source of IL-23 required for protection.
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DISCUSSION
Efforts to distinguish the functions of macrophages and DCs have been limited by the
availability of systems for the selective depletion of each lineage in vivo46. Genetic models have
been generated that have led to the characterization of nonredundant roles for CD8α+ cDCs and
for pDCs17, 18, 19, but a unique role for CD11b+ cDCs has not been studied by a selective
depletion model in vivo so far, to our knowledge. Here we used the Notch2 dependence of
CD11b+ cDCs to analyze their role in host defense. We observed that Notch2-dependent
CD103+CD11b+ cDCs were required for IL-23 production to protect the host from early
susceptibility to infection with C. rodentium, but Batf3-dependent CD103+CD11b− cDCs were
not. That role in innate defense was pathogen specific, as CD103+CD11b+ cDCs were not
necessary for resistance to T. gondii or for the healing of intestinal mucosa after injury. These
findings settle an unresolved question about the critical source of IL-23 required for driving IL22-dependent antimicrobial responses to infection with attaching-and-effacing pathogens2. As
IL-22 also acts in other host-defense processes, such as in chronic inflammatory skin disease6,
future studies should examine the requirement for CD11b+ cDCs in those settings as well.
Given our observation that Notch2 also regulated gene expression in CD8α+ cDCs, we
investigated whether defects in these cDCs could account for early susceptibility to C.
rodentium. However, Batf3−/− and Batf2−/− mice showed normal resistance to C. rodentium. We
also excluded the possibility of a role for other Notch2-independent cDCs. In the absence of
Notch2,

some

CD11b+cDCs

developed

in

the

spleen;

likewise, Zbtb46-expressing

CD103−CD11b+ cDCs may have also developed in the intestine. However, any 'Notch2inexperienced' CD11b+ cDCs remaining in Notch2cKO mice were insufficient for IL-23
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production and protection against infection with C. rodentium. Notch signaling also regulates
development of IL-22-producing ILCs47, 48, but we found that ILC function was not affected by
CD11c-Cre–mediated deletion of Notch2. Nonetheless, this dual role of Notch signaling in
defense against infection with attaching-and-effacing pathogens might represent a coordinated
immunological strategy involving the intentional expression of Notch ligands in pathogenresponsive cellular niches.
Antibody blockade of LTβR in vivo has also been found to diminish IL-23 production
during infection with C. rodentium49, and conditional deletion of Ltbr by CD11c-Cre increases
susceptibility to this pathogen11, 50. In addition, a published study has reported a requirement for
LTβR in the homeostasis of CD4+ cDCs in the spleen38. Such results would suggest a possible
relationship between signaling via Notch2 and signaling via LTβR in cDC differentiation.
Indeed, we found that LTβR selectively influenced the development of splenic ESAM+ cDCs and
intestinal CD103+CD11b+ cDCs, but Flt3L did not. It has been shown that loss of LTβR
signaling directly impairs Il23a expression by cDCs11. However, our results suggest that LTβR
signaling may also control the development of CD103+CD11b+ cDCs, which are a source of IL23, independently of any effects on Il23a expression.
The tissue-resident CD11b+ cDCs critical for early defense against C. rodentium were
affected inZbtb46DTR, Notch2cKO and Flt3l−/− mice and thus seemed to derive from pre-cDCs,
rather than from monocytes. However, our demonstration that Notch2-dependent CD11b+ cDCs
were required for IL-23-dependent protection against C. rodentium does not exclude the
possibility of contributions from macrophages and monocyte-derived cells. Indeed, monocytes
serve a protective role in the eradication of C. rodentium after their recruitment to the lamina
propria during later stages of infection51. So, whereas cDC-derived IL-23 may be critical early,
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monocyte-derived cells31 can produce IL-6 (ref. 52), which could support CD4+ T cell–derived
IL-22 production later during infection53. Our observation that Ccr2−/− mice had diminished
mortality relative to that of Notch2cKO mice, yet still lost weight, is also in agreement with a
model in which monocytes are important in immune responses to C. rodentium. Thus, future
studies should characterize the nonredundant functions of pre-cDC–derived and monocytederived cells in resistance to infection with attaching-and-effacing bacteria.
The role of cDCs in immunological defense has been thought to reside mainly in their
ability to prime the responses of CD4+ T cells and CD8+ T cells54. Our results presented here,
along with the similar requirement for CD8α+ cDCs in IL-12 production for early innate
protection against T. gondii, demonstrate that both branches of cDCs are also critical for the
initiation of innate immunity. These findings may indicate that the DC lineage separated from
monocytes and macrophages before the emergence of adaptive immunity and that it has a
dedicated role in orchestrating the reactions of the expanding family of ILCs3.
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EXPERIMENTAL PROCEDURES
Mice
All animals were bred and maintained in a specific pathogen-free animal facility
according to institutional guidelines and with protocols approved by the Animal Studies
Committee at Washington University in St. Louis. The generation of Zbtb46gfp and Zbtb46DTR
mice has been described15, 16. For depletion of cDCs from Zbtb46DTR mice, diphtheria toxin (40
ng/g; Sigma) was administered on day −3 and day −1 before analysis on day 0. For depletion of
cDCs during infection with C. rodentium, mice were injected with 20ng/g diphtheria toxin 1d
before infection, and doses of 5ng/g were given every 2–3d thereafter to maintain depletion.
Mice of the following genotypes were from Jackson Laboratories:
CD11c-cre (B6.Cg-Tg(Itgax-cre)1-1Reiz/J),
Vav1-cre (B6.Cg-Tg(Vav1-cre)A2Kio/J),
Notch2f/f (B6.129S-Notch2tm3Grid/J),
Ccr2−/− (B6.129S4-Ccr2tm1Ifc/J),
Cd40−/− (B6.129P2-Cd40tm1Kik/J),
Nfkb1−/− (B6;129P-Nfkb1tm1Bal/J),
Ccr7−/−(B6.129P2(C)-Ccr7tm1Rfor/J) and
Cx3cr1gfp (B6.129P-Cx3cr1tm1Litt/J).
The generation of Rbpjf/f, Psen1f/f and Psen2−/− mice has been described56, 57. Flt3l−/− (C57BL/6flt3Ltm1Imx) mice were obtained from Taconic. The generation of Il23−/− mice2, Ltbr−/− mice40 and
Batf−/−, Batf2−/− andBatf3−/− mice17, 41 has been described. The generation of Nik−/− mice has been
described58; these mice were a gift from B. Sleckman. Ifnar1−/− mice were a gift from T. Watts.
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For the generation of Ccr2-eGFP 'knock-in' mice, a targeting construct was designed to insert a
DNA fragment encoding enhanced GFP (eGFP), followed by a polyadenylation signal and
a loxP-flanked neomycin-resistance cassette at the translation start site of Ccr2. The construct
was transfected by electroporation into LK-1 (C57BL/6J) embryonic stem cells59, and one
correctly targeted clone identified by Southern blot analysis was used for the generation of
chimeras. Chimeras were bred to mice with transgenic expression of Cre recombinase from the
cytomegalovirus (CMV) promoter (B6.C-Tg(CMV-Cre)1Cgn/J, Jackson Laboratories)60 for
removal of the neomycin-resistance cassette. For the generation of Irf4−/− mice, Irf4f/f mice
(B6.129S1-Irf4tm1Rdf/J; Jackson Laboratories) were crossed with CMV-Cre mice. For bone
marrow–chimera experiments, the CD45.1+ B6.SJL (B6.SJL-PtprcaPepcb/BoyJ) mice were from
Jackson Laboratories. Unless otherwise indicated, experiments used sex-matched littermates at
8–12 weeks of age. Unirradiated mice used for C. rodentium experiments weighed less than 20 g
when infected, unless specified otherwise.
DC preparation
DCs were collected from lymphoid organs and nonlymphoid organs and were prepared as
described16. Spleens, MLNs, skin-draining (inguinal) lymph nodes and kidneys were minced and
digested for 30 min at 37 °C, with stirring, in 5 ml Iscove's modified Dulbecco's medium plus
10% FCS (cIMDM) with 250 µg/ml collagenase B (Roche) and 30 U/ml DNase I (SigmaAldrich). Cells were passed through a 70-µm strainer before red blood cells were lysed with
ammonium chloride–potassium bicarbonate lysis buffer. Cells were counted on a Vi-CELL
analyzer (Beckman Coulter), and 5×106 to 10×106 cells were used for each antibody-staining
reaction. Lung-cell suspensions were prepared after perfusion by injection of 10 ml Dulbecco's
PBS (DPBS) into the right ventricle after transection of the lower aorta. Dissected and minced
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lungs were digested for 1 h at 37 °C, with stirring, in 5 ml cIMDM with 4 mg/ml collagenase D
(Roche). Suspensions of cells from the small intestine were prepared after removal of Peyer's
patches and fat. Intestines were opened longitudinally, washed of fecal contents and cut into
pieces 1 cm in length and were incubated for 40 min at 37 °C, with rotation at 1g, in Hank's
balanced-salt solution (Life Technologies) plus 5 mM EDTA. Tissue pieces were washed in
DPBS and minced and were incubated for 90 min at 37 °C, with stirring, in 25 ml RPMI medium
plus 2% FBS with collagenase VIII (100 U/ml; C2139; Sigma). Cell suspensions were pelleted,
suspended in 40% Percoll (P4937; Sigma), overlaid on 70% Percoll and centrifuged for 20 min
at 850g. Cells in the interphase were recovered, washed in DPBS and stained. For DC population
expansion in vivo, 10 µg Flt3L (250-31L; PeproTech) was injected intraperitoneally for two
consecutive days and organs were collected after 7 d. For induction of p40, splenocyte samples
were enriched for CD11c+ cells through the use of MACS beads (Miltenyi). After enrichment,
cells were stimulated for 24 h ex vivo with 1 µg/ml LPS (L2630; Sigma) and 50 ng/ml interferonγ (315-05; PeproTech). Brefeldin A (1 µg/ml) was added for the final 4 h. Cells were then
washed, stained for the expression of surface markers (antibodies identified below),
permeabilized with 0.25% saponin and stained for intracellular p40.
Antibodies and flow cytometry
Samples were stained at 4 °C in the presence of Fc Block (2.4G2; BD Biosciences) in
flow cytometry buffer (DPBS plus 0.5% BSA plus 2 mm EDTA). The following antibodies were
from BD Biosciences: allophycocyanin-conjugated antibody to CD4 (anti-CD4 (RM4-5)),
V450–anti-GR1 (RB6-8C5), fluorescein isothiocyanate–anti-CD3ε (145-2C11), fluorescein
isothiocyanate–anti-CD45.1

(A20),

fluorescein

phycoerythrin-indotricarbocyanine–anti-CD24

isothiocyanate–anti-CD21/CD35

(M1/69),
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(7G6),

phycoerythrin-indotricarbocyanine–

anti-CD8α (53-6.7) and allophycocyanin–anti-CD172a (anti-SIRPα; P84). The following
antibodies were from eBioscience: peridinin chlorophyll protein–cyanine 5.5–anti-CD11b
(M1/70), allophycocyanin–anti-CD90.2 (53-2.1), allophycocyanin–eFluor 780–anti-CD11c
(N418),

phycoerythrin–anti-CD23

(B3B4),

phycoerythrin–anti-RORγt

(AFKJS-9),

phycoerythrin–anti-IL22 (1H8PWSR), phycoerythrin–anti-IL12/23 p40 (C17.8), phycoerythrin–
anti-ESAM (1G8), eFluor 450–anti-MHCII (I-A–I-E; M5/114.15.2), phycoerythrin–anti-CD103
(2E7), peridinin chlorophyll protein–cyanine 5.5–anti-CD16/32 (93), allophycocyanin–antiCD45.2 (104), allophycocyanin–eFluor 780–anti-CD117 (2B8), phycoerythrin–anti-CD135
(A2F10), V500–anti-B220 (RA3-6B2), allophycocyanin–anti-F4/80 (B-M8), Alexa Fluor 700–
anti-Sca1 (D7) and peridinin chlorophyll protein–eFluor710–anti-Siglec-H (eBio440C).
Phycoerythrin– and allophycocyanin–conjugated anti-CD205 (anti-DEC-205; NLDC-145) were
from Miltenyi. Biotin anti-CD127 (A7R34) was from BioXCell. In general, all antibodies were
used at a dilution of 1:200; anti-DEC-205 was used at a dilution of 1:20. Cells were analyzed on
a FACSCanto II or FACSAria II (BD) and data were analyzed with FlowJo software (TreeStar).
For immunofluorescence histology experiments, the following reagents were used: rabbit
polyclonal antibody to GFP (A11122), Alexa Fluor 488–conjugated antibody to rabbit IgG
(A11034) and streptavidin–Alexa Fluor 555 (S32355; all from Invitrogen); Alexa Fluor 647–
anti-CD11c (N418; BioLegend); biotin–anti-F4/80 (BM8; Caltag); Alexa Fluor 488– and biotinconjugated anti-B220 (RA3-6B2), biotin–anti-IgD (11-26) and biotin–anti-MADCAM-1
(MECA-367; all from eBioscience); and rabbit polyclonal antibody to β-catenin (C2206) and
indocarbocyanine–conjugated antibody toα-smooth muscle actin (1A4; both from Sigma).
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C. rodentium
Mice were infected by intraoral inoculation of 2×109 colony-forming units of C.
rodentium, strain DBS100 (American Type Culture Collection) as described2. Survival and
weight loss were monitored for 30–45 d. Survival studies were done in accordance with
institutional guidelines and with protocols approved by the Animal Studies Committee at
Washington University in St. Louis. Colon lengths were measured for mice infected for 4 or 9 d.
For histology, distal colons were collected and fixed overnight at 25 °C in 10% buffered
formalin phosphate (4% (wt/wt) formaldehyde, 0.4% (wt/vol) sodium phosphate (monobasic
monohydrate), 0.65% (wt/vol) sodium phosphate (dibasic anhydrous) and 1.5% (wt/vol)
stabilizer methanol; SF100-4; Fisher Scientific), embedded in paraffin, sectioned and stained
with hematoxylin and eosin. For analysis of colony-forming units, spleens and colons from mice
infected for 4 or 9 d were weighed and homogenized and serial dilutions were plated for 24 h at
37 °C in duplicate onto MacConkey agar plates (M7408; Sigma). The severity of colitis (by
histology of samples assessed by a researcher 'single-blinded' to sample identity) was assigned a
score on a scale from 1 to 7, which corresponded to the following: 1, no evidence of
inflammation; 2, little cellular infiltration in <10% of the field; 3, moderate cellular infiltration in
10–25% of the field, crypt elongation, bowel-wall thickening and no evidence of ulceration; 4,
substantial cellular infiltration in 25–50% of field, thickening of the bowel wall beyond the
muscular layer and high vascular density; 5, substantial infiltration in >50% of field, crypt
elongation and distortion and transmural bowel thickening with ulceration; 6, complete loss of
mucosal architecture with ulceration and loss of mucosal vasculature; and 7, coagulation
necrosis. For analysis of IL-22 expression in ILCs, MLN cells isolated from mice infected for 4 d
were stimulated for 4 h with 50 ng/ml PMA (phorbol 12-myristate 13-acetate; P1585; Sigma)
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and 1 µM ionomycin (I0634; Sigma), with or without 10 ng/ml recombinant IL-23 (1887-ML010; R&D Systems), in the presence of 1 µg/ml brefeldin A (B6542; Sigma). Cells were washed
with DPBS and stained for surface expression of specified markers (antibodies identified above).
Cells were then fixed in 2% methanol-free paraformaldehyde (PFA), permeabilized with 0.25%
saponin and stained for intracellular IL-22.
T. gondii
The type II Prugniaud strain of T. gondii expressing a transgene encoding firefly
luciferase and GFP (PRU-FLuc-GFP) used was provided by J. Boothroyd. The parasites were
grown in human foreskin fibroblasts cultures as described61. For infection, freshly egressed
parasites were filtered, counted, and 100 tachyzoites were injected intraperitoneally into mice.
Survival was monitored for 30 d.
Endoscopy-guided mucosal excision
Mice were anesthetized, and colon lumens were visualized with a high-resolution
miniaturized colonoscope system. After inflation of the colon with DPBS, 3F flexible biopsy
forceps were inserted into the sheath adjacent to the camera. Three to five full-thickness areas of
the entire mucosa and submucosa were removed from along the dorsal side of the colon. For this
study, wounds that averaged approximately 1 mm2 (equivalent to 250–300 crypts) were
evaluated. Wounded mice were killed 2 or 6 d after injury, and each wound was frozen
individually in optimal cutting temperature compound. Sections were prepared and fixed in 4%
PFA, boiled in 10 mmol/l citrate buffer and rinsed in DPBS, then nonspecific binding was
blocked by incubation for 20 min with 3% bovine serum albumin and 0.1% Triton X-100,
followed by incubation for 1 h with primary antibodies (identified above). Slides were then
rinsed with DPBS, incubated with secondary antibodies (identified above), stained with bis217

benzimide and then mounted with Mowiol 4-88 (EMD Chemicals). Sections were viewed with a
Zeiss (Oberkochen, Germany) Axiovert 200 microscope equipped with an Axiocam MRM
camera. The selective COX-2 inhibitor NS-398 (Cayman Chem) was dissolved in dumethyl
sulfoxide for preparation of the stock solution. Stocks were further diluted in 5% NaHCO3, and
doses of 5 mg per kg body weight were administered intraperitoneally daily after wounding.
Isolation and transfer of bone marrow progenitor cells
Bone marrow was collected from the femur, tibia, humerus and pelvis. Bones were
fragmented by mortar and pestle, and debris were removed by gradient centrifugation with
Histopaque 1119 (Sigma). Cells were passed through a 70-µm strainer and red blood cells were
lysed with ammonium chloride–potassium bicarbonate lysis buffer. Cells were counted on a ViCELL analyzer, and 5 × 106 to 10 × 106 cells were stained for analysis or the entire bone marrow
was stained for sorting. The gates used to define common myeloid progenitors, common DC
progenitors and pre-DCs were based on published studies62, 63: common myeloid progenitors
were identified as Lin−c-KithiSca-1−CD11c−CD135+CD16/32−CD127− cells; common DC
progenitors were identified as Lin−c-KitintSca-1−CD135+CD16/32−CD127− cells; pre-DCs were
identified as Lin−c-KitloSca-1−CD11c+CD135+CD16/32−CD127− cells; and cDC-restricted precDCs were identified as Zbtb46-GFP+ cells in the pre-DC gate. FACSAria II (BD Biosciences)
was used for cell purification. Cells were sorted into DPBS supplemented with 0.5% BSA and 2
mM EDTA. Cell purities of at least 95% were confirmed by analysis after sorting. For transfer
experiments, purified cell populations were transferred retroorbitally into congenically marked
mice (CD45.1+) after sublethal irradiation with 600 rads of whole-body irradiation.
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Expression microarray analysis
Total RNA was isolated from cDCs with an RNAqueous-Micro kit (Ambion) or from
colonic cells with an RNeasy Mini kit (Qiagen). For Mouse Gene 1.0 ST Arrays, RNA was
amplified with a WT Expression kit (Ambion) and labeled, fragmented and hybridized with a
WT Terminal Labeling and Hybridization kit (Affymetrix). Data were processed by robust
multiarray average summarization and quantile normalization, and expression values were
modeled with ArrayStar software (DNASTAR version 4). For principal-component analysis,
microarray data sets were pre-processed by ArrayStar with robust multiarray average
summarization and quantile normalization, and then replicates were grouped by sample. Either
log-transformed expression values from each replicate or mean log-transformed expression
values from each replicate group were exported in table format, imported into software of the R
project for statistical computing (version 2.13.2), mean-centered by gene, root-mean-square–
scaled by sample, transposed and subjected to principal-component analysis computed by
singular value decomposition without additional centering or scaling. Scores were plotted in R
software.
Quantitative RT-PCR
Gene expression was analyzed in colonic cells isolated from mice infected for 2 or 9 d
with C. rodentium. Bone marrow–derived DCs cultured for 9 d with Flt3L (200 ng/ml) were
stimulated with LPS and interferon-γ as described above. RNA and cDNA were prepared with an
RNeasy Mini kit (Qiagen), Superscript III reverse transcriptase (Invitrogen) and Oligo(dT)20
Primer (Invitrogen). For analysis of Il23a expression in cDCs and macrophages, CD11b+ cDCs
(Aqua−CD45+B220−CD11c+MHCII+CD103+CD11b+)

and

macrophages

(Aqua−CD45+B220−CD11c+MHCII−CD11b+F4/80+) from mice infected for 2 d were sorted to a
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purity of >95%. Total RNA was isolated from sorted cells with an RNAqueous-Micro kit
(Ambion). The StepOnePlus Real-Time PCR system was used according to manufacturer's
instructions (Applied Biosystems) with the relative quantitation standard-curve method with
HotStart-IT SYBR Green qPCR Master Mix (Affymetrix/USB). PCR conditions were as
follows: 10 min at 95 °C, followed by 40 two-step cycles consisting of 15 s at 95 °C and 1 min at
60 °C. Primers used for measurement of Il22, Reg3g, Il23a, Il12a, and Il12b expression were as
follows:
IL22-F, 5′-TGACGACCAGAACATCCAGA-3′;
IL22-R, 5′-CGCCTTGATCTCTCCACTCT-3′;
HPRT-F, 5′-TCAGTCAACGGGGGACATAAA-3′;
HPRT-R, 5′-GGGGCTGTACTGCTTAACCAG-3′;
IL23a-F, 5′-AATAATGTGCCCCGTATCCA-3′;
IL23a-R, 5′-GGATCCTTTGCAAGCAGAAC-3′;
IL12a-F: 5′-GTGAAGACGGCCAGAGAAA-3′;
IL12a-R, 5′-GGTCCCGTGTGATGTCTTC-3′;
IL12b-F, 5′-AGCAGTAGCAGTTCCCCTGA-3′;
IL12b-R, 5′-AGTCCCTTTGGTCCAGTGTG-3′;
Reg3g-F, 5′-ATCATGTCCTGGATGCTGCT-3′; and
Reg3g-R, 5′-AGATGGGGCATCTTTCTTGG-3′.
Immunofluorescence microscopy
Spleens and intestines were fixed for 8 h in 2% PFA, incubated overnight in 30% sucrose
in H2O and embedded in optimal cutting temperature compound, and then cryosections 8 µm in
thickness produced. After two washes in DPBS, nonspecific binding in sections was blocked by
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incubation for 10 min at 21 °C in CAS Block (00-8120; Invitrogen) containing 0.2% Triton X100. Sections were stained with primary and secondary reagents (identified above) diluted in
CAS Block containing 0.2% Triton X-100 and were mounted with ProLong Gold Antifade
reagent containing DAPI (4,6-diamidino-2-phenylindole; P36935; Invitrogen). For staining of
CD11c, spleens were frozen without fixation and then were fixed in acetone for 15 min at 4 °C
before being washed in DPBS and stained. A Zeiss AxioCam MRn microscope equipped with an
AX10 camera was used for four-color epifluorescence microscopy. Monochrome images were
acquired with AxioVision software with either a 10× or a 20× objective and then were exported
into ImageJ software for subsequent color balancing and overlaying.
Bone marrow chimeras
Bone marrow cells from donor mice were collected as described above, and 5×106 to
10×106 total bone marrow cells were transplanted by retroorbital injection into wild-type B6.SJL
recipients. For developmental competition experiments, recipients received a single dose of
1,200 rads of whole-body irradiation on the day of transplantation, and mice were analyzed 8–10
weeks later. For infection experiments, recipients received a total of two doses of 525 rads of
whole-body irradiation, with an interval 4 h between the doses, on the day of transplantation, and
mice were infected 8–10 weeks later. For mixed–bone marrow competition, bone marrow was
obtained from mice of two genotypes, then cells were counted and mixed at a ratio of 1:1, and
Lin−Sca-1+c-Kit+cells were analyzed by flow cytometry to confirm 1:1 chimerism before
transplantation. Il23a−/−bone

marrow

was

distinguished

from Notch2f/f or Notch2cKO bone

marrow by GFP expression. Ltbr−/− bone marrow was distinguished by expression of CD45.1.
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Statistical analysis
In general, differences between groups were analyzed by unpaired, two-tailed Student's ttests. Results with a P value of 0.05 or less were considered significant (Prism; GraphPad
Software). Survival studies were analyzed by the log-rank Mantel-Cox test. For multiple
comparisons, data were analyzed by the one-way ANOVA followed by Tukey's multiplecomparisons test. The appropriate nonparametric test was used when data failed to meet
assumptions for parametric statistics.
Accession codes
GEO: microarray data, GSE45698.
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Figure 7-1: Zbtb46-GFP identifies intestinal cDC populations.
(a,b) Flow cytometry of live cells from the lamina propria (a) and MLNs (b) of Zbtb46gfp/+ mice
(n = 9); pregating, above plots. Numbers adjacent to outlined areas indicate percent cells in each
throughout. MHCII, major histocompatibility complex class II. (c) Fluorescence microscopy of
Zbtb46-GFP, CD4, B220 and β-catenin, and of staining with the DNA-intercalating dye DAPI,
in sections of small intestine (top) and colon (bottom) from chimeras (n = 5) generated by the
reconstitution of wild-type mice with Zbtb46gfp bone marrow. Scale bars, 200 µm (Peyer's patch
and colonic patch) or 100 µm (isolated lymphoid follicles (ILF) and villi). Data are
representative of three independent experiments (a,b) or two independent experiments (c).
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Figure 7-2: Zbtb46+ cDCs are essential for survival after infection with C. rodentium.
(a) Expression of CD103 and F4/80 (right) in lamina propria cells from chimeras generated by
the reconstitution of wild-type (WT) mice with Zbtb46DTR bone marrow, left untreated (− DT) or
treated with diphtheria toxin (40 ng per gram body weight (ng/g)) on day −3 and day −1 (+ DT)
and assessed on day 0 (CD45+B220+ cells pregated at left). (b) Quantification of cDCs and
macrophages (MΦ) in the lamina propria of the chimeras in a (Zbtb46DTR => WT
(donor=>recipient); n = 4), presented per 1 × 106 lamina propria cells. (c,d) Survival (c) and
weight loss (d) of chimeras (key: donor=>recipient; n = 8 per group, except WT => WT +
DT, n = 5) given oral inoculation of C. rodentium (2 × 109 colony-forming units) and otherwise
left untreated (− DT) or treated with diphtheria toxin (20 ng/g) 1 d before infection and every
third day (5 ng/g) for the remainder of the experiment (+ DT). (e,f) Survival (e) and weight loss
(f) of C. rodentium–infected mice (n = 5 (Ccr2+/+), 4 (Ccr2−/−) or 10 (Flt3l+/+ and Flt3l−/−)). NS,
not significant; *P< 0.05 and **P < 0.001 (Student's t-test (b,d,f) or log-rank Mantel-Cox test
(c,e)). Data are from two independent experiments (error bars (b,d,f), s.e.m.).
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Figure 7-3: Canonical Notch2 signaling is required for the development of splenic and
intestinal CD11b+ cDCs.
(a) Flow cytometry of live splenocytes from wild-type mice and mice with Vav1-Cre–mediated
deletion of Rbpj (Rbpjvav), Psen1 and Psen2 (Psen1vavPsen2vav) or Notch2 (Notch2vav), pregated
as MHCII+CD11c+ (left) and CD172a+CD24− (middle) cells. (b) Fluorescence microscopy of
CD11c, IgD and B220 (top) or CD11c and MAdCAM-1 (bottom) in sections of spleen
from Notch2f/f and Notch2vav mice. Scale bars, 200 µm. (c) Flow cytometry of splenocytes
from Notch2f/f mice (top), mice with CD11c-Cre–mediated deletion of a single loxPflanked Notch2 allele (Notch2f/+; middle) and Notch2cKO mice (bottom), stained for various
markers (plot margins). (d) Quantification of cDC development in the Notch2f/f and
Notch2cKO mice in c, presented per 1 × 106 splenocytes. (e) Flow cytometry of cells from the
lamina propria of Notch2f/f, Notch2cKO and Batf3−/− mice, stained for various markers (plot
margins). (f) Immunofluorescence microscopy of cryptopatches (CP) and ILFs from sections of
small intestine from Notch2f/f and Notch2cKO mice, stained for CD11c and CD90 and with DAPI.
Scale bars, 50 µm. *P < 0.01 and **P < 0.001 (Student's t-test). Data are representative of three
independent experiments (a,c,e; n = 6–8 (a), 7 (c) or 3–5 (e) mice per group) or two independent
experiments (b,f; n = 4 (b) or 5 (f) mice) or are from three independent experiments (d; n = 7
mice per group; error bars, s.e.m.).
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Figure 7-4: Notch2 controls the terminal differentiation of CD11b+ and DEC-205+ cDCs.
(a) Microarray analysis of cDC subsets from Notch2f/f (f/f) and Notch2cKO (KO) mice, sorted as
MHCII+CD11c+CD24−CD11b+ cells

(CD11b+ cDCs;

left)

or

MHCII+CD11c+CD24+CD11b−DEC-205+ cells (DEC-205+ cDCs; right); P values (vertical axes),
Welch's t-test. Colors indicate expression more than twofold higher (red) or lower (blue)
in Notch2f/f cells

than

in Notch2cKO cells.

(b)

Principal-component

analysis

(left)

of Notch2f/f and Notch2cKO CD11b+ cDCs (CD11b) and DEC-205+ cDCs (DEC-205), analyzed
by individual replicate (f/f1–f/f3 and KO1–KO3; variance: PC1, 54.0%; PC2, 21.0%), and gene
expression (right) in progenitors (common myeloid progenitors (CMP), granulocyte-macrophage
progenitors (GMP) and common DC progenitors (CDP)) and in CD8+ and CD4+ cDC subsets,
derived from the Immunological Genome Project database for probe sets corresponding to the 20
most positive and negative 'loadings' in PC2 (log-transformed values). (c) Gene expression in
DC progenitors and subsets of probe sets corresponding to the 50 most positive and negative
'loadings' in PC2 (presented as mean-centered, log-transformed values). Each symbol represents
an individual gene; small horizontal lines indicate the mean. (d) Gene expression of selected
probe sets, analyzed as in c. (e) Flow cytometry of splenic CD11b+ cDCs from Ccr2gfp mice
(left), Cx3cr1gfp mice (middle) and Zbtb46gfp mice (right). (f) Contribution of donor cells to bone
marrow progenitors and splenocytes in mixed chimeras generated with CD45.2+ Notch2f/f and
CD45.1+ wild-type bone marrow (Notch2f/f + WT) or CD45.2+ Notch2vav bone marrow and
CD45.1+ wild-type bone marrow (Notch2vav + WT), analyzed 8–10 weeks after lethal irradiation
and transplantation; results are presented as the ratio of Lin−Sca-1+c-Kit+ chimerism in the same
mouse (percent contribution of CD45.2+ cells / percent CD45.2+ cells among Lin−Sca-1+cKit+cells), with chimerism of monocytes, neutrophils and cDCs analyzed among splenocytes.
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Each symbol represents an individual mouse; small horizontal lines indicate the mean. *P < 0.01
and **P < 0.001 (Kruskal-Wallis test with Dunn's multiple comparison test (c) or Student's t-test
(f)). Data are from two independent experiments (a,b, left; n = 3 biological replicates per cell
type), three independent experiments (b, right, c,d; n = 3–5 biological replicates per cell type) or
two independent experiments (f; n= 3–5 mice per group) or are representative of three
independent experiments (e; n = 5–6 mice per group).
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Figure 7-5: LTβR signaling mediates the homeostatic population expansion of Notch2dependent cDCs.
(a) Flow cytometry of live splenocytes from wild-type, Notch2cKO and Ltbr−/− mice, stained for
various markers (plot margins; pregating, left and middle). (b) Flow cytometry of live
splenocytes from mixed chimeras generated with CD45.1+ Ltbr−/− and CD45.2+ wild-type bone
marrow (Ltbr−/− + WT) or with CD45.1+ Ltbr−/− and CD45.2+ Notch2cKO bone marrow
(Ltbr−/− + Notch2cKO), analyzed 8–10 weeks after lethal irradiation and transplantation
(pregating, above plots; neutrophils, CD11c−CD11b+CD24+ cells). Bottom row, red numbers in
top right corners indicate chimerism ratio (percent contribution of CD45.1+Ltbr−/− cells/percent
CD45.1+ Ltbr−/− cells among splenic neutrophils). (c) Contribution of Ltbr−/− bone marrow to
each cell type in the mixed chimeras in b, presented as a ratio of neutrophil chimerism in the
same mouse. Each symbol represents an individual mouse; small horizontal lines indicate the
mean. (d) Contribution of wild-type or Ltbr−/− bone marrow to CD103+CD11b+ cDCs in the
lamina propria from chimeras generated by the reconstitution of CD45.1+CD45.2+ wild-type
mice with CD45.1+CD45.2+ wild-type bone marrow (WT => WT), CD45.1+ Ltbr−/− bone
marrow

(Ltbr−/− => WT)

or

a

mixture

of

Ltbr−/− and

wild-type

bone

marrow

(Ltbr−/−+WT => WT). (e) Quantification of chimerism in mixed chimeras generated with a
mixture of Ltbr−/− and wild-type bone marrow (as in d) or Ifnar1−/− and wild-type bone marrow,
calculated as follows: (percent contribution of mutant cells to intestinal cDCs / percent
contribution of wild-type cells to intestinal cDCs) / (percent contribution mutant cells to splenic
T cells / percent contribution of wild-type cells to splenic T cells). Each symbol represents an
individual mouse; small horizontal lines indicate the mean (± s.e.m.). *P < 0.05, **P < 0.01
and ***P < 0.001 (Student's t-test). Data are representative of three independent experiments
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(a; n = 6 mice per group) or five independent experiments (d; n = 10–11 mice per group) or are
from two independent experiments (b,c; n = 2–3 mice per group) or five independent
experiments (e; n = 10 mice (Ltbr−/−) or 5 mice (Ifnar1−/−)).
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Figure 7-6: Notch2-dependent CD11b+ cDCs are essential for host defense against infection
with C. rodentium.
(a,b) Survival (a) and weight loss (b) of Batf3−/−, Notch2f/f and Notch2cKO mice (n = 9–10 per
group) orally inoculated with C. rodentium (2×109 colony-forming units). (c) C. rodentium titers
in the spleen (left) and colon (right) of mice (n = 6–7 per group) 9 d after inoculation as in a,
presented as colony-forming units (CFU). (d) Colon lengths in mice (n = 3 per group) 9 d after
infection

as

in a.

(e)

Hematoxylin-and-eosin

staining

of

colon

sections

from Notch2f/f and Notch2cKO mice (n = 6–7 per group) 9 d after infection as in a. Scale bars, 200
µm. (f) Histological scores of the sections in e (and similar sections from Batf3−/− mice). (g,h)
Survival (g) and weight loss (h) of mice (n = 8 (wild-type), 5 (Ccr7−/−, Batf2−/− and Batf2+/+) or 6
(Irf4−/−)) infected with C. rodentium as in a. *P < 0.05, **P < 0.01, ***P < 0.001 (log-rank
Mantel-Cox test (a,g), Student's t-test (b,h), one-way analysis of variance (ANOVA) with
Tukey's multiple-comparison test (c,d) or Kruskal-Wallis test with Dunn's multiple-comparison
test (f)). Data are from three independent experiments (a,b) or two independent experiments
(c,d,g,h) or are representative of two independent experiments (e,f; error bars (b–d,f,h), s.e.m.).
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Figure 7-7: Notch2-dependent cDCs are dispensable for colonic wound repair.
(a) Ptgs2 expression in various intestinal cell types, derived from the Immunological Genome
Project database55, assessed by microarray. (b) Whole-mount images of Notch2f/f and Notch2cKO
colonic wounds 6 d after excision (left), and quantification of epithelial coverage in individual
wound beds at day 6 after excision, assessed in whole-mount images (right). Outlined areas (left)
indicate the initial injury site. Scale bars (left), 1 mm. Each symbol (right) represents an
individual mouse (n = 6 per group); small horizontal lines indicate the mean (± s.e.m.). (c) Loss
of α-smooth muscle actin (SMA) underlying wound beds at day 6 after excision
from Notch2f/f, Notch2cKO and Batf3−/− mice, and from Notch2f/f mice treated with NS-398 (far
right), measured in histological sections (gap length / wound bed length). Each symbol
represents an individual mouse (n = 2–6 per group); small horizontal lines indicate the mean (±
s.e.m.). (d) Colonic sections from an untreated Notch2f/f mouse (left) or Notch2f/f mice treated
with NS-398 (5 µg/g; right), stained for β-catenin and α-smooth muscle actin (αSMA) and with
DAPI on day 2 (left) or day 6 (right) after excision (n = 2–3 mice per group). Scale bars, 200 µm.
(e) Colonic sections fromNotch2f/f, Notch2cKO and Batf3−/− mice (n = 3–6 per group) stained for
β-catenin, α-smooth muscle actin and F4/80 and with DAPI at 6 d after excision. Scale bars, 200
µm. Statistical results (b, right), Student's t-test. Data are from one experiment with two to four
replicate arrays (a; mean and s.e.m.) or two independent experiments (b,c) or are representative
of two independent experiments (d,e).
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Figure 7-8: Notch2-dependent CD11b+ cDCs regulate IL-23-dependent antimicrobial
responses to C. rodentium.
(a) Microarray analysis of gene expression in colonic cells from mice 9 d after infection with C.
rodentium, presented as M-plots. Colors indicate higher (red) or lower (blue) expression
in Notch2cKO cells (left) or Batf3−/− cells (right) than in Notch2f/f cells. (b,c) Expression of
selected inflammatory molecule–encoding genes from a with higher expression in Notch2cKO
(KO) mice than in Notch2f/f (f/f) mice (b), and expression of IL-22-stimulated genes2 (c). (d)
Quantitative RT-PCR analysis of Il22 and Reg3g mRNA in colons from Notch2f/f, Notch2cKO and
Batf3−/− mice (n = 6–7 per group) 9 d after infection with C. rodentium, presented in arbitrary
units (AU) relative to expression of the housekeeping gene Hprt. (e) Microarray analysis of gene
expression in colonic cells from Notch2f/f and Notch2cKO mice 4d after infection with C.
rodentium, presented as an M-plot (left), and hematoxylin-and-eosin staining of colons from
those mice (n = 4 per group; right). Scale bars (right), 100 µm. (f) Intracellular IL-22 expression
in ILCs obtained from the MLNs of uninfected Notch2f/f mice (UI) or Notch2f/f and Notch2cKO
mice (n = 4 per group) 4 d after infection with C. rodentium (day 4) and then stimulated ex
vivo with the phorbol ester PMA and ionomycin in the presence (+ IL-23) or absence (− IL-23)
of IL-23 (pregating, above plots). (g) Quantitative RT-PCR analysis of Il23a mRNA in CD11b+
cDCs (CD11c+MHCII+CD103+CD11b+) and macrophages (CD11c+MHCII−CD11b+F4/80+)
sorted from the lamina propria of wild-type uninfected mice (UI) or wild-type mice 2 d after
infection with C. rodentium (day 2), presented as in d (n = 3 mice per group). (h) Survival of
mixed chimeras (n = 5–6 per group) generated by the reconstitution of wild-type mice
with Il23a−/− bone marrow (Il23a−/− => WT), a mixture of Il23a−/− and Notch2cKO bone marrow
(Il23a−/−+Notch2cKO => WT) or Il23a−/− and Notch2f/f bone marrow (Il23a−/− + Notch2f/f => WT),
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or wild-type bone marrow (WT => WT), orally inoculated with 2×109 colony-forming units C.
rodentium 8–10 weeks after lethal irradiation and transplantation. ND, not detected. *P <
0.05, **P < 0.01 and ***P < 0.001 (one-way ANOVA with Tukey's multiple-comparison test
(d), Student's t-test (f) or log-rank Mantel-Cox test (h)). Data are from one experiment (a–c;
average of two to three biological replicates per sample), three independent experiments (d; bars,
s.e.m.), one experiment with two biological replicates per sample (e, left) or two independent
experiments (g,h; error bars (g), s.e.m.) or are representative of two independent experiments (e,
right, f).
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The absence of a microbiota enhances TSLP expression in
mice with defective skin barrier but does not affect the
severity of their allergic inflammation
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ABSTRACT
Evidence is accumulating to suggest that our indigenous microbial communities
(microbiota) may have a role in modulating allergic and immune disorders of the skin. To
examine the link between the microbiota and atopic dermatitis (AD), we examined a mouse
model of defective cutaneous barrier function with an AD-like disease due to loss of Notch
signaling. Comparisons of conventionally raised and germ-free (GF) mice revealed a similar
degree of allergic skin inflammation, systemic atopy, and airway hypersensitivity. GF mutant
animals expressed significantly higher levels of thymic stromal lymphopoietin, a major
proinflammatory cytokine released by skin with defective barrier function, resulting in a more
severe B-lymphoproliferative disorder that persisted into adulthood. These findings suggest a
role for the microbiota in ameliorating stress signals released by keratinocytes in response to
perturbation in cutaneous barrier function.
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INTRODUCTION
Atopic dermatitis (AD) is a common allergic disease that affects about 10% of children in
the United States and generally resolves by puberty (Spergel, 2010). However, up to 70% of
individuals with a history of AD go on to develop asthma and other atopic disorders later in life,
a phenomenon called the “atopic march” (Spergel and Paller, 2003; Spergel, 2010). AD flare-ups
are known to be associated with overgrowth of bacterial species, including Staphylococcus
aureus, in barrier-defective lesional skin (Boguniewicz and Leung, 2011; Kong et al., 2012).
Paradoxically, increased AD prevalence correlates with improvements in human hygiene in the
last century. One explanation for this correlation is that improved hygiene and increased use of
antibiotics have led to decreases in host exposure to microorganisms (Kalliomaki et al.,
2001; Umetsu et al., 2002; Yazdanbakhsh et al., 2002; Romagnani, 2004; Macia et al., 2012),
which may in turn alter immune responses leading to an increase in atopy.
In this study, we used a mouse model of AD generated by removing the floxed alleles
of RBPj, the DNA-binding partner of Notch, in the skin via expression of Msx2-Cre transgene
(Demehri et al., 2008; Dumortier et al., 2010). RBPj and Notch signaling are essential for
coordinating terminal differentiation of epidermal keratinocytes and for formation of a
competent

barrier

(Blanpain et

al.,

2006).

The Msx2-Cre transgene

(Demehri et

al.,

2008; Dumortier et al., 2010) deletes RBPjflox in a mosaic (calico) pattern along the back and
stomach of the mouse, allowing juxtaposed patches of RBPj-deficient and wild-type skin to be
compared and contrasted (Demehri et al., 2008). These mice exhibit many of the hallmarks of
AD including T helper (Th) 2–mediated skin inflammation, high serum IgE levels, and greater
susceptibility to asthma (Demehri et al., 2009; Dumortier et al., 2010). In addition, these mice
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develop a marked, transient B-cell expansion early in life and a myeloproliferative disorder in
adulthood (Demehri et al., 2008, 2009; Dumortier et al., 2010).
Epidermal-derived thymic stromal lymphopoietin (TSLP), an IL-7-like cytokine, is
responsible for driving inflammation, B-cell expansion, and allergen sensitization in these
animals (Demehri et al., 2009; Zhang et al., 2009; Han et al., 2012). Moreover, TSLP is both
necessary and sufficient to drive asthma in another mouse model, and it is upregulated in several
models displaying cutaneous barrier defects (Demehri et al., 2008; Comeau and Ziegler,
2010; Ziegler and Artis, 2010).
Germ-free (GF) mice are widely accepted as being an invaluable tool to characterize the
impact of indigenous microbial communities on host physiology. For example, comparisons of
GF mice and mice colonized with gut microbiota harvested from conventionally raised (CONVR) mouse donors that have been subjected to deliberately manipulated host and environmental
factors, or from human donors representing a variety of physiological or disease states, have
provided important insights about the causal relationship between the microbiota and obesity
(Turnbaugh et al., 2006; Turnbaugh et al., 2009; Liou et al., 2013), immune development
(Ivanov et al., 2009), metabolic syndrome (Vijay-Kumar et al., 2010), cardiovascular disease
(Wang et al., 2011), and severe acute malnutrition (Smith et al., 2013). To investigate the role
that indigenous microbes have in modulating local as well as systemic inflammation, we
generated GF Msx2-Cre/+; RBP-jflox/flox and wild-type littermate controls. GF status did not
affect allergic skin inflammation and asthma susceptibility in mutant or wild type mice contrary
to the prediction of the hygiene hypothesis. However, GF mutant mice produced significantly
higher levels of epidermal TSLP than their microbe-laden, CONV-R counterparts, leading to a
persistent expansion of immature B cells. These results suggest a role for indigenous microbial
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communities in controlling TSLP levels and helping mitigate some deleterious effects such as Blymphoproliferative disorder (B-LPD). They also highlight the role of the microbiota in
modulating cytokine production by keratinocytes.
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RESULTS
Morphogenesis and maintenance of the epidermis and hair follicle in GF mice is unaltered
To assess the contribution of indigenous microbial communities to the phenotypes
documented in our animals, we re-derived Msx2-Cre/+; RBPjflox/flox and wild-type littermate
control embryos into pseudo pregnant sterile dams using an embryo-transfer technique described
in an earlier publication (Faith et al, 2010). The GF status of the resulting mice was confirmed
by aerobic and anaerobic culture as well as by PCR assays targeting conserved regions of the
bacterial 16S rDNA gene. Skin morphology and histology in wild-type GF and CONV-R
animals were indistinguishable (Figure 8-1a and c). At postnatal day 9 (P9), Msx2-Cre/+;
RBPjflox/flox (RBPjCKO) mutant skin had a thickened epidermis, a highly cellular dermis and
hair-follicle-derived epidermal cysts (Figure 8-1a). These changes became more pronounced at
P30 (Figure 8-1c) and occurred independently of the presence or absence of the microbiota.
Immunocytochemical staining for filaggrin, involucrin, and keratin-14 revealed that GF and
CONV-R wild-type mice expressed these differentiation markers in the granular, spinous, and
basal epidermis, respectively (Figure 8-1b and d). Conversely, RBPjCKO mice showed
expansion of keratin-14 into suprabasal cells at P9 (Figure 8-1b). At P30, filaggrin and
involucrin expression overlapped, an indication of abnormal differentiation (Figure 8-1d). Transepidermal water loss measurements detected a barrier defect of similar magnitude in P9 GF and
CONV-R RBPjCKO mice (Supplementary Figure 8-S1 online). Collectively, these observations
indicate that morphological and functional characteristics of the skin and the dysfunction caused
by the absence of Notch signaling are not modulated by the microbiota. This allowed us to ask
whether the microbiota has a role in skin inflammation and atopy in the RBPjCKO model.
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Skin inflammation and AD-like disease persist in GF RBPjCKO mice
To better understand the role that indigenous microbial communities have in skin
inflammation and the systemic diseases associated with cytokine production by the skin with a
chronic barrier defect, we analyzed RBPjCKO mice at 10–13 weeks, the age at which the ADlike phenotype develops (Demehri et al., 2009; Dumortier et al., 2010). GF RBPjCKO mice
were morphologically and histologically indistinguishable from their CONV-R RBPjCKO
counterparts (Figure 8-2a), with all mice displaying the same macroscopic signature of AD,
including excoriation and scaling. Histological analysis of hematoxylin and eosin–stained
sections revealed similar levels of hyperkeratosis, parakeratosis, and acanthosis. Staining for
CD45 (a pan hematopoietic cell marker) and toluidine blue staining revealed similar levels of
skin inflammation and mast cell infiltration, respectively, in both GF and CONV-R animals
(Figure 8-2a and b). Tumor resistance and loss of mutant keratinocytes are TSLP and T cell–
dependent consequences of the severe inflammatory response that develops in RBPjCKO mice
over a period of 75–200 days (Demehri et al., 2012; Di Piazza et al., 2012). The absence of a
microbiota did not affect this inflammatory, Th2-mediated response.
Finally, systemic atopy, as measured by serum IgE levels, was also not significantly
different between the GF and CONV-R RBPjCKO mice (Figure 8-2c); effector/memory CD4+ T
cells (CD44hiCD62Llo) were elevated to similar levels in RBPjCKO mice in the spleen, skindraining lymph nodes, and mesenteric lymph nodes (Figure 8-2d and Supplementary Figure 8S2 online). RBPjCKO animals had higher percentages of FoxP3+ Treg cells among CD4+ T cells
compared with their wild-type littermates in the mesenteric and skin-draining lymph nodes, as
well as in the spleen (Figure 8-2e and Supplementary Figure 8-S2 online).
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GF RBPjCKO mice have elevated TSLP levels but similar asthma susceptibility
TSLP produced by the perturbed epidermis is a significant driver of skin inflammation
and many of the systemic effects in this mouse model (Demehri et al., 2008, 2009, 2012). Given
the similar degree of disruption of epidermal differentiation and cutaneous barrier function
(Figures 8-1 and 8-2, and Supplementary Figure 8-S1 online), we were surprised to find 2-fold
higher epidermal Tslp mRNA levels in the GF RBPjCKO mice compared with CONV-R
controls at P9 (P<0.05; n=6–10 mice/group; Figure 8-3a). Elevated Tslp mRNA levels in the
skin were associated with elevated serum TSLP levels at P9 and P30 (Figure 8-3b).
To determine whether the microbiota ameliorated the severity of asthma in CONV-R
mice, we subjected CONV-R and GF mice to ovalbumin (OVA) sensitization and intranasal
challenge. Wild-type GF and CONV-R littermates displayed similar mild responses to OVA
challenge (Figure 8-3c). Similarly, no significant differences in the severity of the asthmatic
response were detected between GF and CONV-R-RBPjCKO animals, as judged by lung
histology and total counts of leukocytes in lung washings obtained by bronchoalveolar lavage
(Figure 8-3d, e). These data suggest that although the microbiota might well regulate skin and
serum levels of TSLP in the absence of Notch signaling in the skin, the microbiota does not
modulate AD and asthma in this model.
GF RBPjCKO mice have elevated white blood cell counts and persistent B-cell expansion
Epidermal-derived TSLP directly drives B-LPD in newborns. B-LPD severity mirrors
TSLP levels early in life but is resolved after P30 despite persistently high TSLP levels
(Demehri et al., 2008). Myeloproliferative disorder (MPD) replaces B-LPD, persisting into
adulthood (Demehri et al., 2009; Dumortier et al., 2010). Surprisingly, white blood cell (WBC)
counts did not normalize in young (P30-P45) GF RBPjCKO animals (Figure 8-4a). At P80,
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WBC counts in GF RBPjCKO mice remained significantly higher than in CONV-R animals,
splenomegaly

was

more

severe

(Figure

8-4a–c),

B-cell

numbers

were

elevated

(CD45+B220+; Figure 8-4d), and T-cell numbers were unchanged (CD45+CD3+; Figure 8-4d) in
the blood. As previously reported, MPD in RBPjCKO animals coincided with an increase in
granulocyte colony-stimulating factor (G-CSF). Although G-CSF levels were significantly lower
in GF RBPjCKO mice (Figure 8-4f), MPD (CD45+Ly6G+) persisted to the same extent as it did
in CONV-R RBPjCKO animals (Figure 8-4d).
The hematocrit in both the GF and CONV-R RBPjCKO mice was significantly lower
than in their wild-type littermates (Figure 8-4h). We hypothesized that epidermal-derived TSLP
may drive a B-cell-mediated autoimmune hemolytic anemia (AIHA), which could cause low
hematocrit (Iseki et al., 2012). To test whether AIHA occurs in our mice, we measured the levels
of lactate dehyrogenase (LDH) and haptoglobin. In AIHA, release of LDH from lysed red blood
cells elevates its level in serum, and because haptoglobin binds to hemoglobin released from
lysed red blood cells, its level plummets (Tabbara, 1992). We detected no significant difference
in LDH levels between wild-type and RBPjCKO (Figure 8-4i, Supplementary Figure 8S3A online), and serum haptoglobin levels were significantly higher in both GF and CONV-R
RBPjCKO compared with wild-type mice (Figure 8-4j, Supplementary Figure 8-S3B online).
We concluded that it is unlikely that the anemia is due to AIHA. An alternative explanation for
the low hematocrit is that an expanded B-cell and granulocytic compartment may cause a
reactive contraction in other cell types without autoimmunity.
Analysis of P80 GF RBPjCKO mice identified both mature (B220+ CD23+ CD93–;
Supplementary Figure 8-S2 online) and immature (IgD– IgM+) B cells (Figure 8-4e). High levels
of TSLP in newborn GF RBPjCKO animals could affect neonatal B1 cell production dynamics
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or the activities of skin B1 cells in adults (Vosshenrich et al., 2004; Geherin et al., 2012).
Accordingly, we detected a significantly elevated level of resting anti-phosphorylcholine IgM,
most of which is made by B1 cells, in the sera of GF RBPjCKO mice (Figure 8-4g). This is not
solely a result of losing microbial antigens, as GF wild-type mice have significantly lower levels
of anti-phosphorylcholine IgM than their CONV-R counterparts (Figure 8-4g). Collectively,
these data establish that the microbiota has effects on B cells, but not T cells, in mice with
chronic cutaneous barrier defects.
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DISCUSSION
The role of indigenous microbial communities in skin development and function is only
beginning to be explored (Lai et al., 2009; Gallo and Nakatsuji, 2011; Grice and Segre,
2011; Naik et al., 2012). In this study, mice deficient in Notch signaling in their skin that
develop severe, chronic skin inflammation and systemic atopy were re-derived as germ free.
Morphologically and histologically, skin pathology was unaffected by the presence of a
microbiota, and lack of a microbiota did not modulate skin inflammation in these animals.
Surprisingly, despite these similarities, we observed an increase in the production of TSLP by the
skin and the amount of TSLP in the serum of GF animals. These results indicate that the
microbiota has a role in suppressing TSLP production in the barrier-defective skin.
TSLP is emerging as an essential cytokine in the development of allergic responses
(Yoo et al., 2005; Zhou et al., 2005; Demehri et al., 2009; Zhang et al., 2009; Han et al.,
2012; Jiang et al., 2012). Local TSLP expression in the skin is sufficient for the progression from
AD to asthma (Han et al., 2012). Consistent with the finding that TSLP is upregulated in
utero (Demehri et al., 2008), microbial products are not necessary to induce TSLP expression in
barrier-defective skin but may instead limit its expression level or duration.
In contrast to the transient B-LPD that is apparent in neonatal CONV-R RBPjCKO mice
and transitions to MPD in adulthood, both B-LPD and MPD persist to adulthood in GF animals
(Demehri et al., 2008). Previously, we proposed that fetal B cells are responsive to TSLP but
marrow-derived B cells are not (Demehri et al., 2008). The present study demonstrates that
marrow-derived B cells continue to be responsive to TSLP in GF mice. It is possible that in GF
mice, B-cell maturation is delayed or altered in the presence of TSLP, establishing a persistent
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B-LPD and expansion of B1 cells. One mechanistic explanation may relate to the lower G-CSF
levels that we document in GF RBPjCKO animals; G-CSF has been shown to suppress B cells in
the bone marrow (Dumortier et al., 2010; Winkler et al., 2012) and could thus contribute to
resolving B-LPD. These observations also indicate that the link between TSLP and G-CSF
(Dumortier et al., 2010) does not require the presence of a microbiota.
Despite an increase in TSLP and WBC counts, we see no evidence for a more severe
allergic disease in GF RBPjCKO animals. These findings do not support the hypothesis that
complete lack of a microbiota will create a runaway Th2-skewed immune response in this model,
but understanding the generality of this observation will depend on the results of similar
experiments with other AD models. While our findings clearly demonstrate that the microbiota
modulates expression of at least one proinflammatory cytokine in barrier-defective skin, a task
ahead is to identify which microbial species or species consortia from which body habitatassociated communities mediate these observed effects and through which signaling pathways.
Colonization of the GF mice we describe in this report with components of the skin and/or gut
microbiota should provide a path ahead for addressing these questions.
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EXPERIMENTAL PROCEDURES
Mice
All experiments involving mice were conducted using protocols approved by the Animal
Studies Committee of Washington University. Msx2-Cre/+; RBPjflox/flox (RBPjCKO) mice were
generated as previously described (Pan et al., 2004). GF mice were derived by embryo
extraction, sterilization, and transfer into a pseudo pregnant sterile dam (Faith et al., 2010) and
maintained in flexible film gnotobiotic isolators under a strict 12-h light cycle on a standard plant
polysaccharide–rich low-fat chow diet fed ad libitum (B&K Universal; England, UK).
Maintenance of GF status in the colony was confirmed using culture-independent methods (i.e.,
negative PCR assays of fecal DNA using universal primers directed against bacterial 16S rRNA
genes), or culture-based approaches (culturing feces in brain heart infusion broth, nutrient broth,
or Sabouraud dextrose broth under anaerobic conditions). We analyzed age- and sex- matched
GF wild-type littermates and their CONV-R siblings (i.e., mice derived from the same founders
but reared in a mouse barrier facility in a specified pathogen-free state, and acquiring microbes
from their environment beginning at birth).
OVA treatment
Airway challenge was performed on GF and CONV-R mice as outlined previously
(Zhou et al., 2005). Six- to 8-week-old female mice were sensitized by intraperitoneal injection
of 250  µl of a solution containing 50  µg OVA (Sigma A5503; St Louis, MO) dissolved in
phosphate-buffered saline and 1.3  mg aluminum hydroxide gel (Sigma) on experimental days 1
(d1) and d14. Mice were challenged intranasally with 150  µg of OVA dissolved in 40  µl of
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phosphate-buffered saline on d21, d22, and d23. Controls were given the same regimen without
the addition of OVA antigen. Mice were killed on d24.
Histology, immunohistochemistry, and immunofluorescence
After killing, lungs were inflated with 4% paraformaldehyde at 25  cm water pressure.
Dorsal skin and lung tissues were fixed in 4% paraformaldehyde overnight, dehydrated in
ethanol and embedded in paraffin. Five-µm thick sections were used for all analyses. To assess
inflammation and skin morphology, sections were stained with hematoxylin and eosin or
toluidine blue. Mast cell infiltration in the skin was quantified by counting the average number of
toluidine blue positive cells in three randomly selected microscopic fields at 200x magnification.
Paraffin embedded sections were rehydrated and stained with biotinlylated anti-keratin 14 (clone
LL002, Neomarkers), chick anti-filaggrin, and rabbit anti-involucrin, and antigen-antibody
complexes were visualized with Cy5-conjugated streptavidin, Cy3-conjugated anti-rabbit Ig, and
Alexa488-conjugated anti-chicken Ig (all from Jackson ImmunoResearch Laboratory). CD45
staining was performed as previously described (Demehri et al., 2012).
Bronchoalveolar and WBC analyses
Bronchoalveolar fluid was collected by infusing 1  ml of phosphate-buffered saline into
the lung at killing using a Surflo catheter (Terumo Medical; Somerset, NJ) (Demehri et al.,
2009). Bronchoalveolar fluid was spun down, the cell pellet was stained with Giemsa, and at
least 100 cells were counted to determine the differential leukocyte cell counts. Blood was
diluted 1:1 with 10  mM EDTA in phosphate-buffered saline, and total white blood cell count and
hematocrit were measured using a Hemavet 950 analyzer (Drew Scientific; Waterbury, CT).
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Serology
Serum IgE was determined using Mouse IgE ELISA (Immunology Consultants
Laboratory, Portland, OR). Serum TSLP and G-CSF levels were measured using Mouse TSLP
ELISA (Biolegend; San Diego, CA) and Mouse G-CSF ELISA (R&D Systems; Minneapolis,
MN), respectively. Serum anti-phosphorylcholine IgM was measured by coating 96-well flatbottom EIA/RIA plates (Costar; Tewksbury, MA) overnight at 4  °C with 2  µg  ml−1 of PC-BSA
and performing ELISA assays (Foote and Kearney, 2009). To test for hemolytic anemia, serum
LDH was determined using LDH cytotoxicity assay (Cayman Chemical Company; Ann Arbor,
MI), and serum haptoglobin was measured using Mouse Haptoglobin Elisa Test Kit (Life
Diagnostics; West Chester, PA).
Flow cytometry
This method was applied to single-cell suspensions prepared from spleen, skin-draining
lymph nodes, or mesenteric lymph nodes. Cells were surface stained with the reagents listed
in Supplementary

Materials

and

Methods,

fixed

overnight

at

4  °C

using

FoxP3

fixation/permabilization buffer (eBioscience; San Diego, CA), and stained intracellularly using
FoxP3 Permeabilization buffer as per the manufacturer’s instructions. Samples were acquired on
a BD FACS can or BD LSR II flow cytometer. Data were analyzed using FlowJo software
(TreeStar; Ashland, OR).
PCR and quantitative real-time reverse-transcriptase–PCR
To genotype mice, PCR was performed on DNA extracted from toes (Demehri et al.,
2009). For gene expression analysis, mice were euthanized on P9, the skin was removed and
placed on dry ice. The epidermis was scraped off using a scalpel, homogenized, and RNA was
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isolated using RNeasy Mini Kit (Qiagen; Germantown, MD). cDNA was generated using
Superscrpipt RT-II kit (Invitrogen; Grand Island, NY). Quantitative real-time reversetranscriptase–PCR was performed for mouse Tslp and Hprt mRNA (control) as previously
described (Leeet al., 2007; Demehri et al., 2008).
Statistical analysis
An unpaired Student’s t-test was used to test statistical significance; P<0.05 was
considered significant. Mean values±SEM are presented in all graphs.
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Wild Type
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Figure 8-1: Epidermal and hair follicle structure are unaffected in germ-free (GF) mice
compared with their conventionally raised (CONV-R) counterparts.
Hematoxylin and eosin (H&E) staining at (a) P9 and (c) P30 shows skin morphology and
inflammation levels in GF and CONV-R RBPjCKO and wild-type mice. Bar, 50  µm.
Immunocytochemical staining for keratin-14 (K14), involucrin (INV), and filaggrin (FLG) at (b)
P9 and (d) P30 shows skin architecture in GF and CONV-R wild-type and RBPjCKO animals.
Both GF and CONV-R RBPjCKO animals exhibit similar barrier defects. Bar, 10  µm.
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Figure 8-2: Skin inflammation and atopic dermatitis (AD)–like disease persists in germfree (GF) RBPjCKO animals. (a) Conventionally raised (CONV-R) and GF P80 mice. Scale
bar, 1  cm. Hematoxylin and eosin (H&E), CD45 immunohistochemistry, and toluidine blue
staining reveal skin inflammation and mast cell infiltration in both CONV-R and GF wild-type
(Wt) and RBPjCKO (Mut) mice. Bar, 50  µm. (b) Quantification of mast cells viewed in three
randomly selected microscopic fields at × 200 (CONV-R Wt, n=4; CONV-R Mut, n=15; GF Wt,
n=4; GF Mut, n=15). (c) Serum IgE levels in P80 Wt mice (CONV-R, n=10; GF, n=6) and
RBPjCKO animals (CONV-R, n=23; GF, n=23). (d) Flow cytometry gated on CD4+ T cells in
the spleen to detect effector (CD44hi CD62Llo) and naive (CD44lo CD62Lhi) cells in
RBPjCKO (CONV-R, n=9; GF, n=9) and Wt mice (CONV-R, n=4; GF, n=4). A compilation of
results from four independent experiments is shown. (e) Flow cytometry gated on CD4+ T cells
detects regulatory T cells (Treg, Foxp3+) in RPBjCKO (GF and CONV-R, n=6) and Wt mice
(CONV-R and GF, n=3). A compilation of three independent experiments is shown. Asterisks
mark statistical significance; *P<0.05, **P<0.01, ***P<0.001 (unpaired Student’s t-test).
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Figure 8-3: Asthma in germ-free (GF) RBPjCKO mice is not more severe but thymic
stromal lymphopoietin (TSLP) levels are higher than in their conventionally raised
(CONV-R) counterparts. (a) Tslp mRNA levels in P9 CONV-R wild-type (Wt; n=6), CONV-R
RBPjCKO (n=7), GF Wt (n=10), and GF RBPjCKO (n=10) mice. (b) Serum TSLP levels in P9
RBPjCKO (CONV-R, n=7; GF, n=10), P30 (CONV-R, n=7; GF, n=14), and P80 (CONV-R,
n=19; GF, n=24). (c) Hematoxylin and eosin staining of the lungs after ovalbumin (OVA)
challenge at 6–8 weeks shows increased inflammatory infiltrate (arrows) in the RBPjCKO mice.
Bar, 50  µm. (d) White blood cell count in bronchial alveolar lavage fluid (BAL) of Wt (CONVR, n=6; GF, n=10) and RBPjCKO (CONV-R, n=8; GF, n=8) mice. (e) The percentage of
eosinophils, macrophages, lymphocytes, or neutrophils in BAL from RBPjCKO (CONV-R,
n=11; GF, n=9) or Wt (CONV-R, n=3; GF, n=4) mice. The differences between RBPjCKO and
wild-type animals remain evident in a GF state. *P<0.05, **P<0.01, ***P<0.001 (unpaired
Student’s t-test). PBS, phosphate-buffered saline.
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Figure 8-4: B-cell expansion persists in germ-free (GF) RBPjCKO animals. (a) White blood
cell (WBC) counts in P30 RBPjCKO mice (conventionally raised (CONV-R), n=7; GF, n=14)
and P80 (CONV-R, n=33; GF, n=43). (b–c) Spleen size mirrored WBC levels, reported as a
percentage of body weight (wild-type (Wt), CONV-R n=13; GF, n=19; Mut CONV-R, n=34;
GF, n=43). Bar, 1  cm. (d) B-cell (B220+ CD45+), myeloid (Ly6G+), and T cell (CD3+)
expansion in 10- to 12-week-old mice, quantified by flow cytometry (Wt CONV-R, n=5; GF,
n=4; RBPjCKO CONV-R, n=13, GF, n=12). (e) The percentage of immature B220+ cells (IgM+
IgDlo) in GF RPBjCKO animals. Data compiled from five independent experiments (Wt CONVR, n=5, GF, n=4; RBPjCKO CONV-R and GF, n=11). (f) Granulocyte colony-stimulating factor
(G-CSF) levels in serum from GF and CONV-R mice (Wt CONV-R, n=5, GF, n=10; RBPjCKO
CONV-R, n=11; GF n=14). (g) Anti-phosphorylcholine (anti-PC) IgM levels (Wt CONV-R,
n=6; GF, n=10; RBPjCKO CONV-R, n=9; GF n=12). (h) RBPjCKO mice show lower
hematocrit than Wt counterparts (Wt CONV-R, n=13; GF, n=17; RBPjCKO CONV-R, n=34; GF
n=43). (i) Serum lactate dehyrogenase (LDH) levels (Wt CONV-R and GF, n=6; RBPjCKO
CONV-R and GF, n=12). (j) Serum haptoglobin levels (Wt CONV-R and GF, n=6; RBPjCKO
CONV-R and GF, n=12). *P<0.05, **P<0.01, ***P<0.001 (unpaired Student’s t-test).
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